Cover
Cover - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Feb. 23, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2023 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 1-4347 | ||
Entity Registrant Name | ROGERS CORP | ||
Entity Incorporation, State or Country Code | MA | ||
Entity Tax Identification Number | 06-0513860 | ||
Entity Address, Address Line One | 2225 W. Chandler Blvd. | ||
Entity Address, City or Town | Chandler | ||
Entity Address, State or Province | AZ | ||
Entity Address, Postal Zip Code | 85224-6155 | ||
City Area Code | 480 | ||
Local Phone Number | 917-6000 | ||
Title of 12(b) Security | Capital Stock, | ||
Entity Trading Symbol | ROG | ||
Security Exchange Name | NYSE | ||
Entity Well-known Season Filer | Yes | ||
Entity Voluntary Filer | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 3,007,177,815 | ||
Entity Common Stock, Shares Outstanding | 18,655,088 | ||
Documents Incorporated by Reference | Documents Incorporated by Reference Portions of the Registrant’s definitive Proxy Statement related to the 2024 Annual Meeting of Shareholders are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. The Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the Registrant’s fiscal year ended December 31, 2023. | ||
Entity Central Index Key | 0000084748 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2023 | |
Audit Information [Abstract] | |
Auditor Name | PricewaterhouseCoopers LLP |
Auditor Location | Phoenix, Arizona |
Auditor Firm ID | 238 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Net sales | $ 908.4 | $ 971.2 | $ 932.9 |
Cost of sales | 601.3 | 650.2 | 583.8 |
Gross margin | 307.1 | 321 | 349.1 |
Selling, general and administrative expenses | 202.3 | 218.8 | 193.1 |
Research and development expenses | 35.7 | 35.2 | 29.9 |
Restructuring and impairment charges | 16.9 | 66.6 | 3.6 |
Other operating (income) expense, net | (33.1) | (144) | 5.3 |
Operating income | 85.3 | 144.4 | 117.2 |
Equity income in unconsolidated joint ventures | 1.8 | 4.4 | 7 |
Other income (expense), net | (0.7) | 1.1 | 4.6 |
Interest expense, net | (10.1) | (9.5) | (2.5) |
Income before income tax expense | 76.3 | 140.4 | 126.3 |
Income tax expense | 19.7 | 23.8 | 18.2 |
Net income | $ 56.6 | $ 116.6 | $ 108.1 |
Basic earnings per share (in dollars per share) | $ 3.04 | $ 6.21 | $ 5.77 |
Diluted earnings per share (in dollars per share) | $ 3.03 | $ 6.15 | $ 5.73 |
Shares used in computing: | |||
Basic earnings per share (in shares) | 18.6 | 18.8 | 18.7 |
Diluted earnings per share (in shares) | 18.7 | 19 | 18.9 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 56.6 | $ 116.6 | $ 108.1 |
Foreign currency translation adjustment | 18.8 | (40) | (25) |
Actuarial net gain (loss) incurred, net of tax (Note 2) | (0.4) | (0.2) | (0.8) |
Pension settlement charges, net of tax (Note 2) | 0.1 | 0 | 0 |
Amortization of loss, net of tax (Note 2) | 0.3 | 0.2 | 0.2 |
Other comprehensive income (loss) | 18.8 | (40) | (25.6) |
Comprehensive income | $ 75.4 | $ 76.6 | $ 82.5 |
CONSOLIDATED STATEMENTS OF FINA
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash and cash equivalents | $ 131.7 | $ 235.9 |
Accounts receivable, less allowance for credit losses of $1.1 and $1.0 | 161.9 | 177.4 |
Contract assets | 45.2 | 38.9 |
Inventory, Net | 153.5 | 182.4 |
Asbestos-related insurance receivables, current portion | 4.3 | 3.9 |
Other current assets | 30.3 | 21.4 |
Total current assets | 526.9 | 659.9 |
Property, plant and equipment, net of accumulated depreciation of $385.7 and $381.6 | 366.3 | 358.4 |
Operating lease right-of-use assets | 18.9 | 13 |
Goodwill | 359.8 | 352.4 |
Other intangible assets, net of amortization | 123.9 | 133.7 |
Asbestos-related insurance receivables, non-current portion | 52.2 | 55.9 |
Investments in unconsolidated joint ventures | 11.1 | 14.1 |
Deferred income taxes | 49.7 | 50.6 |
Other long-term assets | 8.4 | 8.2 |
Total assets | 1,517.2 | 1,646.2 |
Current liabilities | ||
Accounts payable | 50.3 | 57.3 |
Accrued employee benefits and compensation | 31.1 | 34.2 |
Accrued income taxes payable | 2 | 5.5 |
Operating lease obligations, current portion | 3.5 | 2.8 |
Asbestos-related liabilities, current portion | 5.5 | 5 |
Other accrued liabilities | 24 | 37.7 |
Total current liabilities | 116.4 | 142.5 |
Borrowings under revolving credit facility | 30 | 215 |
Operating lease obligations, non-current portion | 15.4 | 10.7 |
Asbestos-related liabilities, non-current portion | 56 | 60.1 |
Non-current income tax | 7.2 | 10 |
Deferred income taxes | 22.9 | 23.6 |
Other long-term liabilities | 10.3 | 11.8 |
Commitments and contingencies (Note 6 and Note 10) | ||
Shareholders’ equity | ||
Capital stock - $1 par value; 50.0 authorized shares; 18.6 and 18.6 shares issued and outstanding, respectively | 18.6 | 18.6 |
Additional paid-in capital | 151.8 | 140.7 |
Retained earnings | 1,155 | 1,098.4 |
Accumulated other comprehensive loss | (66.4) | (85.2) |
Total shareholders' equity | 1,259 | 1,172.5 |
Total liabilities and shareholders' equity | $ 1,517.2 | $ 1,646.2 |
CONSOLIDATED STATEMENTS OF FI_2
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - USD ($) shares in Millions, $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Allowance for credit losses | $ 1.1 | $ 1 |
Accumulated depreciation | $ 385.7 | $ 381.6 |
Capital Stock, par value (in dollars per share) | $ 1 | $ 1 |
Capital Stock, authorized shares (in shares) | 50 | 50 |
Capital Stock, shares issued (in shares) | 18.6 | 18.6 |
Capital Stock, shares outstanding (in shares) | 18.6 | 18.6 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions | Total | Capital Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss |
Balance, beginning of period at Dec. 31, 2020 | $ 18.7 | $ 148 | $ 873.7 | $ (19.6) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Shares issued for vested restricted stock units, net of shares withheld for taxes | 0 | (2.9) | |||
Shares repurchased | 0 | 0 | |||
Other capital stock activity | 0 | ||||
Other additional paid-in capital activity | 1.5 | ||||
Equity compensation expense | 17 | ||||
Net income | $ 108.1 | 108.1 | |||
Other comprehensive income (loss) | (25.6) | (25.6) | |||
Balance, end of period at Dec. 31, 2021 | 1,118.9 | 18.7 | 163.6 | 981.8 | (45.2) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Shares issued for vested restricted stock units, net of shares withheld for taxes | 0.1 | (10.9) | |||
Shares repurchased | (25) | (0.2) | (24.8) | ||
Other capital stock activity | 0 | ||||
Other additional paid-in capital activity | 1 | ||||
Equity compensation expense | 11.8 | ||||
Net income | 116.6 | 116.6 | |||
Other comprehensive income (loss) | (40) | (40) | |||
Balance, end of period at Dec. 31, 2022 | 1,172.5 | 18.6 | 140.7 | 1,098.4 | (85.2) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Shares issued for vested restricted stock units, net of shares withheld for taxes | 0 | (3.2) | |||
Shares repurchased | 0 | 0 | |||
Other capital stock activity | 0 | ||||
Other additional paid-in capital activity | 0 | ||||
Equity compensation expense | 14.3 | ||||
Net income | 56.6 | 56.6 | |||
Other comprehensive income (loss) | 18.8 | 18.8 | |||
Balance, end of period at Dec. 31, 2023 | $ 1,259 | $ 18.6 | $ 151.8 | $ 1,155 | $ (66.4) |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Activities: | |||
Net income | $ 56.6 | $ 116.6 | $ 108.1 |
Adjustments to reconcile net income to cash provided by operating activities: | |||
Depreciation and amortization | 51.1 | 45.9 | 43.3 |
Equity compensation expense | 14.3 | 11.8 | 17 |
Deferred income taxes | (3.6) | (20.6) | (3.2) |
Equity in undistributed income of unconsolidated joint ventures | (1.8) | (4.4) | (7) |
Dividends received from unconsolidated joint ventures | 4.3 | 4.7 | 5 |
Gain on sale of business | (0.7) | 0 | 0 |
(Gain) loss on sale or disposal of property, plant and equipment | (2.6) | 0.5 | (0.9) |
Impairment charges | 0 | 65.1 | 0.5 |
UTIS fire fixed asset and inventory write-offs | 0 | 0.2 | 1.9 |
Other non-cash charges (benefits), net | 0.6 | 0.2 | (0.5) |
Changes in assets and liabilities: | |||
Accounts receivable | (10.8) | (32.3) | (26.2) |
Proceeds from insurance related to operations | 25.6 | 1.2 | 0.4 |
Contract assets | (5.9) | (3.9) | (10) |
Inventories, net | 28.3 | (51.6) | (34.4) |
Other current assets | 4.2 | (6.3) | 1.7 |
Accounts payable and other accrued expenses | (26.6) | (8.8) | 36.5 |
Other, net | (1.6) | 11.2 | (7.8) |
Net cash provided by operating activities | 131.4 | 129.5 | 124.4 |
Investing Activities: | |||
Acquisition of business, net of cash received | 0 | (3.6) | (168.2) |
Disposition of business | 1.7 | 0 | 0 |
Capital expenditures | (57) | (116.8) | (71.1) |
Proceeds from the sale of property, plant and equipment, net | 5.6 | 0 | 0.7 |
Proceeds from insurance claims | 1.8 | 7.3 | 0 |
Net cash used in investing activities | (47.9) | (113.1) | (238.6) |
Financing Activities: | |||
Proceeds from borrowings under revolving credit facility | 0 | 100 | 190 |
Repayment of debt principal and finance lease obligations | (185.4) | (75.3) | (29.6) |
Line of credit issuance costs | (1.7) | 0 | 0 |
Payments of taxes related to net share settlement of equity awards | (3.2) | (10.8) | (2.9) |
Proceeds from issuance of shares to employee stock purchase plan | 0 | 1 | 1.5 |
Share repurchases | 0 | (25) | 0 |
Net cash (used in) provided by financing activities | (190.3) | (10.1) | 159 |
Effect of exchange rate fluctuations on cash | 2.6 | (2.7) | (4.3) |
Net increase (decrease) in cash and cash equivalents | (104.2) | 3.6 | 40.5 |
Cash and cash equivalents at beginning of period | 235.9 | 232.3 | 191.8 |
Cash and cash equivalents at end of period | 131.7 | 235.9 | 232.3 |
Supplemental Disclosures: | |||
Accrued capital additions | 5.9 | 6.7 | 10.9 |
Cash paid during the year for: | |||
Interest, net of amounts capitalized | 10.4 | 9.7 | 2.4 |
Income taxes, net of refunds | $ 6.9 | $ 60.8 | $ 33.8 |
Basis of Presentation, Organiza
Basis of Presentation, Organization and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation, Organization and Summary of Significant Accounting Policies | Basis of Presentation, Organization and Summary of Significant Accounting Policies As used herein, the terms “Company,” “Rogers,” “we,” “us,” “our” and similar terms mean Rogers Corporation and its consolidated subsidiaries, unless the context indicates otherwise. Principles of Consolidation The consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries, after elimination of intercompany balances and transactions. The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Organization Our reporting structure is comprised of three operating segments: AES, EMS and Other. Advanced Electronics Solutions Our AES operating segment designs, develops, manufactures and sells circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in EV/HEV, automotive (e.g., ADAS), aerospace and defense (e.g., antenna systems, communication systems and phased array radar systems), renewable energy (e.g., wind and solar), wireless infrastructure (e.g., power amplifiers, antennas and small cells), mass transit, industrial (e.g., variable frequency drives), connected devices (e.g., mobile internet devices and thermal solutions) and wired infrastructure (e.g., computing and internet protocol infrastructure) markets. We believe these materials have characteristics that offer performance and other functional advantages in many market applications, which serve to differentiate our products from other commonly available materials. AES products are sold globally to converters, fabricators, distributors and OEMs. Trade names for our AES products include: curamik ® , ROLINX ® , RO4000 ® Series, RO3000 ® Series, RT/duroid ® , CLTE Series ® , TMM ® , AD Series ® , DiClad ® Series, CuClad ® Series, Kappa ® , COOLSPAN ® , TC Series ® , IsoClad ® Series, MAGTREX ® , IM Series™, 2929 Bondply, SpeedWave ® Prepreg, RO4400™/RO4400T™ Series and Radix™. As of December 31, 2023, our AES operating segment had manufacturing and administrative facilities in Chandler, Arizona; Rogers, Connecticut; Bear, Delaware; Eschenbach, Germany; Evergem, Belgium; Budapest, Hungary; and Suzhou, China. Elastomeric Material Solutions Our EMS operating segment designs, develops, manufactures and sells engineered material solutions for a wide variety of applications and markets. These include polyurethane and silicone materials used in cushioning, gasketing and sealing, and vibration management applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense, footwear and impact mitigation markets; customized silicones used in flex heater and semiconductor thermal applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense and medical markets; polytetrafluoroethylene and ultra-high molecular weight polyethylene materials used in wire and cable protection, electrical insulation, conduction and shielding, hose and belt protection, vibration management, cushioning, gasketing and sealing, and venting applications for EV/HEV, general industrial, automotive and aerospace and defense markets. We believe these materials have characteristics that offer functional advantages in many market applications, which serve to differentiate our products from other commonly available materials. EMS products are sold globally to converters, fabricators, distributors and OEMs. Trade names for our EMS products include: PORON ® , BISCO ® , DeWAL ® , ARLON ® , eSorba ® , XRD ® , Silicone Engineering and R/bak ® . As of December 31, 2023, our EMS operating segment had manufacturing and administrative facilities in Rogers, Connecticut; Woodstock, Connecticut; Bear, Delaware; Carol Stream, Illinois; Narragansett, Rhode Island; Evergem, Belgium; Blackburn, England; Siheung, South Korea; and Suzhou, China. We also own 50% of two unconsolidated joint ventures: (1) RIC, a joint venture established in Japan to design, develop, manufacture and sell PORON ® products predominantly for the Japanese market and (2) RIS, a joint venture established in China to design, develop, manufacture and sell PORON ® products primarily for RIC customers in various Asian countries. INOAC Corporation owns the remaining 50% of both RIC and RIS. RIC has manufacturing facilities at the INOAC facilities in Nagoya and Mie, Japan, and RIS has manufacturing facilities at Rogers’ facilities in Suzhou, China. Other Our Other operating segment consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets. We sell our elastomer components under our ENDUR ® trade name and our floats under our NITROPHYL ® trade name. Summary of Significant Accounting Policies Cash and Cash Equivalents Highly liquid investments with original maturities of three months or less are considered cash and cash equivalents. These investments are stated at cost, which approximates fair value Restricted cash is subject to contractual restrictions and not readily available. Our restricted cash balance recorded in cash and cash equivalents, totaled $2.2 million as of December 31, 2023 and 2022, serves as collateral for letters of credit related to our environmental and workers’ compensation liabilities. Foreign Currency All balance sheet accounts of foreign subsidiaries are translated or remeasured at exchange rates in effect at each year end, and income statement items are translated using the average exchange rates for the year. Translation adjustments for those entities that operate under a local currency are recorded directly to a separate component of shareholders’ equity, while remeasurement adjustments for those entities that operate under the parent’s functional currency are recorded in the “Other income (expense), net” line item in the consolidated statements of operations. Currency transaction gains and losses are recorded as income or expense, respectively, in the “Other income (expense), net” line item in the consolidated statements of operations. Such adjustments resulted in gains of $1.1 million, losses of $1.7 million and gains of $3.0 million in 2023, 2022 and 2021, respectively. Accounts Receivable Our accounts receivable, net of allowance for credit losses line item in the consolidated statements of financial position include trade receivables, insurance receivables, tax receivables and other miscellaneous receivables. As of December 31, 2023 and 2022, our trade receivables balances, net of allowance for credit losses, were $143.2 million and $149.2 million, respectively. Allowance for Credit Losses The allowance for credit losses is determined based on a variety of factors that affect the potential collectability of the related receivables, including the length of time receivables are past due, customer credit ratings, financial stability of customers, specific one-time events and past customer history. In addition, in circumstances where we are made aware of a specific customer’s inability to meet its financial obligations, a specific allowance is established. The majority of accounts are individually evaluated on a regular basis and appropriate reserves are established as deemed appropriate based on the criteria previously mentioned. The remainder of the reserve is based on our estimates and takes into consideration historical trends, market conditions and the composition of our customer base. Inventories Inventories are stated at the lower of cost or net realizable value with costs determined primarily on a first-in, first-out (FIFO) basis. We record allowances for estimated losses due to excess, obsolete and slow-moving inventory that is determined for groups of products based on purchases in the recent past and/or expected future demand, as well as market conditions, design cycles and other economic factors. Abnormal amounts of idle facility expense and waste are not capitalized in inventory. The allocation of fixed production overheads to the inventory cost is based on the normal capacity of the production facilities. Property, Plant and Equipment Property, plant and equipment are stated on the basis of cost. For financial reporting purposes, provisions for depreciation are calculated on a straight-line basis over the following estimated useful lives of the underlying assets: Property, Plant and Equipment Classification Estimated Useful Lives Buildings and improvements 30-40 years Machinery and equipment 5-15 years Office equipment 3-10 years Software Costs We capitalize certain internal and external costs of computer software developed or obtained for internal use, principally related to software coding, software configuration, designing system interfaces and installation and testing of the software. We amortize capitalized internal use software costs using the straight-line method over the estimated useful lives of the software, generally from three Leases The Company determines whether an arrangement is a lease at contract inception by establishing if the contract conveys the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. Lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of all minimum lease payments over the lease term. We use an incremental borrowing rate representative of our ability to borrow on a collateralized basis over a similar lease term. Lease terms may include options to extend or terminate the lease. These options are included in the lease term when it is reasonably certain that we will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. We have elected the following policy elections on adoption: separating lease and non-lease components, exclusion of short-term leases on the balance sheet and recognition of lease payments for short-term leases in the consolidated statements of operations on a straight-line basis. Goodwill and Other Intangible Assets We have made acquisitions over the years that included the recognition of intangible assets. Intangible assets are classified into three categories: (1) goodwill; (2) other intangible assets with definite lives subject to amortization; and (3) other intangible assets with indefinite lives not subject to amortization. Other intangible assets can include items such as trademarks and trade names, licensed technology, customer relationships and covenants not to compete, among other things. Each definite-lived other intangible asset is amortized over its respective economic useful life using the economic attribution method. Goodwill is evaluated for impairment annually, and between annual impairment assessments if events or changes in circumstances indicate the carrying value may be impaired, by first performing a qualitative assessment to determine whether a quantitative goodwill impairment assessment is necessary. If it is determined, based on qualitative factors, the fair value of the reporting unit may be more likely than not less than its carrying amount or if significant changes to macro-economic factors related to the reporting unit have occurred that could materially impact fair value, a quantitative goodwill impairment assessment would be required. We can elect to forgo the qualitative assessment and perform a quantitative assessment. The quantitative assessment compares the fair value of a reporting unit with its carrying amount. The application of the quantitative assessment requires significant judgment, including the assignment of assets and liabilities to reporting units and determination of the fair value of each reporting unit. Determining the fair value is subjective and requires the use of significant estimates and assumptions, including financial projections for net sales, gross margin and operating margin, discount rates, terminal growth rates and future market conditions, among others. When performing the quantitative assessment, we have historically estimated the fair value of our reporting units using an income approach based on the present value of future cash flows through a five-year discounted cash flow analysis. Upon performing the quantitative assessment, if the carrying value of the reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess, not to exceed the carrying amount of goodwill. We currently have four reporting units with goodwill: RF Solutions, EMS, curamik ® and Elastomer Components Division (ECD). Consistent with historical practice, the annual impairment test on these reporting units was performed as of November 30, 2023. In 2023, we elected to utilize a qualitative assessment. There were no impairment charges resulting from our goodwill impairment assessment for the year ended December 31, 2023. Our RF Solutions, EMS, curamik ® and ECD reporting units had allocated goodwill of $51.7 million, $239.9 million, $66.0 million and $2.2 million, respectively, as of December 31, 2023. Indefinite-lived other intangible assets are evaluated for impairment annually, and between annual impairment assessments if events or changes in circumstances indicate the carrying value may be impaired, by first performing a qualitative assessment to determine whether a quantitative indefinite-lived other intangible asset impairment assessment is necessary. If it is determined, based on qualitative factors, the fair value of the indefinite-lived other intangible asset may be more likely than not less than its carrying amount or if significant changes to macro-economic factors related to the indefinite-lived other intangible asset have occurred that could materially impact fair value, a quantitative indefinite-lived other intangible asset impairment assessment would be required. We can elect to forgo the qualitative assessment and perform a quantitative assessment. The quantitative assessment compares the fair value of the indefinite-lived other intangible asset with its carrying amount. The application of the quantitative assessment requires significant judgment, including determining the fair value of each indefinite-lived other intangible asset. Fair value is primarily based on income approaches using discounted cash flow models, which have significant assumptions. Such assumptions are subject to variability from year to year and are directly impacted by global market conditions. There were no impairment charges resulting from our indefinite-lived other intangible assets impairment assessment for the year ended December 31, 2023. Our curamik ® reporting unit had an indefinite-lived other intangible asset of $4.3 million as of December 31, 2023. Definite-lived other intangible assets are tested for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable. The recoverability test involves comparing the estimated sum of the undiscounted cash flows for each definite-lived other intangible asset to its respective carrying value. If a definite-lived other intangible asset’s carrying value is greater than the sum of its undiscounted cash flows, then the definite-lived other intangible asset’s carrying value is compared to its estimated fair value and an impairment charge is recognized for the excess and charged to operations. The application of the recoverability test requires significant judgment, including the identification of the asset group and determination of undiscounted cash flows and fair value of the underlying definite-lived other intangible asset. Determination of undiscounted cash flows requires the use of significant estimates and assumptions, including certain financial projections. Fair value is primarily based on income approaches using discounted cash flow models, which have significant assumptions. Such assumptions are subject to variability from year to year and are directly impacted by global market conditions. There were no impairment charges ® reporting units had definite-lived other intangible assets of $0.9 million, $115.3 million and $3.4 million, respectively, as of December 31, 2023. The useful life determination for each indefinite-lived other intangible asset is evaluated each reporting period to determine whether events and circumstances support an indefinite useful life. The useful life determination for each definite-lived other intangible asset is evaluated each reporting period to determine whether events and circumstances warrant a revision to the remaining period of amortization. Pension and Other Postretirement Benefits We sponsor one material defined benefit pension plan, the Rogers Corporation Employees’ Pension Plan (the Union Plan), which covers certain union employees, and we sponsor multiple fully insured or self-funded medical plans and fully insured life insurance plans for retirees. The Union Plan was frozen in 2013 so that future benefits no longer accrue. The costs and obligations associated with these plans are dependent upon various actuarial assumptions used in calculating such amounts. These assumptions include discount rates, long-term rates of return on plan assets, mortality rates, and other factors. The assumptions used in these models are determined as follows: (i) the discount rate used is based on the PruCurve bond index; (ii) the long-term rate of return on plan assets is determined based on historical portfolio results, market conditions and our expectations of future returns; and (iii) the mortality rate is based on a mortality projection that estimates current longevity rates and their impact on the long-term plan obligations. We determine these assumptions based on consultation with outside actuaries and investment advisors. Any changes in these assumptions could have a significant impact on our assets and liabilities. We review these assumptions periodically throughout the year and update as necessary. We are required, as an employer, to: (a) recognize in the consolidated statements of financial position an asset for a plan’s overfunded status or a liability for a plan’s underfunded status; (b) measure a plan’s assets and a plan’s obligations that determine our funded status as of the end of the year; and (c) recognize changes in the funded status of a defined benefit plan in the year in which the changes occur and report these changes in accumulated other comprehensive loss. Additionally, actuarial losses (gains) that are not immediately recognized as net periodic pension cost (credit) are recognized as a component of accumulated other comprehensive loss (income) and amortized into net periodic pension cost (credit) in future periods. Investments were stated at fair value as of the dates reported. Securities traded on a national securities exchange were valued at the last reported sales price on the last business day of the plan year. Fixed-income bonds were valued using price evaluations provided by independent pricing services. The fair value of the guaranteed deposit account was determined through discounting expected future investment cash flow from both investment income and repayment of principal for each investment purchased. The estimated fair values of the participation units owned by the plan in pooled separate accounts were based on quoted redemption values and adjusted for management fees and asset charges, as determined by the recordkeeper, on the last business day of the relevant plan year. Pooled separate accounts are accounts established solely for the purpose of investing the assets of one or more plans. Funds in a separate account are not commingled with other Company assets for investment purposes. Environmental and Product Liabilities We accrue for our environmental investigation, remediation, operating and maintenance costs when it is probable that a liability has been incurred and the amount can be reasonably estimated. For environmental matters, the most likely cost to be incurred is accrued based on an evaluation of currently available facts with respect to each individual site, including existing technology, current laws and regulations and prior remediation experience. For sites with multiple potential responsible parties (PRPs), we consider our likely proportionate share of the anticipated remediation costs and the ability of the other parties to fulfill their obligations in establishing a provision for those costs. When no amount within a range of estimates is more likely to occur than another, we accrue to the low end of the range and disclose the range. When future liabilities are determined to be reimbursable by insurance coverage, an accrual is recorded for the potential liability and a receivable is recorded for the estimated insurance reimbursement amount. We are exposed to the uncertain nature inherent in such remediation and the possibility that initial estimates will not reflect the final outcome of a matter. We review our asbestos-related projections annually in the fourth quarter of each year unless facts and circumstances materially change during the year, at which time we would analyze these projections. We believe the assumptions made on the potential exposure and expected insurance coverage are reasonable at the present time, but are subject to uncertainty based on the actual future outcome of our asbestos litigation. Our estimates of asbestos-related contingent liabilities and related insurance receivables are based on a claim projection analysis and an insurance usage analysis prepared annually by third parties. The claim projection analysis contains numerous assumptions, including number of claims that might be received, the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, dismissal rates, average indemnity costs, average defense costs, costs of medical treatment, the financial resources of other companies that are co-defendants in claims, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, and the impact of potential changes in legislative or judicial standards, including potential tort reform. Furthermore, any predictions with respect to these assumptions are subject to even greater uncertainty as the projection period lengthens. The insurance usage analysis considers, among other things, applicable deductibles, retentions and policy limits, the solvency and historical payment experience of various insurance carriers, the likelihood of recovery as estimated by external legal counsel and existing insurance settlements. We believe the assumptions used in our models for determining our potential exposure and related insurance coverage are reasonable at the present time, but such assumptions are inherently uncertain. Given the inherent uncertainty in making projections, we plan to re-examine periodically the assumptions used in the projections of current and future asbestos claims, and we will update them, if needed, based on our experience, changes in the assumptions underlying our models, and other relevant factors, such as changes in the tort system. Our accrued asbestos liabilities may not approximate our actual asbestos-related indemnity and defense costs, and our accrued insurance recoveries may not be realized. We believe that it is reasonably possible that we may incur additional charges for our asbestos liabilities and defense costs in the future that could exceed existing reserves and insurance recoveries. Investments in Unconsolidated Joint Ventures We account for our investments in and advances to unconsolidated joint ventures, both of which are 50% owned, using the equity method of accounting. Fair Value of Financial Instruments Management believes that the carrying values of financial instruments, including cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value based on the maturities of these instruments. The fair value of our borrowings under our revolving credit facility are determined using discounted cash flows based upon our estimated current interest cost for similar type borrowings or current market value, which falls under Level 2 of the fair value hierarchy. Based on our credit characteristics as of December 31, 2023, borrowings would generally bear interest at SOFR plus 162.5 basis points. As the current borrowings under the Fifth Amended Credit Agreement bear interest at adjusted 1-month SOFR plus 162.5 basis points, we believe the carrying value of our borrowings approximates fair value. For additional information on the calculation of fair value measurements, refer to “Note 3 – Derivatives and Hedging.” Derivative Financial Instruments and Hedging Transactions We are exposed to certain risks related to our ongoing business operations, and, from time to time, we manage these risk exposures by utilizing derivative financial instruments. We do not utilize derivative financial instruments for trading or speculative purposes. The primary risks being managed through our use of derivative instruments are foreign currency exchange rate risk and commodity pricing risk (primarily related to copper). To qualify for hedge accounting treatment, derivatives used for hedging purposes must be designated and deemed effective as a hedge of the identified underlying risk exposure at the inception of the contract. Accordingly, changes in fair value of the derivative contract must be highly correlated with changes in the fair value of the underlying hedged item at inception of the hedge and over the life of the hedge contract. For those derivative instruments that qualify for hedge accounting treatment, if the hedge is highly effective, all changes in the fair value of the derivative hedging instrument are recorded as a component of “Other comprehensive income (loss)” in the consolidated statements of comprehensive income, with the derivative hedging instrument impacts being reclassified to earnings when the hedged item impacts earnings. For those derivative instruments that do not qualify for hedge accounting treatment, any related gains and losses are recognized as a component of “Other income (expense), net” in the consolidated statements of operations. For additional information, refer to “Note 3 – Derivatives and Hedging.” Concentration of Credit and Investment Risk We extend credit on an uncollateralized basis to almost all customers. Concentration of credit and geographic risk with respect to accounts receivable is limited due to the large number and general dispersion of accounts that constitute our customer base. We routinely perform credit evaluations on our customers. As of December 31, 2023 and 2022, there were no customers that individually accounted for more than 10% of total accounts receivable. We did not experience significant credit losses on customers’ accounts in 2023, 2022 or 2021. We are subject to credit and market risk by using derivative instruments. If a counterparty fails to fulfill its performance obligations under a derivative contract, our credit risk will equal the fair value of the derivative instrument. We seek to minimize counterparty credit (or repayment) risk by entering into derivative transactions with major financial institutions with investment grade credit ratings. We invest excess cash principally in investment grade government securities and time deposits. We have established guidelines relative to diversification and maturities in order to maintain safety and liquidity. These guidelines are periodically reviewed and modified to reflect changes in market conditions. Income Taxes We are subject to income taxes in the U.S. and in numerous foreign jurisdictions. We account for income taxes following ASC 740, Income Taxes , recognizing deferred tax assets and liabilities using enacted tax rates for the effect of temporary differences between book and tax basis of recorded assets and liabilities. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some or all of a deferred tax asset will not be realized. We record benefits for uncertain tax positions based on an assessment of whether it is more likely than not that the tax positions will be sustained by the taxing authorities. If this threshold is not met, no tax benefit of the uncertain position is recognized. If the threshold is met, we recognize the largest amount of the tax benefit that is greater than fifty percent likely to be realized upon ultimate settlement. We recognize interest and penalties within the “Income tax expense” line item in the consolidated statements of operations. Accrued interest and penalties are included within the related tax liability line item in the consolidated statements of financial position. Revenue Recognition Recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the providing entity expects to be entitled in exchange for those goods or services. We recognize revenue when all of the following criteria are met: (1) we have entered into a binding agreement, (2) the performance obligations have been identified, (3) the transaction price to the customer has been determined, (4) the transaction price has been allocated to the performance obligations in the contract, and (5) the performance obligations have been satisfied. The majority of our shipping terms permit us to recognize revenue at point of shipment. Some shipping terms require the goods to be cleared through customs or be received by the customer before title passes. In those instances, revenue is not recognized until either the customer has received the goods or they have passed through customs, depending on the circumstances. Shipping and handling costs are treated as fulfillment costs. Sales tax or VAT are excluded from the measurement of the transaction price. We manufacture some products to customer specifications which are customized to such a degree that it is unlikely that another entity would purchase these products or that we could modify these products for another customer. These products are deemed to have no alternative use to the Company whereby we have an enforceable right to payment evidenced by contractual termination clauses. In accordance with ASC 606, for those circumstances we recognize revenue on an over-time basis. Revenue recognition does not occur until the product meets the definition of “no alternative use” and therefore, items that have not yet reached that point in the production process are not included in the population of items with over-time revenue recognition. As appropriate, we record estimated reductions to revenue for customer returns, allowances, and warranty claims. Provisions for such reductions are made at the time of sale and are typically derived from historical trends and other relevant information. Earnings Per Share Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding. Equity Compensation Equity compensation mainly consists of expense related to restricted stock units and deferred stock units. Performance-based restricted stock unit compensation expense is based on achievement of both market and service conditions. The fair value of these awards is determined based on a Monte Carlo simulation valuation model on the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period with no changes for final projected payout of the awards. Time-based restricted stock unit compensation expense is based on the achievement of only service conditions. The fair value of these awards is determined based on the market value of the underlying stock price on the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period. Deferred stock units, which are granted to non-management directors, are fully vested on the date of grant and the related shares are generally issued on the 13-month anniversary of the grant date unless the director elects to defer the receipt of those shares. The fair value of the |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive Loss The changes in accumulated other comprehensive loss by component for each of the fiscal years in the two-year period ended December 31, 2023 were as follows: (Dollars and accompanying footnotes in millions) Foreign Currency Translation Adjustments Pension and Other Postretirement Benefits (1) Total Balance as of December 31, 2021 $ (35.6) $ (9.6) $ (45.2) Other comprehensive income (loss) before reclassifications (40.0) (0.2) (40.2) Amounts reclassified to earnings — 0.2 0.2 Net other comprehensive income (loss) for period (40.0) — (40.0) Balance as of December 31, 2022 (75.6) (9.6) (85.2) Other comprehensive income (loss) before reclassifications 18.8 (0.4) 18.4 Amounts reclassified to earnings — 0.4 0.4 Net other comprehensive income (loss) for period 18.8 — 18.8 Balance as of December 31, 2023 $ (56.8) $ (9.6) $ (66.4) (1) Net of taxes of $1.8 million, $1.9 million and $2.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. The impacts to the consolidated statements of operations related to items reclassified to earnings were as follows: Years Ended December 31, (Dollars in millions) Financial Statement Line Item 2023 2022 Amortization/settlement of pension and other postretirement benefits Pension settlement charges (1) (0.1) — Other income (expense), net (1) (0.4) (0.4) Income tax (expense) benefit 0.1 0.2 Net income $ (0.4) $ (0.2) (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension cost. For additional details, refer to “Note 8 – Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plan.” |
Derivatives and Hedging
Derivatives and Hedging | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Derivatives and Hedging | Derivatives and Hedging The valuation of our derivative contracts used to manage their respective risks is described below: • Foreign Currency – The fair value of any foreign currency option derivative is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics. • Commodity – The fair value of copper derivatives is computed using a combination of intrinsic and time value valuation models, which are collectively a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate and volatility. The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end. The time value valuation model incorporates changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative instrument’s strike price and the remaining time to the underlying copper derivative instrument’s expiration date from the period end date. As of December 31, 2023, we did not have any derivative contracts that qualified for hedge accounting treatment. Foreign Currency In 2023, we entered into U.S. dollar, euro, Korean won, and Japanese yen forward contracts. We entered into these foreign currency forward contracts to mitigate certain global transactional exposures. These contracts do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in the “Other income (expense), net” line item in the consolidated statements of operations in the period in which the adjustment occurred. As of December 31, 2023, the notional values of these foreign currency forward contracts were as follows: Notional Values of Foreign Currency Derivatives USD/CNH $ 25,900,000 KRW/USD ₩ 1,291,700,000 EUR/USD € 12,600,000 JPY/EUR ¥ 250,000,000 Commodity As of December 31, 2023, we had 12 outstanding contracts to hedge exposure related to the purchase of copper in our AES operating segment. These contracts are held with financial institutions and are intended to offset rising copper prices and do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in the “Other income (expense), net” line item in the con solidated statements of operations in the period in which the adjustment occurred. As of December 31, 2023, the volume of our copper contracts outstanding were as follows: Volume of Copper Derivatives January 2024 - March 2024 69 metric tons per month April 2024 - June 2024 69 metric tons per month July 2024 - September 2024 69 metric tons per month October 2024 - December 2024 69 metric tons per month Effects on Financial Statements The following table presents the impact from these instruments on the consolidated statements of operations and consolidated statements of comprehensive income: Years Ended December 31, (Dollars in millions) Financial Statement Line Item 2023 2022 2021 Foreign Currency Contracts Contracts not designated as hedging instruments Other income (expense), net $ 1.0 $ (0.3) $ (2.9) Copper Derivatives Contracts Contracts not designated as hedging instruments Other income (expense), net $ (0.6) $ 0.8 $ 3.9 The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. • Level 1 – Quoted prices in active markets for identical assets or liabilities. • Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The fair values of derivative instruments measured at fair value on a recurring basis, categorized by contract type and level of inputs used in the valuation, were as follows: Derivative Instruments at Fair Value as of December 31, 2023 (Dollars in millions) Level 1 Level 2 Level 3 Total (1) Foreign currency contracts $ — $ (0.2) $ — $ (0.2) Copper derivative contracts $ — $ 0.4 $ — $ 0.4 Derivative Instruments at Fair Value as of December 31, 2022 (Dollars in millions) Level 1 Level 2 Level 3 Total (1) Foreign currency contracts $ — $ (0.1) $ — $ (0.1) Copper derivative contracts $ — $ 0.5 $ — $ 0.5 (1) All balances were recorded in the “Other current assets” or the “Other accrued liabilities” line items in the consolidated statements of financial position. |
Inventories, net
Inventories, net | 12 Months Ended |
Dec. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Inventories, net | Inventories, net The “Inventories, net” line item in the consolidated statements of financial position consisted of the following: As of December 31, (Dollars in millions) 2023 2022 Raw materials $ 71.5 $ 87.9 Work-in-process 45.6 45.1 Finished goods 36.4 49.4 Total inventories, net $ 153.5 $ 182.4 |
Property, Plant and Equipment
Property, Plant and Equipment | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | Property, Plant and Equipment The “Property, plant and equipment, net” line item in the consolidated statements of financial position consisted of the following: As of December 31, (Dollars in millions) 2023 2022 Land and improvements $ 16.8 $ 23.9 Buildings and improvements 177.2 169.5 Machinery and equipment 343.0 334.1 Office equipment 70.7 61.5 Property plant and equipment, gross 607.7 589.0 Accumulated depreciation (385.7) (381.6) Property, plant and equipment, net 222.0 207.4 Construction in process 144.3 151.0 Total property, plant and equipment, net $ 366.3 $ 358.4 Depreciation expense was $37.7 million, $29.5 million and $29.0 million in 2023, 2022 and 2021, respectively. Additionally, we recognized $47.2 million and $0.5 million of impairment charges in 2022 and 2021, respectively. For additional information related to the impairment charges, refer to “ Note 14 – Supplemental Financial Information. ” |
Leases
Leases | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Leases | Leases Finance Leases Amortization expense related to our finance lease right-of-use assets, which is primarily included in the “Cost of sales” line item of the consolidated statements of operations, was immaterial for each of the years ended December 31, 2023, 2022 and 2021. Interest expense related to our finance lease obligations, which is included in the “Interest expense, net” line item of the consolidated statements of operations, was immaterial for each of the years ended December 31, 2023, 2022 and 2021. Payments made on the principal portion of our finance lease obligations were immaterial for each of the years ended December 31, 2023, 2022 and 2021. Operating Leases We have operating leases primarily related to manufacturing and R&D facilities, as well as vehicles. Our expenses and payments for operating leases were as follows: Year Ended December 31, (Dollars in millions) 2023 2022 2021 Operating leases expense $ 4.1 $ 2.8 $ 3.0 Short-term leases expense $ 0.7 $ 0.6 $ 0.3 Payments on operating lease obligations $ 4.0 $ 3.1 $ 2.8 Lease Balances in Statements of Financial Position The assets and liabilities balances related to finance and operating leases reflected in the consolidated statements of financial position were as follows: As of December 31, (Dollars in millions) Financial Statement Line Item 2023 2022 Finance lease right-of-use assets Property, plant and equipment, net $ 1.5 $ 1.7 Operating lease right-of-use assets Operating lease right-of-use assets $ 18.9 $ 13.0 Finance lease obligations, current portion Other accrued liabilities $ 0.4 $ 0.5 Finance lease obligations, non-current portion Other long-term liabilities $ 1.1 $ 1.3 Total finance lease obligations $ 1.5 $ 1.8 Operating lease obligations, current portion Operating lease obligations, current portion $ 3.5 $ 2.8 Operating lease obligations, non-current portion Operating lease obligations, non-current portion $ 15.4 $ 10.7 Total operating lease obligations $ 18.9 $ 13.5 Net Future Minimum Lease Payments The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of December 31, 2023: Finance Operating (Dollars in millions) Leases Signed Less: Leases Not Yet Commenced Leases in Effect Leases Signed Less: Leases Not Yet Commenced Leases in Effect 2024 $ 0.4 $ — $ 0.4 $ 4.4 $ — $ 4.4 2025 0.4 — 0.4 3.9 (0.1) 3.8 2026 0.4 — 0.4 3.1 (0.1) 3.0 2027 0.2 — 0.2 2.6 — 2.6 2028 0.1 — 0.1 1.9 — 1.9 Thereafter 0.1 — 0.1 7.3 — 7.3 Total lease payments 1.6 — 1.6 23.2 (0.2) 23.0 Less: Interest (0.1) — (0.1) (4.1) — (4.1) Present Value of Net Future Minimum Lease Payments $ 1.5 $ — $ 1.5 $ 19.1 $ (0.2) $ 18.9 The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments: 2023 2022 Weighted Average Remaining Lease Term Finance leases 4.0 years 4.6 years Operating leases 7.0 years 6.5 years Weighted Average Discount Rate Finance leases 4.14% 3.89% Operating leases 5.35% 5.24% |
Leases | Leases Finance Leases Amortization expense related to our finance lease right-of-use assets, which is primarily included in the “Cost of sales” line item of the consolidated statements of operations, was immaterial for each of the years ended December 31, 2023, 2022 and 2021. Interest expense related to our finance lease obligations, which is included in the “Interest expense, net” line item of the consolidated statements of operations, was immaterial for each of the years ended December 31, 2023, 2022 and 2021. Payments made on the principal portion of our finance lease obligations were immaterial for each of the years ended December 31, 2023, 2022 and 2021. Operating Leases We have operating leases primarily related to manufacturing and R&D facilities, as well as vehicles. Our expenses and payments for operating leases were as follows: Year Ended December 31, (Dollars in millions) 2023 2022 2021 Operating leases expense $ 4.1 $ 2.8 $ 3.0 Short-term leases expense $ 0.7 $ 0.6 $ 0.3 Payments on operating lease obligations $ 4.0 $ 3.1 $ 2.8 Lease Balances in Statements of Financial Position The assets and liabilities balances related to finance and operating leases reflected in the consolidated statements of financial position were as follows: As of December 31, (Dollars in millions) Financial Statement Line Item 2023 2022 Finance lease right-of-use assets Property, plant and equipment, net $ 1.5 $ 1.7 Operating lease right-of-use assets Operating lease right-of-use assets $ 18.9 $ 13.0 Finance lease obligations, current portion Other accrued liabilities $ 0.4 $ 0.5 Finance lease obligations, non-current portion Other long-term liabilities $ 1.1 $ 1.3 Total finance lease obligations $ 1.5 $ 1.8 Operating lease obligations, current portion Operating lease obligations, current portion $ 3.5 $ 2.8 Operating lease obligations, non-current portion Operating lease obligations, non-current portion $ 15.4 $ 10.7 Total operating lease obligations $ 18.9 $ 13.5 Net Future Minimum Lease Payments The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of December 31, 2023: Finance Operating (Dollars in millions) Leases Signed Less: Leases Not Yet Commenced Leases in Effect Leases Signed Less: Leases Not Yet Commenced Leases in Effect 2024 $ 0.4 $ — $ 0.4 $ 4.4 $ — $ 4.4 2025 0.4 — 0.4 3.9 (0.1) 3.8 2026 0.4 — 0.4 3.1 (0.1) 3.0 2027 0.2 — 0.2 2.6 — 2.6 2028 0.1 — 0.1 1.9 — 1.9 Thereafter 0.1 — 0.1 7.3 — 7.3 Total lease payments 1.6 — 1.6 23.2 (0.2) 23.0 Less: Interest (0.1) — (0.1) (4.1) — (4.1) Present Value of Net Future Minimum Lease Payments $ 1.5 $ — $ 1.5 $ 19.1 $ (0.2) $ 18.9 The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments: 2023 2022 Weighted Average Remaining Lease Term Finance leases 4.0 years 4.6 years Operating leases 7.0 years 6.5 years Weighted Average Discount Rate Finance leases 4.14% 3.89% Operating leases 5.35% 5.24% |
Goodwill and Other Intangible A
Goodwill and Other Intangible Assets | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill for the period ending December 31, 2023, by operating segment, were as follows: (Dollars in millions) Advanced Electronics Solutions Elastomeric Material Solutions Other Total December 31, 2022 $ 115.4 $ 234.8 $ 2.2 $ 352.4 Foreign currency translation adjustment 2.3 5.1 — 7.4 December 31, 2023 $ 117.7 $ 239.9 $ 2.2 $ 359.8 Other Intangible Assets The carrying amount of other intangible assets were as follows: December 31, 2023 December 31, 2022 (Dollars in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Customer relationships $ 177.9 $ 90.0 $ 87.9 $ 178.6 $ 85.6 $ 93.0 Technology 77.4 58.1 19.3 82.4 59.1 23.3 Trademarks and trade names 19.4 7.4 12.0 19.1 6.6 12.5 Covenants not to compete 1.3 0.9 0.4 1.9 1.2 0.7 Total definite-lived other intangible assets 276.0 156.4 119.6 282.0 152.5 129.5 Indefinite-lived other intangible asset 4.3 — 4.3 4.2 — 4.2 Total other intangible assets $ 280.3 $ 156.4 $ 123.9 $ 286.2 $ 152.5 $ 133.7 In the table above, gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations. Amortization expense was $13.4 million, $16.4 million and $14.3 million in 2023, 2022 and 2021, respectively. Additionally, in 2022, we impaired $17.9 million of customer relationships, technology and trademarks and trade names definite-lived other intangible assets related to our high-performance engineered cellular elastomer business. For additional information related to the impairment charges, refer to “ Note 14 – Supplemental Financial Information. ” The estimated annual future amortization expense is $12.4 million, $10.8 million, $10.4 million, $10.0 million and $7.8 million in 2024, 2025, 2026, 2027 and 2028, respectively. These amounts could vary based on changes in foreign currency exchange rates. The weighted average amortization period as of December 31, 2023, by definite-lived other intangible asset class, is presented in the table below: Definite-Lived Other Intangible Asset Class Weighted Average Remaining Amortization Period Customer relationships 7.4 years Technology 3.3 years Trademarks and trade names 10.0 years Covenants not to compete 0.5 years Total definite-lived other intangible assets 7.0 years |
Pension Benefits, Other Postret
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans | 12 Months Ended |
Dec. 31, 2023 | |
Retirement Benefits [Abstract] | |
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plan | Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plan Pension and Other Postretirement Benefits Pension and Other Postretirement Benefit Plans As of December 31, 2023, we had one qualified noncontributory defined benefit pension plan: the Union Plan. Additionally, we sponsor non-qualified noncontributory defined benefit pension plans and postretirement benefit plans including multiple fully insured or self-funded medical plans and life insurance plans for certain retirees. The measurement date for all plans is December 31 st for each respective plan year. Plan Assets and Plan Benefit Obligations The following table summarizes the change in plan assets and changes in benefit obligations: Pension Benefits Other Postretirement Benefits (Dollars in millions) 2023 2022 2023 2022 Change in plan assets: Fair value of plan assets as of January 1 $ 26.3 $ 33.5 $ — $ — Actual return on plan assets 1.9 (5.6) — — Settlement (0.3) — — — Employer contributions 0.3 — — — Benefit payments (1.5) (1.6) — — Fair value of plan assets as of December 31 $ 26.7 $ 26.3 $ — $ — Change in plan benefit obligations: Fair value of plan benefit obligations as of January 1 $ 21.3 $ 28.7 $ 1.4 $ 1.4 Service cost — — 0.1 0.1 Interest cost 1.1 0.7 0.1 — Actuarial (gain) loss 0.8 (6.6) — (0.1) Settlement (0.3) — — — Benefit payments (1.5) (1.5) — — Fair value of plan benefit obligations as of December 31 $ 21.4 $ 21.3 $ 1.6 $ 1.4 Amount overfunded (underfunded) $ 5.3 $ 5.0 $ (1.6) $ (1.4) The increase in our pension plan benefit obligations in 2023 was primarily driven by actuarial losses and interest costs, partially offset by benefit payments and settlements. The decrease in our pension plan benefit obligations in 2022 was primarily driven by actuarial gains and benefit payments, partially offset by interest costs. The pension-related balances reflected in the consolidated statements of financial position consisted of the following: Pension Benefits Other Postretirement Benefits As of December 31, As of December 31, (Dollars in millions) 2023 2022 2023 2022 Assets & Liabilities: Non-current assets $ 5.3 $ 5.2 $ — $ — Current liabilities — — (0.2) (0.2) Non-current liabilities — (0.2) (1.4) (1.2) Net assets (liabilities) $ 5.3 $ 5.0 $ (1.6) $ (1.4) Accumulated Other Comprehensive Loss: Net actuarial (loss) gain $ (11.6) $ (11.8) $ 0.2 $ 0.2 Accumulated other comprehensive (loss) income $ (11.6) $ (11.8) $ 0.2 $ 0.2 The PBO, ABO, and fair value of plan assets for our pension plan with plan assets in excess of its PBO or ABO were as follows: (Dollars in millions) 2023 2022 Projected benefit obligation $ 21.5 $ 21.0 Accumulated benefit obligation $ 21.5 $ 21.0 Fair value of plan assets $ 26.7 $ 26.3 The PBO and ABO of plan assets for our other postretirement benefit plans with a PBO or ABO in excess of plan assets were as follows: (Dollars in millions) 2023 2022 Projected benefit obligation $ (1.6) $ (1.4) Accumulated benefit obligation $ (1.6) $ (1.4) Fair value of plan assets $ — $ — The PBO, ABO, and fair value of plan assets for our pension plan with a PBO or ABO in excess of its plan assets were immaterial as of December 31, 2023 and 2022. Components of Net Periodic Benefit Cost (Credit) The components of net periodic benefit cost (credit) were as follows: Pension Benefits Other Postretirement Benefits Years Ended December 31, Years Ended December 31, (Dollars in millions) 2023 2022 2021 2023 2022 2021 Service cost $ — $ — $ — $ 0.1 $ 0.1 $ 0.1 Interest cost 1.1 0.7 0.7 0.1 — — Expected return of plan assets (1.4) (1.3) (1.5) — — — Amortization of prior service credit — — — — — (0.1) Amortization of net loss (gain) 0.5 0.4 0.4 — — — Settlement 0.1 — — — — — Net periodic benefit cost (credit) $ 0.3 $ (0.2) $ (0.4) $ 0.2 $ 0.1 $ — Plan Assumptions The key plan assumptions utilized in our annual plan measurements were as follows: Pension Benefits Other Postretirement Benefits 2023 2022 2023 2022 Weighted average assumptions used in benefit obligations: Discount rate 4.75 % 5.25 % 4.75 % 5.00 % Weighted average assumptions used in net periodic benefit costs: Discount rate 5.25 % 2.75 % 5.00 % 2.25 % Expected long-term rate of return on assets 5.59 % 4.17 % — % — % For measurement purposes as of December 31, 2023, we assumed an annual health care cost trend rate of 7.00% for covered health care benefits for retirees pre-age 65 or post-age 65. For measurement purposes as of December 31, 2022, we assumed an annual health care cost trend rate of 6.25% for covered health care benefits for retirees pre-age 65 or post-age 65. Our pension plan assets are invested with the objective of achieving a total rate of return over the long-term that is sufficient to fund future pension obligations. In managing these assets and our investment strategy, we consider future cash contributions to the plan as well as the potential of the portfolio underperforming the market. We set asset allocation target ranges based on current funding status and future projections in order to mitigate the portfolio performance risk while maintaining its funded status. Fixed income securities comprise a substantial percentage of our plan assets portfolio. As of December 31, 2023, we held approximately 90% fixed income and short-term cash securities and 10% equity securities in our portfolio, compared to December 31, 2022 when we held approximately 91% fixed income and short-term cash securities and 9% equity securities. In determining our investment strategy and calculating the net benefit cost, we utilized an expected long-term rate of return on plan assets, which was developed based on several factors, including the plans’ asset allocation targets, the historical and projected performance on those asset classes, as well as the plan’s current asset composition. To justify our assumptions, we analyzed certain data points related to portfolio performance. Based on the historical returns and the projected future returns, we determined that a target return of 5.22% is appropriate for the current portfolio. The following table presents the fair value of the pension plan net assets by asset category and level, within the fair value hierarchy, as of December 31, 2023 and 2022: Fair Value of Plan Assets as of December 31, 2023 (Dollars in millions) Level 1 Level 2 Level 3 Total Fixed income bonds $ 0.2 $ 22.3 $ — $ 22.5 Mutual funds 3.0 — — 3.0 Pooled separate accounts — 0.1 — 0.1 Guaranteed deposit account — — 1.1 1.1 Total plan assets at fair value $ 3.2 $ 22.4 $ 1.1 $ 26.7 Fair Value of Plan Assets as of December 31, 2022 (Dollars in millions) Level 1 Level 2 Level 3 Total Fixed income bonds $ — $ 22.2 $ — $ 22.2 Mutual funds 2.5 — — 2.5 Pooled separate accounts — 0.5 — 0.5 Guaranteed deposit account — — 1.1 1.1 Total plan assets at fair value $ 2.5 $ 22.7 $ 1.1 $ 26.3 The following table presents a summary of changes in the fair value of the guaranteed deposit account’s Level 3 assets for the year ended December 31, 2023: (Dollars in millions) Guaranteed Deposit Account Balance as of December 31, 2022 $ 1.1 Change in unrealized gain (loss) — Purchases, sales, issuances and settlements (net) — Balance as of December 31, 2023 $ 1.1 Cash Flows We were not required to make any contributions to our qualified noncontributory defined benefit pension plan in 2023 and 2022. We made expected benefit payments for our qualified noncontributory defined benefit pension plan through the utilization of plan assets in 2023 and 2022. As there is no funding requirement for the non-qualified noncontributory defined benefit pension plans and other postretirement benefit plans, we funded benefit payments, which were immaterial in 2023 and 2022, as incurred using cash from operations. The benefit payments are based on the same assumptions used to measure our benefit obligations as of December 31, 2023. The following table sets forth the expected benefit payments to be paid for our pension plans and our other postretirement benefit plans: (Dollars in millions) Pension Benefits Other Postretirement Benefits 2024 $ 1.7 $ 0.2 2025 $ 1.7 $ 0.2 2026 $ 1.7 $ 0.2 2027 $ 1.7 $ 0.2 2028 $ 1.6 $ 0.1 2029-2033 $ 7.6 $ 0.8 Employee Savings and Investment Plan We sponsor the RESIP, a 401(k) plan for domestic employees. In 2023, employees could defer an amount they choose, up to the annual IRS limit of $22,500. Certain eligible participants are also allowed to contribute the maximum catch-up contribution per IRS regulations. We match each eligible employee’s annual pre-tax contributions at a rate of 100% for the first 1% of the employee’s salary and 50% for the next 5% of each employee’s salary for a total match of 3.5%. Unless otherwise indicated by the participant, the matching dollars are invested in the same funds as the participant’s contributions. RESIP related expense amounted to $4.6 million, $11.8 million and $5.6 million in 2023, 2022 and 2021, respectively. The higher expense in 2022 was primarily due to a $6.5 million discretionary RESIP contribution related to the previously anticipated merger with DuPont. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt | Debt In October 2020, we entered into the Fourth Amended Credit Agreement. The Fourth Amended Credit Agreement amended and restated the Third Amended Credit Agreement, and provided for a revolving credit facility with up to a $450.0 million borrowing capacity, with sublimits for multicurrency borrowings, letters of credit and swing-line notes, in addition to a $175.0 million accordion feature. Borrowings may have been used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Fourth Amended Credit Agreement). The Fourth Amended Credit Agreement extended the maturity, the date on which all amounts borrowed or outstanding under the Fourth Amended Credit Agreement were due, from February 17, 2022 to March 31, 2024. All obligations under the Fourth Amended Credit Agreement were guaranteed by each of our existing and future material domestic subsidiaries, as defined in the Fourth Amended Credit Agreement (the Guarantors). The obligations were also secured by a Fourth Amended and Restated Pledge and Security Agreement, dated as of February 17, 2022, entered into by us and the Guarantors which granted to the administrative agent, for the benefit of the lenders, a security interest, subject to certain exceptions, in substantially all of our and the Guarantors’ non-real estate assets. These assets included, but were not limited to, receivables, equipment, intellectual property, inventory, and stock in certain subsidiaries. In March 2021, the FCA publicly announced that immediately after December 31, 2021, publication of most Euro, Swiss Franc, Japanese Yen and Pound Sterling LIBOR settings would permanently cease. In October 2021, Rogers Corporation and JPMorgan Chase entered into an amendment (Amendment No 1) to the Fourth Amended Credit Agreement to adopt a new benchmark interest rate to replace the discontinued LIBOR reference rates. Borrowings under the Fourth Amended Credit Agreement could have been made as alternate base rate loans, euro-currency loans, or RFR loans. Alternate base rate loans bear interest at a base reference rate plus a spread of 62.5 to 100.0 basis points, depending on our leverage ratio. The base reference rate was the greatest of (a) the prime rate in effect on such day, (b) the NYFRB rate in effect on such day plus ½ of 1%, and (c) the adjusted LIBOR for a one-month interest period in dollars on such day (or if such day was not a business day, the immediately preceding business day) plus 1%. Euro-currency loans bear interest based on adjusted LIBOR plus a spread of 162.5 to 200.0 basis points, depending on our leverage ratio. RFR loans bears interest based upon the SONIA plus 0.0326% plus a spread of 162.5 to 200.0 basis points. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Fourth Amended Credit Agreement, we incurred an annual fee of 25 to 35 basis points (based upon our leverage ratio), paid quarterly, of the unused amount of the lenders’ commitments under the Fourth Amended Credit Agreement. The Fourth Amended Credit Agreement contained customary representations and warranties, covenants, mandatory prepayments and events of default under which our payment obligations may have been accelerated. If an event of default occurred, the lenders may have, among other things, terminated their commitments and declared all outstanding borrowings to be immediately due and payable together with accrued interest and fees. The financial covenants included requirements to maintain (1) a total net leverage ratio of no more than 3.25 to 1.00, subject to a one-time election to increase the maximum total net leverage ratio to 3.50 to 1.00 for one The Fourth Amended Credit Agreement generally permitted us to pay cash dividends to our shareholders, provided that (i) no default or event of default had occurred and was continuing or would have resulted from the dividend payment and (ii) our total net leverage ratio does not exceed 2.75 to 1.00. If our total net leverage ratio exceeded 2.75 to 1.00, we may have nonetheless made up to $20.0 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of default had occurred and was continuing or would have resulted from the payments. On March 24, 2023, we entered into the Fifth Amended Credit Agreement which amends and restates the Fourth Amended Credit Agreement, and provides for (1) a revolving credit facility with up to $450.0 million of revolving loans, with sub-limits for multicurrency borrowings, letters of credit and swing-line notes, and (2) a $225.0 million expansion feature. Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Fifth Amended Credit Agreement). The Fifth Amended Credit Agreement extends the maturity, the date on which all amounts borrowed or outstanding under the Fifth Amended Credit Agreement are due, from March 31, 2024 to March 24, 2028. All obligations under the Fifth Amended Credit Agreement are guaranteed by each of our existing and future material domestic subsidiaries, as defined in the Fifth Amended Credit Agreement (the Guarantors). The obligations are also secured by a Fifth Amended and Restated Pledge and Security Agreement, dated as of March 24, 2023, entered into by us and the Guarantors which grants to the administrative agent, for the benefit of the lenders, a security interest, subject to certain exceptions, in substantially all of the non-real estate assets of ours and the Guarantors. These assets include, but are not limited to, receivables, equipment, intellectual property, inventory, and stock in certain subsidiaries. Borrowings under the Fifth Amended Credit Agreement bear interest based on one of two options. Alternate base rate loans will bear interest at a rate that includes a base reference rate plus a spread of 62.5 to 100.0 basis points, depending on our leverage ratio. The base reference rate will be the greater of the (1) prime rate, (2) federal funds effective rate plus 50.0 basis points, and (3) one-month Term SOFR plus 110.0 basis points. Loans bearing an interest rate determined by reference to the Adjusted Term SOFR Rate, the Adjusted EURIBOR, or the Adjusted TIBOR (each as defined in the Fifth Amended Credit Agreement) will bear interest based on the screen rate plus a spread of 162.5 to 200.0 basis points, depending on our leverage ratio. Based on our leverage ratio as of December 31, 2023, the spread was 162.5 basis points. In addition to interest payable on the principal amount of indebtedness outstanding, we incur an annual fee of 25.0 to 35.0 basis points (based upon our leverage ratio), paid quarterly, of the unused amount of the lenders’ commitments under the Fifth Amended Credit Agreement. The Fifth Amended Credit Agree ment contains customary representations and warranties, covenants, mandatory prepayments and events of default under which the Company’s payment obligations may be accelerated. The financial covenants include a requirement to maintain (1) a total net leverage ratio of no more than 3.25 to 1.00, subject to a one-time election to increase the maximum total net leverage ratio to 3.75 to 1.00 for one us to pay cash dividends to our shareholders, provided that (i) no default or event of default has occurred and is continuing or would result from the dividend payment and (ii) our total net leverage ratio does not exceed 2.75 to 1.00. If our total net leverage ratio exceeds 2.75 to 1.00, we may nonetheless make up to $20.0 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of default has occurred and is continuing or would result from the payments. Our total net leverage ratio did not exceed 2.75 to 1.00 and our interest coverage ratio was greater than or equal to 3.00 to 1.00 as of December 31, 2023. There were no new borrowings under our revolving credit facility in 2023, and $100.0 million and $190.0 million in new borrowings under our revolving credit facility in 2022 and 2021, respectively. Our new borrowings in 2022 were for use in various operations, while our new borrowings in 2021 were primarily used to fund our acquisition of Silicone Engineering. We made discretionary principal payments on our revolving credit facility of $185.0 million, $75.0 million and $25.0 million in 2023, 2022 and 2021, respectively. We had $30.0 million and $215.0 million of outstanding borrowings under our revolving credit facility as of December 31, 2023 and 2022, respectively. We had $2.1 million and $0.9 million of outstanding line of credit issuance costs as of December 31, 2023 and 2022, respectively, which will be amortized over the life of the Fifth Amended Credit Agreement. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Legal & Environmental We are currently engaged in the following legal and environmental proceedings: Asbestos Products Litigation Overview We, like many other industrial companies, have been named as a defendant in a number of lawsuits filed in courts across the country by persons alleging personal injury from exposure to products containing asbestos. We have never mined, milled, manufactured or marketed asbestos; rather, we made and provided to industrial users a limited number of products that contained encapsulated asbestos, but we stopped manufacturing these products in the late 1980s. Most of the claims filed against us involve numerous defendants, sometimes as many as several hundred. In virtually all of the cases against us, the plaintiffs are seeking unspecified damages above a jurisdictional minimum against multiple defendants who may have manufactured, sold or used asbestos-containing products to which the plaintiffs were allegedly exposed and from which they purportedly suffered injury. Most of these cases are being litigated in Maryland, Illinois, Missouri and New York; however, we are also defending cases in other states. We continue to vigorously defend these cases, primarily on the basis of the plaintiffs’ inability to establish compensable loss as a result of exposure to our products. The indemnity and defense costs of our asbestos-related product liability litigation to date have been substantially covered by insurance. The following table summarizes the change in number of asbestos claims outstanding during 2023 and 2022: 2023 2022 Claims outstanding as of January 1 537 543 New claims filed 136 129 Pending claims concluded (1) (167) (135) Claims outstanding as of December 31 506 537 (1) For the year ended December 31, 2023, 155 claims were dismissed and 12 claims were settled. For the year ended December 31, 2022, 119 claims were dismissed and 16 claims were settled. Settlements totaled approximately $4.5 million for the year ended December 31, 2023, compared to $2.4 million for the year ended December 31, 2022. Impacts on Financial Statements We recognize a liability for asbestos-related contingencies that are probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos-related matters, we record asbestos-related insurance receivables that are deemed probable. The liability projection period covers all current and future indemnity and defense costs through 2064, which represents the expected end of our asbestos liability exposure with no further ongoing claims expected beyond that date. This conclusion was based on our history and experience with the claims data, the diminished volatility and consistency of observable claims data, the period of time that has elapsed since we stopped manufacturing products that contained encapsulated asbestos and an expected downward trend in claims due to the average age of our claimants, which is approaching the average life expectancy. To date, the indemnity and defense costs of our asbestos-related product liability litigation have been substantially covered by insurance. Although we have exhausted coverage under some of our insurance policies, we believe that we have applicable primary, excess and/or umbrella coverage for claims arising with respect to most of the years during which we manufactured and marketed asbestos-containing products. In addition, we have entered into a cost sharing agreement with most of our primary, excess and umbrella insurance carriers to facilitate the ongoing administration and payment of claims covered by the carriers. The cost sharing agreement may be terminated by any party, but will continue until a party elects to terminate it. As of the filing date for this report, the agreement has not been terminated, and no carrier had informed us it intended to terminate the agreement. We expect to continue to exhaust individual primary, excess and umbrella coverages over time, and there is no assurance that such exhaustion will not accelerate due to additional claims, damages and settlements or that coverage will be available as expected. We are responsible for uninsured indemnity and defense costs, and we paid $0.4 million, $0.6 million and $0.5 million in 2023, 2022 and 2021, respectively, related to such costs. The amounts recorded for the asbestos-related liability and the related insurance receivables are based on facts known at the time and a number of assumptions. However, projecting future events, such as the number of new claims to be filed each year, the average cost of disposing of such claims, the length of time it takes to dispose of such claims, coverage issues among insurers and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the U.S., could cause the actual liability and insurance recoveries for us to be higher or lower than those projected or recorded. The full extent of our financial exposure to asbestos-related litigation remains very difficult to estimate and could include both compensatory and punitive damage awards. Changes recorded in the estimated liability and estimated insurance recovery based on the projections of asbestos litigation and corresponding insurance coverage, result in the recognition of expense or income. We recognized an immaterial impact to the statements of operations in 2023, 2022 and 2021. Our projected asbestos-related claims and insurance receivables were as follows: As of December 31, (Dollars in millions) 2023 2022 Asbestos-related liabilities $ 61.5 $ 65.1 Asbestos-related insurance receivables $ 56.5 $ 59.8 Environmental Voluntary Corrective Action Program Our location in Rogers, Connecticut is part of the Connecticut Voluntary Corrective Action Program (VCAP). As part of this program, we partnered with the Connecticut Department of Energy and Environmental Protection (CT DEEP) to determine the corrective actions to be taken at the site related to contamination issues. We evaluated this matter and completed internal due diligence work related to the site in the fourth quarter of 2015. Remediation activities on the site are ongoing and are recorded as reductions to the accrual as they are incurred. We have incurred aggregate remediation costs Other Matters In addition to the above issues, the nature and scope of our business brings us in regular contact with the general public and a variety of businesses and government agencies. Such activities inherently subject us to the possibility of litigation, including other production liability and environmental matters, commercial disputes, intellectual property matters, personal injury claims, tax claims and employment matters, which are defended and handled in the ordinary course of business. Although the outcome of no legal matter can be predicted with certainty, it is the opinion of management that facts known at the present time do not indicate that such litigation, either individually or in the aggregate, will have a material adverse effect on our business, results of operations, cash flows or financial position. |
Earnings Per Share
Earnings Per Share | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding. The following table sets forth the computation of basic and diluted earnings per share: Years Ended December 31, (Dollars and shares in millions, except per share amounts) 2023 2022 2021 Numerator: Net income $ 56.6 $ 116.6 $ 108.1 Denominator: Weighted average shares outstanding - basic 18.6 18.8 18.7 Effect of dilutive shares 0.1 0.2 0.2 Weighted average shares outstanding - diluted 18.7 19.0 18.9 Basic earnings per share $ 3.04 $ 6.21 $ 5.77 Diluted earnings per share $ 3.03 $ 6.15 $ 5.73 Dilutive shares are calculated using the treasury stock method and primarily include unvested restricted stock units. Anti-dilutive shares are excluded from the calculation of diluted shares and diluted earnings per share. For 2023, 2022 and 2021, an immaterial number of shares were excluded each year. |
Capital Stock and Equity Compen
Capital Stock and Equity Compensation | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Capital Stock and Equity Compensation | Capital Stock and Equity Compensation Capital Stock Our 2019 Long-Term Equity Compensation Plan, which was approved by our shareholders in May 2019, permits the granting of restricted stock units and certain other forms of equity awards to officers and other key employees. Under this plan, we also grant each non-management director deferred stock units, which permit non-management directors to receive, at a later date, one share of Rogers capital stock for each deferred stock unit, with no payment of any consideration by the director at the time the shares were received. Shares of capital stock reserved for possible future issuance were as follows: As of December 31, 2023 2022 Shares reserved for issuance under outstanding restricted stock unit awards 248,055 255,310 Deferred compensation to be paid in stock, including deferred stock units 8,100 6,850 Additional shares reserved for issuance under Rogers Corporation 2019 Long-Term Equity Compensation Plan 842,046 914,439 Shares reserved for issuance under the Rogers Corporation Employee Stock Purchase Plan 59,611 59,611 Total 1,157,812 1,236,210 Share Repurchases In 2015, we initiated a share repurchase program (the Program) of up to $100.0 million of the Company’s capital stock to mitigate the dilutive effects of stock options exercises and vesting of restricted stock units granted by the Company, in addition to enhancing shareholder value. The Program has no expiration date and may be suspended or discontinued at any time without notice. There were no share repurchases in 2023 or 2021. In 2022, we purchased 237,806 shares for a total value of $25.0 million using cash from operations and cash on hand. As of December 31, 2023, $24.0 million remained available to purchase under the Program. Equity Compensation Performance-Based Restricted Stock Units As of December 31, 2023, we had performance-based restricted stock units from 2023 and 2021 outstanding. These awards generally cliff vest at the end of a three-year measurement period. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed during the measurement period. Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures. The outstanding awards have one measurement criteria: the three-year total shareholder return (TSR) on our capital stock as compared to that of a specified group of peer companies. The TSR measurement criteria of the awards is considered a market condition. As such, the fair value of this measurement criteria is determined on the grant date using a Monte Carlo simulation valuation model. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period with no changes for final projected payout of the awards. We account for forfeitures as they occur. Below were the assumptions used in the Monte Carlo calculation for each material award granted in 2023 and 2021: February 9, 2023 February 10, 2021 Expected volatility 53.2% 51.0% Expected term 2.9 years 2.9 years Risk-free interest rate 4.08% 0.18% Expected volatility – In determining expected volatility, we have considered a number of factors, including historical volatility. Expected term – We use the vesting period of the award to determine the expected term assumption for the Monte Carlo simulation valuation model. Risk-free interest rate – We use an implied “spot rate” yield on U.S. Treasury Constant Maturity rates as of the grant date for our assumption of the risk-free interest rate. Expected dividend yield – We do not currently pay dividends on our capital stock; therefore, a dividend yield of 0% was used in the Monte Carlo simulation valuation model. A summary of activity of the outstanding performance-based restricted stock units for 2023, 2022 and 2021 is presented below: 2023 2022 2021 Awards Outstanding Weighted- Awards Outstanding Weighted- Awards Outstanding Weighted- Awards outstanding as of January 1 65,513 $ 201.18 114,554 $ 196.23 111,059 $ 170.84 Awards granted 50,551 241.47 26,819 176.33 41,507 258.17 Stock issued (8,775) 147.58 (60,053) 179.72 — — Awards forfeited (33,761) 174.43 (15,807) 204.69 (38,012) 189.69 Awards outstanding as of December 31 73,528 $ 247.55 65,513 $ 201.18 114,554 $ 196.23 We recognized $3.7 million, $2.3 million and $7.7 million of compensation expense related to performance-based restricted stock units in 2023, 2022 and 2021, respectively. As of December 31, 2023, there was $8.2 million of total unrecognized compensation cost related to unvested performance-based restricted stock units. That cost is expected to be recognized over a weighted average period of 1.0 year. Time-Based Restricted Stock Units As of December 31, 2023, we had time-based restricted stock unit awards from 2023, 2022 and 2021 outstanding. The outstanding awards all ratably vest on the first, second and third anniversaries of the original grant date. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed subsequent to the last grant anniversary date. Each time-based restricted stock unit represents a right to receive one share of the Rogers’ capital stock at the end of the vesting period. The fair value of the award is determined by the market value of the underlying stock price at the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period. We account for forfeitures as they occur. A summary of activity of the outstanding time-based restricted stock units for 2023, 2022 and 2021 is presented below: 2023 2022 2021 Awards Outstanding Weighted- Awards Outstanding Weighted- Awards Outstanding Weighted- Awards outstanding as of January 1 124,284 $ 194.60 96,989 $ 157.49 102,142 $ 120.16 Awards granted 67,734 148.85 96,620 219.60 50,640 180.19 Stock issued (62,251) 173.52 (48,253) 183.00 (46,329) 146.45 Awards forfeited (28,768) 213.84 (21,072) 223.90 (9,464) 146.58 Awards outstanding as of December 31 100,999 $ 171.43 124,284 $ 194.60 96,989 $ 157.49 We recognized $9.2 million, $8.2 million and $7.6 million of compensation expense related to time-based restricted stock units in 2023, 2022 and 2021, respectively. As of December 31, 2023, there was $10.9 million of total unrecognized compensation cost related to unvested time-based restricted stock units. That cost is expected to be recognized over a weighted average period of 0.9 years. Deferred Stock Units We grant deferred stock units to non-management directors. These awards are fully vested on the date of grant and the related shares are generally issued on the 13-month anniversary of the grant date unless the individual elects to defer the receipt of those shares. Each deferred stock unit results in the issuance of one share of Rogers’ capital stock. The grant of deferred stock units is typically done annually during the second quarter of each year. The fair value of the award is determined by the market value of the underlying stock price at the grant date. A summary of activity of the outstanding deferred stock units for 2023, 2022 and 2021 is presented below: 2023 2022 2021 Awards Outstanding Weighted- Awards Outstanding Weighted- Awards Outstanding Weighted- Awards outstanding as of January 1 6,850 $ 232.51 9,500 $ 173.82 12,450 $ 113.96 Awards granted 8,100 161.90 4,800 272.12 6,450 188.60 Stock issued (6,850) 232.51 (7,450) 183.20 (9,400) 104.68 Awards outstanding as of December 31 8,100 $ 161.9 6,850 $ 232.51 9,500 $ 173.82 We recognized $1.3 million, $1.3 million and $1.2 million of compensation expense related to deferred stock units in 2023, 2022 and 2021, respectively. |
Operating Segment and Geographi
Operating Segment and Geographic Information | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Operating Segment and Geographic Information | Operating Segment and Geographic Information Our reporting structure is comprised of the following strategic operating segments: AES and EMS. Our remaining operations, which represent our non-core businesses, are reported in the Other operating segment. We believe this structure aligns our external reporting presentation with how we currently manage and view our business internally. Operating Segment Information The following table presents a disaggregation of revenue from contracts with customers and other pertinent financial information, for the periods indicated; inter-segment sales have been eliminated from the net sales data: (Dollars in millions) Advanced Electronics Solutions Elastomeric Material Solutions Other Total December 31, 2023 Net sales - recognized over time $ 234.1 $ 19.6 $ 15.8 $ 269.5 Net sales - recognized at a point in time $ 275.6 $ 359.4 $ 3.9 $ 638.9 Total net sales $ 509.7 $ 379.0 $ 19.7 $ 908.4 Operating income $ 2.6 $ 76.1 $ 6.6 $ 85.3 Total assets $ 762.8 $ 742.0 $ 12.4 $ 1,517.2 Capital expenditures $ 30.5 $ 25.9 $ 0.6 $ 57.0 Depreciation & amortization $ 27.6 $ 22.8 $ 0.7 $ 51.1 Investment in unconsolidated joint ventures $ — $ 11.1 $ — $ 11.1 Equity income in unconsolidated joint ventures $ — $ 1.8 $ — $ 1.8 December 31, 2022 Net sales - recognized over time $ 227.0 $ 15.9 $ 16.4 $ 259.3 Net sales - recognized at a point in time $ 303.2 $ 404.1 $ 4.6 $ 711.9 Total net sales $ 530.2 $ 420.0 $ 21.0 $ 971.2 Operating income $ 77.1 $ 60.4 $ 6.9 $ 144.4 Total assets $ 854.2 $ 778.7 $ 13.3 $ 1,646.2 Capital expenditures $ 58.9 $ 57.6 $ 0.3 $ 116.8 Depreciation & amortization $ 21.7 $ 23.5 $ 0.7 $ 45.9 Investment in unconsolidated joint ventures $ — $ 14.1 $ — $ 14.1 Equity income in unconsolidated joint ventures $ — $ 4.4 $ — $ 4.4 December 31, 2021 Net sales - recognized over time $ 244.1 $ 14.9 $ 18.8 $ 277.8 Net sales - recognized at a point in time $ 290.4 $ 363.1 $ 1.6 $ 655.1 Total net sales $ 534.5 $ 378.0 $ 20.4 $ 932.9 Operating income $ 50.2 $ 60.1 $ 6.9 $ 117.2 Total assets $ 826.7 $ 759.6 $ 12.3 $ 1,598.6 Capital expenditures $ 38.9 $ 31.8 $ 0.4 $ 71.1 Depreciation & amortization $ 22.9 $ 19.7 $ 0.7 $ 43.3 Investment in unconsolidated joint ventures $ — $ 16.3 $ — $ 16.3 Equity income in unconsolidated joint ventures $ — $ 7.0 $ — $ 7.0 Operating Segment Net Sales by Geographic Area The following table presents net sales by our operating segment operations by geographic area for the years indicated: (Dollars in millions) Net Sales (1) Region/Country Advanced Electronics Solutions Elastomeric Material Solutions Other Total December 31, 2023 United States $ 81.1 $ 155.4 $ 3.9 $ 240.4 Other Americas 3.6 13.7 0.3 17.6 Total Americas 84.7 169.1 4.2 258.0 China 144.6 93.0 4.3 241.9 Other APAC 88.3 31.7 5.6 125.6 Total APAC 232.9 124.7 9.9 367.5 Germany 95.2 28.3 0.5 124.0 Other EMEA 96.9 56.9 5.1 158.9 Total EMEA 192.1 85.2 5.6 282.9 Total net sales $ 509.7 $ 379.0 $ 19.7 $ 908.4 December 31, 2022 United States $ 122.7 $ 169.4 $ 4.5 $ 296.6 Other Americas 6.6 15.4 0.3 22.3 Total Americas 129.3 184.8 4.8 318.9 China 154.4 121.7 7.4 283.5 Other APAC 75.2 31.4 2.7 109.3 Total APAC 229.6 153.1 10.1 392.8 Germany 78.7 30.4 1.1 110.2 Other EMEA 92.6 51.7 5.0 149.3 Total EMEA 171.3 82.1 6.1 259.5 Total net sales $ 530.2 $ 420.0 $ 21.0 $ 971.2 December 31, 2021 United States $ 93.6 $ 161.2 $ 4.5 $ 259.3 Other Americas 3.1 10.2 0.8 14.1 Total Americas 96.7 171.4 5.3 273.4 China 193.4 122.0 4.8 320.2 Other APAC 85.1 27.6 2.6 115.3 Total APAC 278.5 149.6 7.4 435.5 Germany 72.6 29.2 0.8 102.6 Other EMEA 86.7 27.8 6.9 121.4 Total EMEA 159.3 57.0 7.7 224.0 Total net sales $ 534.5 $ 378.0 $ 20.4 $ 932.9 (1) Net sales are allocated to countries based on the location of the customer. The table above lists individual countries with 10% or more of net sales for the periods indicated. Contract Assets We had contract assets primarily related to unbilled revenue for revenue recognized related to products that are deemed to have no alternative use whereby we have the right to payment. Revenue is recognized in advance of billing to the customer in these circumstances as billing is typically performed at the time of shipment to the customer. The unbilled revenue is included in the “Contract assets” financial statement line item in the consolidated statements of financial position. Our contract assets by operating segment were as follows: As of December 31, (Dollars in millions) 2023 2022 Advanced Electronics Solutions $ 41.4 $ 33.8 Elastomeric Material Solutions 0.4 1.6 Other 3.4 3.5 Total contract assets $ 45.2 $ 38.9 We did not have any contract liabilities as of December 31, 2023 or 2022. No impairment losses were recognized in 2023, 2022 or 2021 on any contract assets arising from our contracts with customers. Long-Lived Assets by Geographic Area Our long-lived assets (1) by geographic area were as follows: As of December 31, (Dollars in millions) 2023 2022 United States $ 384.1 $ 401.2 England 166.7 161.9 Germany 148.9 139.7 Other 169.2 154.7 Total long-lived assets $ 868.9 $ 857.5 (1) Long-lived assets are based on the location of the asset and are comprised of goodwill, other intangible assets, property, plant and equipment and right-of-use assets. Countries with 10% or more of long-lived assets have been disclosed. |
Supplemental Financial Informat
Supplemental Financial Information | 12 Months Ended |
Dec. 31, 2023 | |
Supplemental Income Statement Elements [Abstract] | |
Supplemental Financial Information | Supplemental Financial Information Restructuring and Impairment Charges The components of the “Restructuring and impairment charges” line item in the consolidated statements of operations were as follows: Years Ended December 31, (Dollars in millions) 2023 2022 2021 Restructuring charges Global workforce reduction $ 8.8 $ — $ — Facility consolidations 8.1 0.4 — Manufacturing footprint optimization — 1.1 3.1 Total restructuring charges 16.9 1.5 3.1 Impairment charges Fixed assets impairment charges — 47.2 0.5 Other impairment charges — 17.9 — Total impairment charges — 65.1 0.5 Total restructuring and impairment charges $ 16.9 $ 66.6 $ 3.6 Restructuring Charges - Global Workforce Reduction On February 16, 2023, we announced a plan to reduce our global workforce that was substantially completed in the first half of 2023, and concluded in the fourth quarter of 2023. The plan significantly reduced our manufacturing costs and operating expenses. We incurred $8.8 million in pre-tax restructuring charges related to this plan, all of which was in the form of cash-based expenditures and substantially all of which were related to employee severance and other termination benefits. (Dollars in millions) Global Workforce Reduction Restructuring Severance and Related Benefits Balance as of December 31, 2022 $ — Provisions 8.5 Payments (8.6) Foreign currency translation adjustment 0.1 Balance as of December 31, 2023 $ — Restructuring Charges - Facility Consolidations In late 2022 and early 2023, we announced our intention to exit certain facilities in the U.S. and Asia. The plan significantly reduced our manufacturing costs and operating expenses. We incurred $8.1 million in pre-tax restructuring charges related to these facility consolidations, most of which were in the form of accelerated depreciation. As part of our facility consolidations plan, on February 17, 2023, we entered into an asset purchase agreement to sell our high-performance engineered cellular elastomer business in our EMS operating segment for a purchase price of $1.8 million, which was completed in early September 2023. The assets primarily comprised of the property, plant and equipment, including the facility, accounts receivable, contract assets and inventories, net, while the liabilities were primarily comprised of accounts payable and other accrued liabilities, along with the previously recognized accrual against the net assets of the business based on the estimated fair value of the business in December 2022. We incurred $1.2 million of selling costs in 2023, which were recorded in the “Selling, general and administrative expenses” line item in the consolidated statements of operations. Further, on September 22, 2023, we completed the sale of one of our Suzhou, China facilities, which had a carrying value of $3.0 million, for $6.8 million, resulting in a pre-tax gain of $1.9 million, inclusive of selling and disposal costs. The sale was completed in December 2023. The net impact of this transaction was recorded in the “Other operating (income) expense, net” line item in the consolidated statements of operations. As of December 31, 2023, we recognized $13.1 million of assets held for sale within the “Other current assets” financial statement line item of our consolidated statements of financial position. This includes $13.1 million for land and building at our Price Road facility in Chandler, Arizona. Restructuring Charges - Manufacturing Footprint Optimization During the third quarter of 2020, we commenced manufacturing footprint optimization plans involving certain Europe and Asia manufacturing locations, primarily impacting our AES operating segment, in order to achieve greater cost competitiveness as well as align capacity with end market demand. The majority of the restructuring activities were completed in the first half of 2021. We incurred restructuring charges and related expenses of $1.1 million and $3.1 million in 2022 and 2021, respectively. Impairment Charges We recognized $65.1 million and $0.5 million of impairment charges in 2022 and 2021, respectively. The impairment charges in 2022 primarily related to certain AES operating segment equipment-in-process in the U.S. as well as certain EMS operating segment intangible assets and fixed assets related to our high-performance engineered cellular elastomer business in the U.S. The impairment of the equipment-in-process in our AES operating segment was triggered by our decision in November 2022 to exit the Price Road facility in Arizona. The impairment charges in 2021 were primarily related to AES operating segment fixed assets in Belgium. Allocation of Restructuring and Impairment Charges to Operating Segments The following table summarizes the allocation of restructuring and impairment charges to our operating segments: Years Ended December 31, (Dollars in millions) 2023 2022 2021 Advanced Electronics Solutions Allocated restructuring charges $ 10.7 $ 1.1 $ 3.0 Allocated impairment charges — 40.5 0.5 Elastomeric Material Solutions Allocated restructuring charges 6.2 0.4 0.1 Allocated impairment charges — 24.6 — Total restructuring and impairment charges $ 16.9 $ 66.6 $ 3.6 Other Operating (Income) Expense, Net The components of the “Other operating (income) expense, net” line item in the consolidated statements of operations were as follows: Years Ended December 31, (Dollars in millions) 2023 2022 2021 UTIS fire Fixed assets write-offs $ — $ — $ 1.1 Inventory charges — 0.2 0.9 Professional services 0.9 1.4 2.7 Lease obligations — 0.4 1.0 Lease impairments — — 0.5 Compensation & benefits — 2.4 2.1 Third-party property claims — — 4.7 Other — (0.2) 0.1 Insurance recoveries (31.4) (6.6) (6.9) Total UTIS fire (30.5) (2.4) 6.2 Regulatory termination fee, net — (142.1) — Loss (gain) on sale or disposal of property, plant and equipment (2.6) 0.5 (0.9) Total other operating (income) expense, net $ (33.1) $ (144.0) $ 5.3 In early February 2021, there was a fire at our UTIS manufacturing facility in Ansan, South Korea, which manufactures eSorba® polyurethane foams used in portable electronics and display applications. The site was safely evacuated and there were no reported injuries; however, there was extensive damage to the manufacturing site and some damage to nearby property. Commercial production at our new location in Siheung, South Korea commenced in late-January 2023. In 2023, in connection with the UTIS fire, we recognized insurance recoveries of $31.4 million related to our business interruption and property damage insurance claims and incurred $0.9 million for various professional services. In 2022, in connection with the UTIS fire, we recognized insurance recoveries of $6.6 million related to our ongoing insurance claim for property damage and compensation and benefits of hourly employees, incurred $1.4 million for various professional services and incurred $2.4 million for compensation and benefits for UTIS manufacturing employees subsequent to the fire. In 2021, in connection with the UTIS fire, we recognized fixed asset write-offs and inventory charges of $1.1 million and $0.9 million, respectively, related to property destroyed in the fire, a $4.7 million contingent liability pertaining to damage to nearby property and a $0.5 million contingent liability pertaining to our obligations for the fire damage to the building in connection with the underlying lease agreement. Further, in 2021 we incurred $2.7 million of fees for various professional services in connection with the assessment of the fire and the efforts to rebuild and resume operations and $2.1 million of compensation and benefits for UTIS manufacturing employees, subsequent to the fire. In 2021, we also recognized anticipated insurance recoveries of $6.9 million related to our ongoing insurance claim for property damage and compensation and benefits of hourly employees, less the applicable $0.3 million deductible. In 2022, we recognized income from a regulatory termination fee of $142.1 million, which was net of an incurred transaction-related fee. For additional information, refer to “Note 16 – Mergers and Acquisitions.” Interest Expense, Net The components of the “Interest expense, net” line item in the consolidated statements of operations were as follows: Years Ended December 31, (Dollars in millions) 2023 2022 2021 Interest on revolving credit facility $ 9.6 $ 9.0 $ 0.9 Line of credit fees 0.8 0.5 1.1 Debt issuance amortization costs 0.7 0.7 0.7 Interest income (1.2) (0.7) (0.5) Other 0.2 — 0.4 Total interest expense, net $ 10.1 $ 9.5 $ 2.5 |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The “Income before income tax expense” line item in the consolidated statements of operations consisted of: (Dollars in millions) 2023 2022 2021 Domestic $ 9.1 $ 58.4 $ 34.4 Foreign 67.2 82.0 91.9 Total $ 76.3 $ 140.4 $ 126.3 The “Income tax expense” line item in the consolidated statements of operations consisted of: (Dollars in millions) Current Deferred Total 2023 Domestic $ 0.4 $ (0.6) $ (0.2) Foreign 22.9 (3.0) 19.9 Total $ 23.3 $ (3.6) $ 19.7 2022 Domestic $ 26.8 $ (18.8) $ 8.0 Foreign 17.6 (1.8) 15.8 Total $ 44.4 $ (20.6) $ 23.8 2021 Domestic $ 5.2 $ (2.9) $ 2.3 Foreign 16.2 (0.3) 15.9 Total $ 21.4 $ (3.2) $ 18.2 Deferred tax assets and liabilities as of December 31, 2023 and 2022, were comprised of the following: (Dollars in millions) 2023 2022 Deferred tax assets Accrued employee benefits and compensation $ 7.7 $ 8.7 Net operating loss carryforwards 11.8 4.4 Tax credit carryforwards 6.7 2.8 Reserves and accruals 5.7 4.7 Operating leases 3.6 4.2 Capitalized research and development 25.6 21.3 Other 6.9 10.2 Total deferred tax assets 68.0 56.3 Less deferred tax asset valuation allowance (11.4) (2.8) Total deferred tax assets, net of valuation allowance 56.6 53.5 Deferred tax liabilities Depreciation and amortization 17.7 14.4 Postretirement benefit obligations 0.7 0.7 Unremitted earnings 1.5 2.6 Operating leases 4.1 4.6 Other 5.8 4.2 Total deferred tax liabilities 29.8 26.5 Net deferred tax asset (liability) $ 26.8 $ 27.0 As of December 31, 2023, we had state net operating loss carryforwards totaling $8.1 million in various state taxing jurisdictions, which expire between 2024 and 2043, and approximately $3.6 million of state research credit carryforwards, which will expire between 2024 and 2040. We also had a $0.8 million federal research and development (R&D) credit carryforward that will expire in 2043. We believe that it is more likely than not that the benefit from certain of the state net operating loss and state R&D credits carryforwards will not be realized. In recognition of this risk, we have provided a valuation allowance of $1.5 million relating to these carryforwards. We currently have approximately $3.1 million of foreign tax credits that begin to expire in 2028. As of December 31, 2023, we had foreign net operating loss carryforwards totaling $52.7 million. Luxembourg losses totaled $31.4 million, of which $3.9 million will expire between 2034 and 2039, and the rest will be carried forward indefinitely. We believe it is more likely than not that these losses will expire unused, and have provided a valuation allowance for all Luxembourg net operating loss carryforwards. China losses totaled $14.7 million, which expire between 2024 and 2028. We believe it is more likely than not that these losses will expire unused, and have provided a valuation allowance for all China net operating loss carryforwards. Korea losses totaled $6.6 million, which expire between 2036 and 2038. We had a valuation allowance of $11.4 million as of December 31, 2023 and $2.8 million as of December 31, 2022, against certain of our deferred tax assets, primarily carryforwards expected to expire unused and deferred tax assets that are capital in nature. No valuation allowance has been provided on our other deferred tax assets, as we believe it is more likely than not that all such assets will be realized in the applicable jurisdictions. Differences between forecasted and actual future operating results or changes in carryforward periods could adversely impact the amount of deferred tax asset considered realizable. Income tax expense differs from the amount computed by applying the U.S. federal statutory income tax rate to income before income taxes. The reasons for this difference were as follows: (Dollars in millions) 2023 2022 2021 Tax expense at Federal statutory income tax rate $ 16.0 $ 29.5 $ 26.5 Impact of foreign operations 4.0 1.5 2.0 Foreign source income, net of tax credits (2.3) (6.5) (4.9) State tax, net of federal (0.5) 6.9 0.2 Deferred tax adjustment 1.2 — — Unrecognized tax benefits (0.2) 1.9 (8.8) Equity compensation excess tax deductions 0.3 (3.0) 0.3 General business credits (2.4) (0.8) (0.9) Distribution related foreign taxes 1.1 1.5 2.5 Executive compensation limitation 0.9 2.9 1.6 Valuation allowance change 0.7 (6.9) 0.5 Other 0.9 (3.2) (0.8) Income tax expense $ 19.7 $ 23.8 $ 18.2 Our effective income tax rate for 2023 was 25.8% compared to 16.9% for 2022. The 2023 rate increase was primarily due to the impact of the 2022 valuation allowance releases not recurring in 2023. We did not make any changes in 2023 to our position on the permanent reinvestment of our historical earnings from foreign operations. With the exception of certain Chinese subsidiaries, we continue to assert that historical foreign earnings are indefinitely reinvested. As of December 31, 2023 and 2022, we had recorded a deferred tax liability of $1.5 million and $2.5 million, respectively, for Chinese withholding tax on undistributed earnings that are not indefinitely reinvested. The other remaining foreign subsidiaries have both the intent and ability to indefinitely reinvest their undistributed earnings and we estimate that, if these undistributed earnings are distributed, they may give rise to an estimated $2.6 million of additional tax liabilities. If circumstances change and it becomes apparent that some, or all of the undistributed earnings as of December 31, 2023 will not be indefinitely reinvested, the provision for the tax consequences, if any, will be recorded in the period when circumstances change. Distributions out of current and future earnings are permissible to fund discretionary activities such as business acquisitions. However, when distributions are made, this could result in a higher effective tax rate. Unrecognized tax benefits, excluding potential interest and penalties, for the years ended December 31, 2023 and 2022, were as follows: (Dollars in millions) 2023 2022 2021 Beginning balance as of January 1 $ 8.9 $ 6.6 $ 15.7 Gross increases - current period tax positions 1.1 3.4 1.0 Gross increases - tax positions in prior periods — 0.2 1.2 Gross decreases - tax positions in prior periods (0.5) (0.2) (9.2) Foreign currency exchange 0.1 (0.1) — Settlements 0.1 (1.0) (2.1) Lapse of statue of limitations $ (1.2) $ — $ — Ending balance as of December 31 $ 8.5 $ 8.9 $ 6.6 Included in the balance of unrecognized tax benefits as of December 31, 2023 were $6.9 million of tax benefits that, if recognized, would impact the effective tax rate. We recognized interest accrued related to unrecognized tax benefit as income tax expense. Related to the unrecognized tax benefits noted above, as of December 31, 2023 and 2022, we had accrued potential interest and penalties of approximately $1.4 million and $1.1 million, respectively. We are subject to taxation in the U.S. and various state and foreign jurisdictions. Our tax years from 2019 through 2023 are subject to examination by the tax authorities. With few exceptions, we are no longer subject to U.S. federal, state, local and foreign examinations by tax authorities for the years before 2019. |
Mergers and Acquisitions
Mergers and Acquisitions | 12 Months Ended |
Dec. 31, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Mergers and Acquisitions | Mergers and Acquisitions Acquisition of Silicone Engineering Ltd. On October 8, 2021, we acquired Silicone Engineering, a leading European manufacturer of silicone material solutions based in Blackburn, England, for a combined purchase price of $172.3 million for the company, net of cash acquired, and its facility. As part of the agreement, there was a $4.1 million holdback, upon which we could issue claims against until six months after the close of the acquisition, at which point in time the holdback amount, less any holdback claims, was to be paid to the previous owners of Silicone Engineering. In April 2022, we paid $1.3 million of the holdback in exchange for a 6-month extension of the holdback period. In October 2022, we paid back the remaining of the holdback, less an immaterial amount for claims. Substantially all of our $190.0 million in borrowings under our existing credit facility in October 2021 were used to fund the transaction, with the remaining amounts being used for general corporate purposes. Silicone Engineering has expanded our existing advanced silicones platform in our EMS operating segment and provides us a European Center of Excellence to service customers requiring premium silicone solutions for applications in the EV/HEV, industrial, medical and other markets. Pro-Forma Financial Information The following unaudited pro forma financial information presents the combined results of operations of Rogers and Silicone Engineering as if the Silicone Engineering acquisition had occurred on January 1, 2020. The unaudited pro forma financial information is not intended to represent or be indicative of our consolidated results of operations that would have been reported had the Silicone Engineering acquisition been completed as of January 1, 2020 and should not be taken as indicative of our future consolidated results of operations. For the Years Ended December 31, (Dollars in millions) 2021 Net sales $ 973.2 Net income $ 120.1 Terminated Merger Agreement with DuPont On November 1, 2021, we entered into a definitive merger agreement to be acquired by DuPont in an all-cash transaction. Our shareholders approved the merger agreement at a special shareholder meeting held on January 25, 2022. Consummation of the merger was subject to various customary closing conditions, including regulatory approval by the SAMR, and either party had the right to terminate the merger agreement if the merger had not closed on or before November 1, 2022. As of November 1, 2022, the parties had not received regulatory approval from SAMR and on that date, DuPont issued a notice of termination of the merger agreement. Pursuant to the terms of the merger agreement, we received a regulatory termination fee in the amount of $162.5 million, before taxes, and incurred a transaction-related fee of $20.4 million. |
Recent Accounting Standards
Recent Accounting Standards | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Recent Accounting Standards | Recent Accounting Standards Recently Issued Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU 2023-07 enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures. This amendment will improve the disclosures about a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard requires using the retrospective approach. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard should be applied on a prospective basis and retrospective application to all periods presented is permitted. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes. |
Schedule II
Schedule II | 12 Months Ended |
Dec. 31, 2023 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Schedule II | SCHEDULE II (Dollars in millions) Balance at Beginning of Period Charged to (Reduction of) Costs and Expenses Taken Against Allowance Other (Deductions) Recoveries Balance at End of Period Allowance for Credit Losses December 31, 2023 $ 1.0 $ 0.4 $ — $ (0.3) $ 1.1 December 31, 2022 $ 1.2 $ 0.2 $ (0.4) $ — $ 1.0 December 31, 2021 $ 1.7 $ 0.4 $ (0.2) $ (0.7) $ 1.2 (Dollars in millions) Balance at Beginning of Period Charged to (Reduction of) Costs and Expenses Taken Against Allowance Other (Deductions) Recoveries Balance at End of Period Inventory E&O Reserves December 31, 2023 $ 17.0 $ 14.0 $ (5.1) $ (3.9) $ 22.0 December 31, 2022 $ 16.4 $ 8.2 $ (4.6) $ (3.0) $ 17.0 December 31, 2021 $ 22.4 $ 8.4 $ (7.4) $ (7.0) $ 16.4 (Dollars in millions) Balance at Beginning of Period Charged to (Reduction of) Costs and Expenses Taken Against Allowance Other (Deductions) Recoveries Balance at End of Period Valuation on Allowance for Deferred Tax Assets December 31, 2023 $ 2.8 $ 0.7 $ 7.9 $ — $ 11.4 December 31, 2022 $ 9.8 $ 0.4 $ (7.3) $ — $ 2.8 December 31, 2021 $ 9.3 $ 0.5 $ — $ — $ 9.8 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure | |||
Net income | $ 56.6 | $ 116.6 | $ 108.1 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Basis of Presentation, Organi_2
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries, after elimination of intercompany balances and transactions. The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. |
Organization | Organization Our reporting structure is comprised of three operating segments: AES, EMS and Other. Advanced Electronics Solutions Our AES operating segment designs, develops, manufactures and sells circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in EV/HEV, automotive (e.g., ADAS), aerospace and defense (e.g., antenna systems, communication systems and phased array radar systems), renewable energy (e.g., wind and solar), wireless infrastructure (e.g., power amplifiers, antennas and small cells), mass transit, industrial (e.g., variable frequency drives), connected devices (e.g., mobile internet devices and thermal solutions) and wired infrastructure (e.g., computing and internet protocol infrastructure) markets. We believe these materials have characteristics that offer performance and other functional advantages in many market applications, which serve to differentiate our products from other commonly available materials. AES products are sold globally to converters, fabricators, distributors and OEMs. Trade names for our AES products include: curamik ® , ROLINX ® , RO4000 ® Series, RO3000 ® Series, RT/duroid ® , CLTE Series ® , TMM ® , AD Series ® , DiClad ® Series, CuClad ® Series, Kappa ® , COOLSPAN ® , TC Series ® , IsoClad ® Series, MAGTREX ® , IM Series™, 2929 Bondply, SpeedWave ® Prepreg, RO4400™/RO4400T™ Series and Radix™. As of December 31, 2023, our AES operating segment had manufacturing and administrative facilities in Chandler, Arizona; Rogers, Connecticut; Bear, Delaware; Eschenbach, Germany; Evergem, Belgium; Budapest, Hungary; and Suzhou, China. Elastomeric Material Solutions Our EMS operating segment designs, develops, manufactures and sells engineered material solutions for a wide variety of applications and markets. These include polyurethane and silicone materials used in cushioning, gasketing and sealing, and vibration management applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense, footwear and impact mitigation markets; customized silicones used in flex heater and semiconductor thermal applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense and medical markets; polytetrafluoroethylene and ultra-high molecular weight polyethylene materials used in wire and cable protection, electrical insulation, conduction and shielding, hose and belt protection, vibration management, cushioning, gasketing and sealing, and venting applications for EV/HEV, general industrial, automotive and aerospace and defense markets. We believe these materials have characteristics that offer functional advantages in many market applications, which serve to differentiate our products from other commonly available materials. EMS products are sold globally to converters, fabricators, distributors and OEMs. Trade names for our EMS products include: PORON ® , BISCO ® , DeWAL ® , ARLON ® , eSorba ® , XRD ® , Silicone Engineering and R/bak ® . As of December 31, 2023, our EMS operating segment had manufacturing and administrative facilities in Rogers, Connecticut; Woodstock, Connecticut; Bear, Delaware; Carol Stream, Illinois; Narragansett, Rhode Island; Evergem, Belgium; Blackburn, England; Siheung, South Korea; and Suzhou, China. We also own 50% of two unconsolidated joint ventures: (1) RIC, a joint venture established in Japan to design, develop, manufacture and sell PORON ® products predominantly for the Japanese market and (2) RIS, a joint venture established in China to design, develop, manufacture and sell PORON ® products primarily for RIC customers in various Asian countries. INOAC Corporation owns the remaining 50% of both RIC and RIS. RIC has manufacturing facilities at the INOAC facilities in Nagoya and Mie, Japan, and RIS has manufacturing facilities at Rogers’ facilities in Suzhou, China. Other Our Other operating segment consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets. We sell our elastomer components under our ENDUR ® trade name and our floats under our NITROPHYL ® trade name. |
Cash and Cash Equivalents | Cash and Cash Equivalents Highly liquid investments with original maturities of three months or less are considered cash and cash equivalents. These investments are stated at cost, which approximates fair value |
Restricted Cash | Restricted cash is subject to contractual restrictions and not readily available. Our restricted cash balance recorded in cash and cash equivalents, totaled $2.2 million as of December 31, 2023 and 2022, serves as collateral for letters of credit related to our environmental and workers’ compensation liabilities. |
Foreign Currency | Foreign Currency |
Accounts Receivable | Accounts Receivable |
Allowance for Credit Losses | Allowance for Credit Losses The allowance for credit losses is determined based on a variety of factors that affect the potential collectability of the related receivables, including the length of time receivables are past due, customer credit ratings, financial stability of customers, specific one-time events and past customer history. In addition, in circumstances where we are made aware of a specific customer’s inability to meet its financial obligations, a specific allowance is established. The majority of accounts are individually evaluated on a regular basis and appropriate reserves are established as deemed appropriate based on the criteria previously mentioned. The remainder of the reserve is based on our estimates and takes into consideration historical trends, market conditions and the composition of our customer base. |
Inventories | Inventories Inventories are stated at the lower of cost or net realizable value with costs determined primarily on a first-in, first-out (FIFO) basis. We record allowances for estimated losses due to excess, obsolete and slow-moving inventory that is determined for groups of products based on purchases in the recent past and/or expected future demand, as well as market conditions, design cycles and other economic factors. Abnormal amounts of idle facility expense and waste are not capitalized in inventory. The allocation of fixed production overheads to the inventory cost is based on the normal capacity of the production facilities. |
Property, Plant and Equipment | Property, Plant and Equipment |
Software Costs | Software Costs We capitalize certain internal and external costs of computer software developed or obtained for internal use, principally related to software coding, software configuration, designing system interfaces and installation and testing of the software. We amortize capitalized internal use software costs using the straight-line method over the estimated useful lives of the software, generally from three |
Leases | Leases The Company determines whether an arrangement is a lease at contract inception by establishing if the contract conveys the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. Lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of all minimum lease payments over the lease term. We use an incremental borrowing rate representative of our ability to borrow on a collateralized basis over a similar lease term. Lease terms may include options to extend or terminate the lease. These options are included in the lease term when it is reasonably certain that we will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. We have elected the following policy elections on adoption: separating lease and non-lease components, exclusion of short-term leases on the balance sheet and recognition of lease payments for short-term leases in the consolidated statements of operations on a straight-line basis. |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets We have made acquisitions over the years that included the recognition of intangible assets. Intangible assets are classified into three categories: (1) goodwill; (2) other intangible assets with definite lives subject to amortization; and (3) other intangible assets with indefinite lives not subject to amortization. Other intangible assets can include items such as trademarks and trade names, licensed technology, customer relationships and covenants not to compete, among other things. Each definite-lived other intangible asset is amortized over its respective economic useful life using the economic attribution method. Goodwill is evaluated for impairment annually, and between annual impairment assessments if events or changes in circumstances indicate the carrying value may be impaired, by first performing a qualitative assessment to determine whether a quantitative goodwill impairment assessment is necessary. If it is determined, based on qualitative factors, the fair value of the reporting unit may be more likely than not less than its carrying amount or if significant changes to macro-economic factors related to the reporting unit have occurred that could materially impact fair value, a quantitative goodwill impairment assessment would be required. We can elect to forgo the qualitative assessment and perform a quantitative assessment. The quantitative assessment compares the fair value of a reporting unit with its carrying amount. The application of the quantitative assessment requires significant judgment, including the assignment of assets and liabilities to reporting units and determination of the fair value of each reporting unit. Determining the fair value is subjective and requires the use of significant estimates and assumptions, including financial projections for net sales, gross margin and operating margin, discount rates, terminal growth rates and future market conditions, among others. When performing the quantitative assessment, we have historically estimated the fair value of our reporting units using an income approach based on the present value of future cash flows through a five-year discounted cash flow analysis. Upon performing the quantitative assessment, if the carrying value of the reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess, not to exceed the carrying amount of goodwill. We currently have four reporting units with goodwill: RF Solutions, EMS, curamik ® and Elastomer Components Division (ECD). Consistent with historical practice, the annual impairment test on these reporting units was performed as of November 30, 2023. In 2023, we elected to utilize a qualitative assessment. There were no impairment charges resulting from our goodwill impairment assessment for the year ended December 31, 2023. Our RF Solutions, EMS, curamik ® and ECD reporting units had allocated goodwill of $51.7 million, $239.9 million, $66.0 million and $2.2 million, respectively, as of December 31, 2023. Indefinite-lived other intangible assets are evaluated for impairment annually, and between annual impairment assessments if events or changes in circumstances indicate the carrying value may be impaired, by first performing a qualitative assessment to determine whether a quantitative indefinite-lived other intangible asset impairment assessment is necessary. If it is determined, based on qualitative factors, the fair value of the indefinite-lived other intangible asset may be more likely than not less than its carrying amount or if significant changes to macro-economic factors related to the indefinite-lived other intangible asset have occurred that could materially impact fair value, a quantitative indefinite-lived other intangible asset impairment assessment would be required. We can elect to forgo the qualitative assessment and perform a quantitative assessment. The quantitative assessment compares the fair value of the indefinite-lived other intangible asset with its carrying amount. The application of the quantitative assessment requires significant judgment, including determining the fair value of each indefinite-lived other intangible asset. Fair value is primarily based on income approaches using discounted cash flow models, which have significant assumptions. Such assumptions are subject to variability from year to year and are directly impacted by global market conditions. There were no impairment charges resulting from our indefinite-lived other intangible assets impairment assessment for the year ended December 31, 2023. Our curamik ® reporting unit had an indefinite-lived other intangible asset of $4.3 million as of December 31, 2023. Definite-lived other intangible assets are tested for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable. The recoverability test involves comparing the estimated sum of the undiscounted cash flows for each definite-lived other intangible asset to its respective carrying value. If a definite-lived other intangible asset’s carrying value is greater than the sum of its undiscounted cash flows, then the definite-lived other intangible asset’s carrying value is compared to its estimated fair value and an impairment charge is recognized for the excess and charged to operations. The application of the recoverability test requires significant judgment, including the identification of the asset group and determination of undiscounted cash flows and fair value of the underlying definite-lived other intangible asset. Determination of undiscounted cash flows requires the use of significant estimates and assumptions, including certain financial projections. Fair value is primarily based on income approaches using discounted cash flow models, which have significant assumptions. Such assumptions are subject to variability from year to year and are directly impacted by global market conditions. There were no impairment charges ® reporting units had definite-lived other intangible assets of $0.9 million, $115.3 million and $3.4 million, respectively, as of December 31, 2023. The useful life determination for each indefinite-lived other intangible asset is evaluated each reporting period to determine whether events and circumstances support an indefinite useful life. The useful life determination for each definite-lived other intangible asset is evaluated each reporting period to determine whether events and circumstances warrant a revision to the remaining period of amortization. |
Pension and Other Postretirement Benefits | Pension and Other Postretirement Benefits We sponsor one material defined benefit pension plan, the Rogers Corporation Employees’ Pension Plan (the Union Plan), which covers certain union employees, and we sponsor multiple fully insured or self-funded medical plans and fully insured life insurance plans for retirees. The Union Plan was frozen in 2013 so that future benefits no longer accrue. The costs and obligations associated with these plans are dependent upon various actuarial assumptions used in calculating such amounts. These assumptions include discount rates, long-term rates of return on plan assets, mortality rates, and other factors. The assumptions used in these models are determined as follows: (i) the discount rate used is based on the PruCurve bond index; (ii) the long-term rate of return on plan assets is determined based on historical portfolio results, market conditions and our expectations of future returns; and (iii) the mortality rate is based on a mortality projection that estimates current longevity rates and their impact on the long-term plan obligations. We determine these assumptions based on consultation with outside actuaries and investment advisors. Any changes in these assumptions could have a significant impact on our assets and liabilities. We review these assumptions periodically throughout the year and update as necessary. We are required, as an employer, to: (a) recognize in the consolidated statements of financial position an asset for a plan’s overfunded status or a liability for a plan’s underfunded status; (b) measure a plan’s assets and a plan’s obligations that determine our funded status as of the end of the year; and (c) recognize changes in the funded status of a defined benefit plan in the year in which the changes occur and report these changes in accumulated other comprehensive loss. Additionally, actuarial losses (gains) that are not immediately recognized as net periodic pension cost (credit) are recognized as a component of accumulated other comprehensive loss (income) and amortized into net periodic pension cost (credit) in future periods. Investments were stated at fair value as of the dates reported. Securities traded on a national securities exchange were valued at the last reported sales price on the last business day of the plan year. Fixed-income bonds were valued using price evaluations provided by independent pricing services. The fair value of the guaranteed deposit account was determined through discounting expected future investment cash flow from both investment income and repayment of principal for each investment purchased. The estimated fair values of the participation units owned by the plan in pooled separate accounts were based on quoted redemption values and adjusted for management fees and asset charges, as determined by the recordkeeper, on the last business day of the relevant plan year. Pooled separate accounts are accounts established solely for the purpose of investing the assets of one or more plans. Funds in a separate account are not commingled with other Company assets for investment purposes. |
Environmental and Product Liabilities | Environmental and Product Liabilities We accrue for our environmental investigation, remediation, operating and maintenance costs when it is probable that a liability has been incurred and the amount can be reasonably estimated. For environmental matters, the most likely cost to be incurred is accrued based on an evaluation of currently available facts with respect to each individual site, including existing technology, current laws and regulations and prior remediation experience. For sites with multiple potential responsible parties (PRPs), we consider our likely proportionate share of the anticipated remediation costs and the ability of the other parties to fulfill their obligations in establishing a provision for those costs. When no amount within a range of estimates is more likely to occur than another, we accrue to the low end of the range and disclose the range. When future liabilities are determined to be reimbursable by insurance coverage, an accrual is recorded for the potential liability and a receivable is recorded for the estimated insurance reimbursement amount. We are exposed to the uncertain nature inherent in such remediation and the possibility that initial estimates will not reflect the final outcome of a matter. We review our asbestos-related projections annually in the fourth quarter of each year unless facts and circumstances materially change during the year, at which time we would analyze these projections. We believe the assumptions made on the potential exposure and expected insurance coverage are reasonable at the present time, but are subject to uncertainty based on the actual future outcome of our asbestos litigation. Our estimates of asbestos-related contingent liabilities and related insurance receivables are based on a claim projection analysis and an insurance usage analysis prepared annually by third parties. The claim projection analysis contains numerous assumptions, including number of claims that might be received, the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, dismissal rates, average indemnity costs, average defense costs, costs of medical treatment, the financial resources of other companies that are co-defendants in claims, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, and the impact of potential changes in legislative or judicial standards, including potential tort reform. Furthermore, any predictions with respect to these assumptions are subject to even greater uncertainty as the projection period lengthens. The insurance usage analysis considers, among other things, applicable deductibles, retentions and policy limits, the solvency and historical payment experience of various insurance carriers, the likelihood of recovery as estimated by external legal counsel and existing insurance settlements. We believe the assumptions used in our models for determining our potential exposure and related insurance coverage are reasonable at the present time, but such assumptions are inherently uncertain. Given the inherent uncertainty in making projections, we plan to re-examine periodically the assumptions used in the projections of current and future asbestos claims, and we will update them, if needed, based on our experience, changes in the assumptions underlying our models, and other relevant factors, such as changes in the tort system. Our accrued asbestos liabilities may not approximate our actual asbestos-related indemnity and defense costs, and our accrued insurance recoveries may not be realized. We believe that it is reasonably possible that we may incur additional charges for our asbestos liabilities and defense costs in the future that could exceed existing reserves and insurance recoveries. |
Investments in Unconsolidated Joint Ventures | Investments in Unconsolidated Joint Ventures We account for our investments in and advances to unconsolidated joint ventures, both of which are 50% owned, using the equity method of accounting. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments |
Derivative Financial Instruments and Hedging Transactions | Derivative Financial Instruments and Hedging Transactions We are exposed to certain risks related to our ongoing business operations, and, from time to time, we manage these risk exposures by utilizing derivative financial instruments. We do not utilize derivative financial instruments for trading or speculative purposes. The primary risks being managed through our use of derivative instruments are foreign currency exchange rate risk and commodity pricing risk (primarily related to copper). To qualify for hedge accounting treatment, derivatives used for hedging purposes must be designated and deemed effective as a hedge of the identified underlying risk exposure at the inception of the contract. Accordingly, changes in fair value of the derivative contract must be highly correlated with changes in the fair value of the underlying hedged item at inception of the hedge and over the life of the hedge contract. |
Concentration of Credit and Investment Risk | Concentration of Credit and Investment Risk We are subject to credit and market risk by using derivative instruments. If a counterparty fails to fulfill its performance obligations under a derivative contract, our credit risk will equal the fair value of the derivative instrument. We seek to minimize counterparty credit (or repayment) risk by entering into derivative transactions with major financial institutions with investment grade credit ratings. We invest excess cash principally in investment grade government securities and time deposits. We have established guidelines relative to diversification and maturities in order to maintain safety and liquidity. These guidelines are periodically reviewed and modified to reflect changes in market conditions. |
Income Taxes | Income Taxes We are subject to income taxes in the U.S. and in numerous foreign jurisdictions. We account for income taxes following ASC 740, Income Taxes , recognizing deferred tax assets and liabilities using enacted tax rates for the effect of temporary differences between book and tax basis of recorded assets and liabilities. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some or all of a deferred tax asset will not be realized. We record benefits for uncertain tax positions based on an assessment of whether it is more likely than not that the tax positions will be sustained by the taxing authorities. If this threshold is not met, no tax benefit of the uncertain position is recognized. If the threshold is met, we recognize the largest amount of the tax benefit that is greater than fifty percent likely to be realized upon ultimate settlement. We recognize interest and penalties within the “Income tax expense” line item in the consolidated statements of operations. Accrued interest and penalties are included within the related tax liability line item in the consolidated statements of financial position. |
Revenue Recognition | Revenue Recognition Recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the providing entity expects to be entitled in exchange for those goods or services. We recognize revenue when all of the following criteria are met: (1) we have entered into a binding agreement, (2) the performance obligations have been identified, (3) the transaction price to the customer has been determined, (4) the transaction price has been allocated to the performance obligations in the contract, and (5) the performance obligations have been satisfied. The majority of our shipping terms permit us to recognize revenue at point of shipment. Some shipping terms require the goods to be cleared through customs or be received by the customer before title passes. In those instances, revenue is not recognized until either the customer has received the goods or they have passed through customs, depending on the circumstances. Shipping and handling costs are treated as fulfillment costs. Sales tax or VAT are excluded from the measurement of the transaction price. We manufacture some products to customer specifications which are customized to such a degree that it is unlikely that another entity would purchase these products or that we could modify these products for another customer. These products are deemed to have no alternative use to the Company whereby we have an enforceable right to payment evidenced by contractual termination clauses. In accordance with ASC 606, for those circumstances we recognize revenue on an over-time basis. Revenue recognition does not occur until the product meets the definition of “no alternative use” and therefore, items that have not yet reached that point in the production process are not included in the population of items with over-time revenue recognition. As appropriate, we record estimated reductions to revenue for customer returns, allowances, and warranty claims. Provisions for such reductions are made at the time of sale and are typically derived from historical trends and other relevant information. |
Earnings Per Share | Earnings Per Share Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding. |
Equity Compensation | Equity Compensation Equity compensation mainly consists of expense related to restricted stock units and deferred stock units. Performance-based restricted stock unit compensation expense is based on achievement of both market and service conditions. The fair value of these awards is determined based on a Monte Carlo simulation valuation model on the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period with no changes for final projected payout of the awards. Time-based restricted stock unit compensation expense is based on the achievement of only service conditions. The fair value of these awards is determined based on the market value of the underlying stock price on the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period. Deferred stock units, which are granted to non-management directors, are fully vested on the date of grant and the related shares are generally issued on the 13-month anniversary of the grant date unless the director elects to defer the receipt of those shares. The fair value of these awards is determined based on the market value of the underlying stock price on the grant date. The compensation related to these grants is expensed immediately on the date of grant. |
Business Combination Purchase Price Allocation | Business Combination Purchase Price Allocation The application of the acquisition method requires the allocation of the purchase price amongst the acquisition date fair values of identifiable assets acquired and liabilities assumed in a business combination. Fair values are determined using the income approach, market approach and/or cost approach depending on the nature of the asset or liability being valued and the reliability of available information. The income approach estimates fair value by discounting associated lifetime expected future cash flows to their present value and relies on significant assumptions regarding future revenues, expenses, working capital levels and discount rates. The market approach estimates fair value by analyzing recent actual market transactions for similar assets or liabilities. The cost approach estimates fair value based on the expected cost to replace or reproduce the asset or liability and relies on assumptions regarding the occurrence and extent of any physical, functional and/or economic obsolescence. |
Restructuring Activities | Restructuring Activities We record charges associated with restructuring activities, such as employee termination benefits, when management approves and commits to a plan of termination, or over the future service period, if any. Other costs associated with restructuring activities may include contract termination costs, including costs related to leased facilities to be abandoned or subleased, and facility and employee relocation costs. |
Advertising Costs | Advertising Costs Advertising costs are expensed as incurred and included in the "Selling, general and administrative expenses” line item of the consolidated statements of operations, amounted to $3.5 million, $3.3 million and $2.7 million in 2023, 2022 and 2021, respectively. |
Reclassification | Reclassification Certain reclassifications have been made in the 2022 and 2021 financial statements and notes to conform to the 2023 presentation. |
Recently Issued Standards | Recently Issued Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU 2023-07 enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures. This amendment will improve the disclosures about a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard requires using the retrospective approach. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard should be applied on a prospective basis and retrospective application to all periods presented is permitted. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes. |
Basis of Presentation, Organi_3
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Property, Plant and Equipment | For financial reporting purposes, provisions for depreciation are calculated on a straight-line basis over the following estimated useful lives of the underlying assets: Property, Plant and Equipment Classification Estimated Useful Lives Buildings and improvements 30-40 years Machinery and equipment 5-15 years Office equipment 3-10 years The “Property, plant and equipment, net” line item in the consolidated statements of financial position consisted of the following: As of December 31, (Dollars in millions) 2023 2022 Land and improvements $ 16.8 $ 23.9 Buildings and improvements 177.2 169.5 Machinery and equipment 343.0 334.1 Office equipment 70.7 61.5 Property plant and equipment, gross 607.7 589.0 Accumulated depreciation (385.7) (381.6) Property, plant and equipment, net 222.0 207.4 Construction in process 144.3 151.0 Total property, plant and equipment, net $ 366.3 $ 358.4 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Loss (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Schedule of Changes in Accumulated Other Comprehensive Income (Loss) | The changes in accumulated other comprehensive loss by component for each of the fiscal years in the two-year period ended December 31, 2023 were as follows: (Dollars and accompanying footnotes in millions) Foreign Currency Translation Adjustments Pension and Other Postretirement Benefits (1) Total Balance as of December 31, 2021 $ (35.6) $ (9.6) $ (45.2) Other comprehensive income (loss) before reclassifications (40.0) (0.2) (40.2) Amounts reclassified to earnings — 0.2 0.2 Net other comprehensive income (loss) for period (40.0) — (40.0) Balance as of December 31, 2022 (75.6) (9.6) (85.2) Other comprehensive income (loss) before reclassifications 18.8 (0.4) 18.4 Amounts reclassified to earnings — 0.4 0.4 Net other comprehensive income (loss) for period 18.8 — 18.8 Balance as of December 31, 2023 $ (56.8) $ (9.6) $ (66.4) (1) Net of taxes of $1.8 million, $1.9 million and $2.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. |
Schedule of Reclassification of Accumulated Other Comprehensive Income (Loss) | The impacts to the consolidated statements of operations related to items reclassified to earnings were as follows: Years Ended December 31, (Dollars in millions) Financial Statement Line Item 2023 2022 Amortization/settlement of pension and other postretirement benefits Pension settlement charges (1) (0.1) — Other income (expense), net (1) (0.4) (0.4) Income tax (expense) benefit 0.1 0.2 Net income $ (0.4) $ (0.2) (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension cost. For additional details, refer to “Note 8 – Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plan.” |
Derivatives and Hedging (Tables
Derivatives and Hedging (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Notional Amounts of Outstanding Derivative Positions | As of December 31, 2023, the notional values of these foreign currency forward contracts were as follows: Notional Values of Foreign Currency Derivatives USD/CNH $ 25,900,000 KRW/USD ₩ 1,291,700,000 EUR/USD € 12,600,000 JPY/EUR ¥ 250,000,000 As of December 31, 2023, the volume of our copper contracts outstanding were as follows: Volume of Copper Derivatives January 2024 - March 2024 69 metric tons per month April 2024 - June 2024 69 metric tons per month July 2024 - September 2024 69 metric tons per month October 2024 - December 2024 69 metric tons per month |
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following table presents the impact from these instruments on the consolidated statements of operations and consolidated statements of comprehensive income: Years Ended December 31, (Dollars in millions) Financial Statement Line Item 2023 2022 2021 Foreign Currency Contracts Contracts not designated as hedging instruments Other income (expense), net $ 1.0 $ (0.3) $ (2.9) Copper Derivatives Contracts Contracts not designated as hedging instruments Other income (expense), net $ (0.6) $ 0.8 $ 3.9 |
Schedule of Derivative Instruments Measured at Fair Value on a Recurring Basis | The fair values of derivative instruments measured at fair value on a recurring basis, categorized by contract type and level of inputs used in the valuation, were as follows: Derivative Instruments at Fair Value as of December 31, 2023 (Dollars in millions) Level 1 Level 2 Level 3 Total (1) Foreign currency contracts $ — $ (0.2) $ — $ (0.2) Copper derivative contracts $ — $ 0.4 $ — $ 0.4 Derivative Instruments at Fair Value as of December 31, 2022 (Dollars in millions) Level 1 Level 2 Level 3 Total (1) Foreign currency contracts $ — $ (0.1) $ — $ (0.1) Copper derivative contracts $ — $ 0.5 $ — $ 0.5 (1) All balances were recorded in the “Other current assets” or the “Other accrued liabilities” line items in the consolidated statements of financial position. |
Inventories, net (Tables)
Inventories, net (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | The “Inventories, net” line item in the consolidated statements of financial position consisted of the following: As of December 31, (Dollars in millions) 2023 2022 Raw materials $ 71.5 $ 87.9 Work-in-process 45.6 45.1 Finished goods 36.4 49.4 Total inventories, net $ 153.5 $ 182.4 |
Property, Plant and Equipment (
Property, Plant and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property, Plant and Equipment | For financial reporting purposes, provisions for depreciation are calculated on a straight-line basis over the following estimated useful lives of the underlying assets: Property, Plant and Equipment Classification Estimated Useful Lives Buildings and improvements 30-40 years Machinery and equipment 5-15 years Office equipment 3-10 years The “Property, plant and equipment, net” line item in the consolidated statements of financial position consisted of the following: As of December 31, (Dollars in millions) 2023 2022 Land and improvements $ 16.8 $ 23.9 Buildings and improvements 177.2 169.5 Machinery and equipment 343.0 334.1 Office equipment 70.7 61.5 Property plant and equipment, gross 607.7 589.0 Accumulated depreciation (385.7) (381.6) Property, plant and equipment, net 222.0 207.4 Construction in process 144.3 151.0 Total property, plant and equipment, net $ 366.3 $ 358.4 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Schedule of Lease Expense, Payments for Operating Leases and Information Related to Lease Term and Discount Rates | Our expenses and payments for operating leases were as follows: Year Ended December 31, (Dollars in millions) 2023 2022 2021 Operating leases expense $ 4.1 $ 2.8 $ 3.0 Short-term leases expense $ 0.7 $ 0.6 $ 0.3 Payments on operating lease obligations $ 4.0 $ 3.1 $ 2.8 The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments: 2023 2022 Weighted Average Remaining Lease Term Finance leases 4.0 years 4.6 years Operating leases 7.0 years 6.5 years Weighted Average Discount Rate Finance leases 4.14% 3.89% Operating leases 5.35% 5.24% |
Schedule of Assets and Liabilities Balance Related to Finance and Operating Leases | The assets and liabilities balances related to finance and operating leases reflected in the consolidated statements of financial position were as follows: As of December 31, (Dollars in millions) Financial Statement Line Item 2023 2022 Finance lease right-of-use assets Property, plant and equipment, net $ 1.5 $ 1.7 Operating lease right-of-use assets Operating lease right-of-use assets $ 18.9 $ 13.0 Finance lease obligations, current portion Other accrued liabilities $ 0.4 $ 0.5 Finance lease obligations, non-current portion Other long-term liabilities $ 1.1 $ 1.3 Total finance lease obligations $ 1.5 $ 1.8 Operating lease obligations, current portion Operating lease obligations, current portion $ 3.5 $ 2.8 Operating lease obligations, non-current portion Operating lease obligations, non-current portion $ 15.4 $ 10.7 Total operating lease obligations $ 18.9 $ 13.5 |
Schedule of Finance Lease Liability Maturity | The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of December 31, 2023: Finance Operating (Dollars in millions) Leases Signed Less: Leases Not Yet Commenced Leases in Effect Leases Signed Less: Leases Not Yet Commenced Leases in Effect 2024 $ 0.4 $ — $ 0.4 $ 4.4 $ — $ 4.4 2025 0.4 — 0.4 3.9 (0.1) 3.8 2026 0.4 — 0.4 3.1 (0.1) 3.0 2027 0.2 — 0.2 2.6 — 2.6 2028 0.1 — 0.1 1.9 — 1.9 Thereafter 0.1 — 0.1 7.3 — 7.3 Total lease payments 1.6 — 1.6 23.2 (0.2) 23.0 Less: Interest (0.1) — (0.1) (4.1) — (4.1) Present Value of Net Future Minimum Lease Payments $ 1.5 $ — $ 1.5 $ 19.1 $ (0.2) $ 18.9 |
Schedule of Operating Lease Liability Maturity | The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of December 31, 2023: Finance Operating (Dollars in millions) Leases Signed Less: Leases Not Yet Commenced Leases in Effect Leases Signed Less: Leases Not Yet Commenced Leases in Effect 2024 $ 0.4 $ — $ 0.4 $ 4.4 $ — $ 4.4 2025 0.4 — 0.4 3.9 (0.1) 3.8 2026 0.4 — 0.4 3.1 (0.1) 3.0 2027 0.2 — 0.2 2.6 — 2.6 2028 0.1 — 0.1 1.9 — 1.9 Thereafter 0.1 — 0.1 7.3 — 7.3 Total lease payments 1.6 — 1.6 23.2 (0.2) 23.0 Less: Interest (0.1) — (0.1) (4.1) — (4.1) Present Value of Net Future Minimum Lease Payments $ 1.5 $ — $ 1.5 $ 19.1 $ (0.2) $ 18.9 |
Goodwill and Other Intangible_2
Goodwill and Other Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | The changes in the carrying amount of goodwill for the period ending December 31, 2023, by operating segment, were as follows: (Dollars in millions) Advanced Electronics Solutions Elastomeric Material Solutions Other Total December 31, 2022 $ 115.4 $ 234.8 $ 2.2 $ 352.4 Foreign currency translation adjustment 2.3 5.1 — 7.4 December 31, 2023 $ 117.7 $ 239.9 $ 2.2 $ 359.8 |
Schedule of Intangible Assets | The carrying amount of other intangible assets were as follows: December 31, 2023 December 31, 2022 (Dollars in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Customer relationships $ 177.9 $ 90.0 $ 87.9 $ 178.6 $ 85.6 $ 93.0 Technology 77.4 58.1 19.3 82.4 59.1 23.3 Trademarks and trade names 19.4 7.4 12.0 19.1 6.6 12.5 Covenants not to compete 1.3 0.9 0.4 1.9 1.2 0.7 Total definite-lived other intangible assets 276.0 156.4 119.6 282.0 152.5 129.5 Indefinite-lived other intangible asset 4.3 — 4.3 4.2 — 4.2 Total other intangible assets $ 280.3 $ 156.4 $ 123.9 $ 286.2 $ 152.5 $ 133.7 |
Schedule of Weighted Average Amortization Period, by Intangible Asset Class | The weighted average amortization period as of December 31, 2023, by definite-lived other intangible asset class, is presented in the table below: Definite-Lived Other Intangible Asset Class Weighted Average Remaining Amortization Period Customer relationships 7.4 years Technology 3.3 years Trademarks and trade names 10.0 years Covenants not to compete 0.5 years Total definite-lived other intangible assets 7.0 years |
Pension Benefits, Other Postr_2
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Retirement Benefits [Abstract] | |
Schedule of Change In Benefit Obligation | The following table summarizes the change in plan assets and changes in benefit obligations: Pension Benefits Other Postretirement Benefits (Dollars in millions) 2023 2022 2023 2022 Change in plan assets: Fair value of plan assets as of January 1 $ 26.3 $ 33.5 $ — $ — Actual return on plan assets 1.9 (5.6) — — Settlement (0.3) — — — Employer contributions 0.3 — — — Benefit payments (1.5) (1.6) — — Fair value of plan assets as of December 31 $ 26.7 $ 26.3 $ — $ — Change in plan benefit obligations: Fair value of plan benefit obligations as of January 1 $ 21.3 $ 28.7 $ 1.4 $ 1.4 Service cost — — 0.1 0.1 Interest cost 1.1 0.7 0.1 — Actuarial (gain) loss 0.8 (6.6) — (0.1) Settlement (0.3) — — — Benefit payments (1.5) (1.5) — — Fair value of plan benefit obligations as of December 31 $ 21.4 $ 21.3 $ 1.6 $ 1.4 Amount overfunded (underfunded) $ 5.3 $ 5.0 $ (1.6) $ (1.4) |
Schedule of Change in Plan Assets | The following table summarizes the change in plan assets and changes in benefit obligations: Pension Benefits Other Postretirement Benefits (Dollars in millions) 2023 2022 2023 2022 Change in plan assets: Fair value of plan assets as of January 1 $ 26.3 $ 33.5 $ — $ — Actual return on plan assets 1.9 (5.6) — — Settlement (0.3) — — — Employer contributions 0.3 — — — Benefit payments (1.5) (1.6) — — Fair value of plan assets as of December 31 $ 26.7 $ 26.3 $ — $ — Change in plan benefit obligations: Fair value of plan benefit obligations as of January 1 $ 21.3 $ 28.7 $ 1.4 $ 1.4 Service cost — — 0.1 0.1 Interest cost 1.1 0.7 0.1 — Actuarial (gain) loss 0.8 (6.6) — (0.1) Settlement (0.3) — — — Benefit payments (1.5) (1.5) — — Fair value of plan benefit obligations as of December 31 $ 21.4 $ 21.3 $ 1.6 $ 1.4 Amount overfunded (underfunded) $ 5.3 $ 5.0 $ (1.6) $ (1.4) |
Schedule Of Amounts Recognized In Consolidated Balance Sheet | The pension-related balances reflected in the consolidated statements of financial position consisted of the following: Pension Benefits Other Postretirement Benefits As of December 31, As of December 31, (Dollars in millions) 2023 2022 2023 2022 Assets & Liabilities: Non-current assets $ 5.3 $ 5.2 $ — $ — Current liabilities — — (0.2) (0.2) Non-current liabilities — (0.2) (1.4) (1.2) Net assets (liabilities) $ 5.3 $ 5.0 $ (1.6) $ (1.4) Accumulated Other Comprehensive Loss: Net actuarial (loss) gain $ (11.6) $ (11.8) $ 0.2 $ 0.2 Accumulated other comprehensive (loss) income $ (11.6) $ (11.8) $ 0.2 $ 0.2 |
Schedule Of Net Periodic Benefit Cost Not Yet Recognized | The pension-related balances reflected in the consolidated statements of financial position consisted of the following: Pension Benefits Other Postretirement Benefits As of December 31, As of December 31, (Dollars in millions) 2023 2022 2023 2022 Assets & Liabilities: Non-current assets $ 5.3 $ 5.2 $ — $ — Current liabilities — — (0.2) (0.2) Non-current liabilities — (0.2) (1.4) (1.2) Net assets (liabilities) $ 5.3 $ 5.0 $ (1.6) $ (1.4) Accumulated Other Comprehensive Loss: Net actuarial (loss) gain $ (11.6) $ (11.8) $ 0.2 $ 0.2 Accumulated other comprehensive (loss) income $ (11.6) $ (11.8) $ 0.2 $ 0.2 |
Schedule of Projected Benefit Obligation and Fair Value of Plan Assets | The PBO, ABO, and fair value of plan assets for our pension plan with plan assets in excess of its PBO or ABO were as follows: (Dollars in millions) 2023 2022 Projected benefit obligation $ 21.5 $ 21.0 Accumulated benefit obligation $ 21.5 $ 21.0 Fair value of plan assets $ 26.7 $ 26.3 The PBO and ABO of plan assets for our other postretirement benefit plans with a PBO or ABO in excess of plan assets were as follows: (Dollars in millions) 2023 2022 Projected benefit obligation $ (1.6) $ (1.4) Accumulated benefit obligation $ (1.6) $ (1.4) Fair value of plan assets $ — $ — |
Schedule of Accumulated Benefit Obligation and Fair Value of Plan Assets | The PBO, ABO, and fair value of plan assets for our pension plan with plan assets in excess of its PBO or ABO were as follows: (Dollars in millions) 2023 2022 Projected benefit obligation $ 21.5 $ 21.0 Accumulated benefit obligation $ 21.5 $ 21.0 Fair value of plan assets $ 26.7 $ 26.3 The PBO and ABO of plan assets for our other postretirement benefit plans with a PBO or ABO in excess of plan assets were as follows: (Dollars in millions) 2023 2022 Projected benefit obligation $ (1.6) $ (1.4) Accumulated benefit obligation $ (1.6) $ (1.4) Fair value of plan assets $ — $ — |
Schedule of Components of Net Periodic Benefit Cost | The components of net periodic benefit cost (credit) were as follows: Pension Benefits Other Postretirement Benefits Years Ended December 31, Years Ended December 31, (Dollars in millions) 2023 2022 2021 2023 2022 2021 Service cost $ — $ — $ — $ 0.1 $ 0.1 $ 0.1 Interest cost 1.1 0.7 0.7 0.1 — — Expected return of plan assets (1.4) (1.3) (1.5) — — — Amortization of prior service credit — — — — — (0.1) Amortization of net loss (gain) 0.5 0.4 0.4 — — — Settlement 0.1 — — — — — Net periodic benefit cost (credit) $ 0.3 $ (0.2) $ (0.4) $ 0.2 $ 0.1 $ — |
Schedule of Weighted-Average Assumptions Used | The key plan assumptions utilized in our annual plan measurements were as follows: Pension Benefits Other Postretirement Benefits 2023 2022 2023 2022 Weighted average assumptions used in benefit obligations: Discount rate 4.75 % 5.25 % 4.75 % 5.00 % Weighted average assumptions used in net periodic benefit costs: Discount rate 5.25 % 2.75 % 5.00 % 2.25 % Expected long-term rate of return on assets 5.59 % 4.17 % — % — % |
Schedule of Allocation Of Plan Assets | The following table presents the fair value of the pension plan net assets by asset category and level, within the fair value hierarchy, as of December 31, 2023 and 2022: Fair Value of Plan Assets as of December 31, 2023 (Dollars in millions) Level 1 Level 2 Level 3 Total Fixed income bonds $ 0.2 $ 22.3 $ — $ 22.5 Mutual funds 3.0 — — 3.0 Pooled separate accounts — 0.1 — 0.1 Guaranteed deposit account — — 1.1 1.1 Total plan assets at fair value $ 3.2 $ 22.4 $ 1.1 $ 26.7 Fair Value of Plan Assets as of December 31, 2022 (Dollars in millions) Level 1 Level 2 Level 3 Total Fixed income bonds $ — $ 22.2 $ — $ 22.2 Mutual funds 2.5 — — 2.5 Pooled separate accounts — 0.5 — 0.5 Guaranteed deposit account — — 1.1 1.1 Total plan assets at fair value $ 2.5 $ 22.7 $ 1.1 $ 26.3 |
Schedule of Changes in Fair Value of Level 3 Assets | The following table presents a summary of changes in the fair value of the guaranteed deposit account’s Level 3 assets for the year ended December 31, 2023: (Dollars in millions) Guaranteed Deposit Account Balance as of December 31, 2022 $ 1.1 Change in unrealized gain (loss) — Purchases, sales, issuances and settlements (net) — Balance as of December 31, 2023 $ 1.1 |
Schedule of Future Benefit Payments | The following table sets forth the expected benefit payments to be paid for our pension plans and our other postretirement benefit plans: (Dollars in millions) Pension Benefits Other Postretirement Benefits 2024 $ 1.7 $ 0.2 2025 $ 1.7 $ 0.2 2026 $ 1.7 $ 0.2 2027 $ 1.7 $ 0.2 2028 $ 1.6 $ 0.1 2029-2033 $ 7.6 $ 0.8 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Change in Number of Asbestos Claims Outstanding | The following table summarizes the change in number of asbestos claims outstanding during 2023 and 2022: 2023 2022 Claims outstanding as of January 1 537 543 New claims filed 136 129 Pending claims concluded (1) (167) (135) Claims outstanding as of December 31 506 537 (1) For the year ended December 31, 2023, 155 claims were dismissed and 12 claims were settled. For the year ended December 31, 2022, 119 claims were dismissed and 16 claims were settled. Settlements totaled approximately $4.5 million for the year ended December 31, 2023, compared to $2.4 million for the year ended December 31, 2022. |
Schedule of Asbestos-Related Claims and Insurance Receivables | Our projected asbestos-related claims and insurance receivables were as follows: As of December 31, (Dollars in millions) 2023 2022 Asbestos-related liabilities $ 61.5 $ 65.1 Asbestos-related insurance receivables $ 56.5 $ 59.8 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Computation of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share: Years Ended December 31, (Dollars and shares in millions, except per share amounts) 2023 2022 2021 Numerator: Net income $ 56.6 $ 116.6 $ 108.1 Denominator: Weighted average shares outstanding - basic 18.6 18.8 18.7 Effect of dilutive shares 0.1 0.2 0.2 Weighted average shares outstanding - diluted 18.7 19.0 18.9 Basic earnings per share $ 3.04 $ 6.21 $ 5.77 Diluted earnings per share $ 3.03 $ 6.15 $ 5.73 |
Capital Stock and Equity Comp_2
Capital Stock and Equity Compensation (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Schedule of Shares of Capital Stock Reserved for Possible Future Issuance | Shares of capital stock reserved for possible future issuance were as follows: As of December 31, 2023 2022 Shares reserved for issuance under outstanding restricted stock unit awards 248,055 255,310 Deferred compensation to be paid in stock, including deferred stock units 8,100 6,850 Additional shares reserved for issuance under Rogers Corporation 2019 Long-Term Equity Compensation Plan 842,046 914,439 Shares reserved for issuance under the Rogers Corporation Employee Stock Purchase Plan 59,611 59,611 Total 1,157,812 1,236,210 |
Schedule of Weighted-Average Assumptions Used | Below were the assumptions used in the Monte Carlo calculation for each material award granted in 2023 and 2021: February 9, 2023 February 10, 2021 Expected volatility 53.2% 51.0% Expected term 2.9 years 2.9 years Risk-free interest rate 4.08% 0.18% |
Schedule of Restricted Stock And Restricted Stock Activity | A summary of activity of the outstanding performance-based restricted stock units for 2023, 2022 and 2021 is presented below: 2023 2022 2021 Awards Outstanding Weighted- Awards Outstanding Weighted- Awards Outstanding Weighted- Awards outstanding as of January 1 65,513 $ 201.18 114,554 $ 196.23 111,059 $ 170.84 Awards granted 50,551 241.47 26,819 176.33 41,507 258.17 Stock issued (8,775) 147.58 (60,053) 179.72 — — Awards forfeited (33,761) 174.43 (15,807) 204.69 (38,012) 189.69 Awards outstanding as of December 31 73,528 $ 247.55 65,513 $ 201.18 114,554 $ 196.23 A summary of activity of the outstanding time-based restricted stock units for 2023, 2022 and 2021 is presented below: 2023 2022 2021 Awards Outstanding Weighted- Awards Outstanding Weighted- Awards Outstanding Weighted- Awards outstanding as of January 1 124,284 $ 194.60 96,989 $ 157.49 102,142 $ 120.16 Awards granted 67,734 148.85 96,620 219.60 50,640 180.19 Stock issued (62,251) 173.52 (48,253) 183.00 (46,329) 146.45 Awards forfeited (28,768) 213.84 (21,072) 223.90 (9,464) 146.58 Awards outstanding as of December 31 100,999 $ 171.43 124,284 $ 194.60 96,989 $ 157.49 A summary of activity of the outstanding deferred stock units for 2023, 2022 and 2021 is presented below: 2023 2022 2021 Awards Outstanding Weighted- Awards Outstanding Weighted- Awards Outstanding Weighted- Awards outstanding as of January 1 6,850 $ 232.51 9,500 $ 173.82 12,450 $ 113.96 Awards granted 8,100 161.90 4,800 272.12 6,450 188.60 Stock issued (6,850) 232.51 (7,450) 183.20 (9,400) 104.68 Awards outstanding as of December 31 8,100 $ 161.9 6,850 $ 232.51 9,500 $ 173.82 |
Operating Segment and Geograp_2
Operating Segment and Geographic Information (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Reportable Segment Information | The following table presents a disaggregation of revenue from contracts with customers and other pertinent financial information, for the periods indicated; inter-segment sales have been eliminated from the net sales data: (Dollars in millions) Advanced Electronics Solutions Elastomeric Material Solutions Other Total December 31, 2023 Net sales - recognized over time $ 234.1 $ 19.6 $ 15.8 $ 269.5 Net sales - recognized at a point in time $ 275.6 $ 359.4 $ 3.9 $ 638.9 Total net sales $ 509.7 $ 379.0 $ 19.7 $ 908.4 Operating income $ 2.6 $ 76.1 $ 6.6 $ 85.3 Total assets $ 762.8 $ 742.0 $ 12.4 $ 1,517.2 Capital expenditures $ 30.5 $ 25.9 $ 0.6 $ 57.0 Depreciation & amortization $ 27.6 $ 22.8 $ 0.7 $ 51.1 Investment in unconsolidated joint ventures $ — $ 11.1 $ — $ 11.1 Equity income in unconsolidated joint ventures $ — $ 1.8 $ — $ 1.8 December 31, 2022 Net sales - recognized over time $ 227.0 $ 15.9 $ 16.4 $ 259.3 Net sales - recognized at a point in time $ 303.2 $ 404.1 $ 4.6 $ 711.9 Total net sales $ 530.2 $ 420.0 $ 21.0 $ 971.2 Operating income $ 77.1 $ 60.4 $ 6.9 $ 144.4 Total assets $ 854.2 $ 778.7 $ 13.3 $ 1,646.2 Capital expenditures $ 58.9 $ 57.6 $ 0.3 $ 116.8 Depreciation & amortization $ 21.7 $ 23.5 $ 0.7 $ 45.9 Investment in unconsolidated joint ventures $ — $ 14.1 $ — $ 14.1 Equity income in unconsolidated joint ventures $ — $ 4.4 $ — $ 4.4 December 31, 2021 Net sales - recognized over time $ 244.1 $ 14.9 $ 18.8 $ 277.8 Net sales - recognized at a point in time $ 290.4 $ 363.1 $ 1.6 $ 655.1 Total net sales $ 534.5 $ 378.0 $ 20.4 $ 932.9 Operating income $ 50.2 $ 60.1 $ 6.9 $ 117.2 Total assets $ 826.7 $ 759.6 $ 12.3 $ 1,598.6 Capital expenditures $ 38.9 $ 31.8 $ 0.4 $ 71.1 Depreciation & amortization $ 22.9 $ 19.7 $ 0.7 $ 43.3 Investment in unconsolidated joint ventures $ — $ 16.3 $ — $ 16.3 Equity income in unconsolidated joint ventures $ — $ 7.0 $ — $ 7.0 Operating Segment Net Sales by Geographic Area The following table presents net sales by our operating segment operations by geographic area for the years indicated: (Dollars in millions) Net Sales (1) Region/Country Advanced Electronics Solutions Elastomeric Material Solutions Other Total December 31, 2023 United States $ 81.1 $ 155.4 $ 3.9 $ 240.4 Other Americas 3.6 13.7 0.3 17.6 Total Americas 84.7 169.1 4.2 258.0 China 144.6 93.0 4.3 241.9 Other APAC 88.3 31.7 5.6 125.6 Total APAC 232.9 124.7 9.9 367.5 Germany 95.2 28.3 0.5 124.0 Other EMEA 96.9 56.9 5.1 158.9 Total EMEA 192.1 85.2 5.6 282.9 Total net sales $ 509.7 $ 379.0 $ 19.7 $ 908.4 December 31, 2022 United States $ 122.7 $ 169.4 $ 4.5 $ 296.6 Other Americas 6.6 15.4 0.3 22.3 Total Americas 129.3 184.8 4.8 318.9 China 154.4 121.7 7.4 283.5 Other APAC 75.2 31.4 2.7 109.3 Total APAC 229.6 153.1 10.1 392.8 Germany 78.7 30.4 1.1 110.2 Other EMEA 92.6 51.7 5.0 149.3 Total EMEA 171.3 82.1 6.1 259.5 Total net sales $ 530.2 $ 420.0 $ 21.0 $ 971.2 December 31, 2021 United States $ 93.6 $ 161.2 $ 4.5 $ 259.3 Other Americas 3.1 10.2 0.8 14.1 Total Americas 96.7 171.4 5.3 273.4 China 193.4 122.0 4.8 320.2 Other APAC 85.1 27.6 2.6 115.3 Total APAC 278.5 149.6 7.4 435.5 Germany 72.6 29.2 0.8 102.6 Other EMEA 86.7 27.8 6.9 121.4 Total EMEA 159.3 57.0 7.7 224.0 Total net sales $ 534.5 $ 378.0 $ 20.4 $ 932.9 (1) Net sales are allocated to countries based on the location of the customer. The table above lists individual countries with 10% or more of net sales for the periods indicated. Our contract assets by operating segment were as follows: As of December 31, (Dollars in millions) 2023 2022 Advanced Electronics Solutions $ 41.4 $ 33.8 Elastomeric Material Solutions 0.4 1.6 Other 3.4 3.5 Total contract assets $ 45.2 $ 38.9 |
Schedule of Long-lived Assets By Geographic Region | Our long-lived assets (1) by geographic area were as follows: As of December 31, (Dollars in millions) 2023 2022 United States $ 384.1 $ 401.2 England 166.7 161.9 Germany 148.9 139.7 Other 169.2 154.7 Total long-lived assets $ 868.9 $ 857.5 (1) Long-lived assets are based on the location of the asset and are comprised of goodwill, other intangible assets, property, plant and equipment and right-of-use assets. Countries with 10% or more of long-lived assets have been disclosed. |
Supplemental Financial Inform_2
Supplemental Financial Information (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Supplemental Income Statement Elements [Abstract] | |
Schedule of Restructuring and Impairment Charges | The components of the “Restructuring and impairment charges” line item in the consolidated statements of operations were as follows: Years Ended December 31, (Dollars in millions) 2023 2022 2021 Restructuring charges Global workforce reduction $ 8.8 $ — $ — Facility consolidations 8.1 0.4 — Manufacturing footprint optimization — 1.1 3.1 Total restructuring charges 16.9 1.5 3.1 Impairment charges Fixed assets impairment charges — 47.2 0.5 Other impairment charges — 17.9 — Total impairment charges — 65.1 0.5 Total restructuring and impairment charges $ 16.9 $ 66.6 $ 3.6 The following table summarizes the allocation of restructuring and impairment charges to our operating segments: Years Ended December 31, (Dollars in millions) 2023 2022 2021 Advanced Electronics Solutions Allocated restructuring charges $ 10.7 $ 1.1 $ 3.0 Allocated impairment charges — 40.5 0.5 Elastomeric Material Solutions Allocated restructuring charges 6.2 0.4 0.1 Allocated impairment charges — 24.6 — Total restructuring and impairment charges $ 16.9 $ 66.6 $ 3.6 |
Schedule of Restructuring and Related Costs | (Dollars in millions) Global Workforce Reduction Restructuring Severance and Related Benefits Balance as of December 31, 2022 $ — Provisions 8.5 Payments (8.6) Foreign currency translation adjustment 0.1 Balance as of December 31, 2023 $ — |
Schedule of Components of Other Operating (Income) Expense, Net | The components of the “Other operating (income) expense, net” line item in the consolidated statements of operations were as follows: Years Ended December 31, (Dollars in millions) 2023 2022 2021 UTIS fire Fixed assets write-offs $ — $ — $ 1.1 Inventory charges — 0.2 0.9 Professional services 0.9 1.4 2.7 Lease obligations — 0.4 1.0 Lease impairments — — 0.5 Compensation & benefits — 2.4 2.1 Third-party property claims — — 4.7 Other — (0.2) 0.1 Insurance recoveries (31.4) (6.6) (6.9) Total UTIS fire (30.5) (2.4) 6.2 Regulatory termination fee, net — (142.1) — Loss (gain) on sale or disposal of property, plant and equipment (2.6) 0.5 (0.9) Total other operating (income) expense, net $ (33.1) $ (144.0) $ 5.3 |
Schedule of Components of Interest Expense, Net | The components of the “Interest expense, net” line item in the consolidated statements of operations were as follows: Years Ended December 31, (Dollars in millions) 2023 2022 2021 Interest on revolving credit facility $ 9.6 $ 9.0 $ 0.9 Line of credit fees 0.8 0.5 1.1 Debt issuance amortization costs 0.7 0.7 0.7 Interest income (1.2) (0.7) (0.5) Other 0.2 — 0.4 Total interest expense, net $ 10.1 $ 9.5 $ 2.5 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of Consolidated Income (loss) from Continuing Operations Before Income Taxes by Location | The “Income before income tax expense” line item in the consolidated statements of operations consisted of: (Dollars in millions) 2023 2022 2021 Domestic $ 9.1 $ 58.4 $ 34.4 Foreign 67.2 82.0 91.9 Total $ 76.3 $ 140.4 $ 126.3 |
Schedule of Income Tax Expense (Benefit) by Location | The “Income tax expense” line item in the consolidated statements of operations consisted of: (Dollars in millions) Current Deferred Total 2023 Domestic $ 0.4 $ (0.6) $ (0.2) Foreign 22.9 (3.0) 19.9 Total $ 23.3 $ (3.6) $ 19.7 2022 Domestic $ 26.8 $ (18.8) $ 8.0 Foreign 17.6 (1.8) 15.8 Total $ 44.4 $ (20.6) $ 23.8 2021 Domestic $ 5.2 $ (2.9) $ 2.3 Foreign 16.2 (0.3) 15.9 Total $ 21.4 $ (3.2) $ 18.2 |
Schedule of Deferred Tax Assets and Liabilities | Deferred tax assets and liabilities as of December 31, 2023 and 2022, were comprised of the following: (Dollars in millions) 2023 2022 Deferred tax assets Accrued employee benefits and compensation $ 7.7 $ 8.7 Net operating loss carryforwards 11.8 4.4 Tax credit carryforwards 6.7 2.8 Reserves and accruals 5.7 4.7 Operating leases 3.6 4.2 Capitalized research and development 25.6 21.3 Other 6.9 10.2 Total deferred tax assets 68.0 56.3 Less deferred tax asset valuation allowance (11.4) (2.8) Total deferred tax assets, net of valuation allowance 56.6 53.5 Deferred tax liabilities Depreciation and amortization 17.7 14.4 Postretirement benefit obligations 0.7 0.7 Unremitted earnings 1.5 2.6 Operating leases 4.1 4.6 Other 5.8 4.2 Total deferred tax liabilities 29.8 26.5 Net deferred tax asset (liability) $ 26.8 $ 27.0 |
Schedule of Effective Income Tax Rate Reconciliation | Income tax expense differs from the amount computed by applying the U.S. federal statutory income tax rate to income before income taxes. The reasons for this difference were as follows: (Dollars in millions) 2023 2022 2021 Tax expense at Federal statutory income tax rate $ 16.0 $ 29.5 $ 26.5 Impact of foreign operations 4.0 1.5 2.0 Foreign source income, net of tax credits (2.3) (6.5) (4.9) State tax, net of federal (0.5) 6.9 0.2 Deferred tax adjustment 1.2 — — Unrecognized tax benefits (0.2) 1.9 (8.8) Equity compensation excess tax deductions 0.3 (3.0) 0.3 General business credits (2.4) (0.8) (0.9) Distribution related foreign taxes 1.1 1.5 2.5 Executive compensation limitation 0.9 2.9 1.6 Valuation allowance change 0.7 (6.9) 0.5 Other 0.9 (3.2) (0.8) Income tax expense $ 19.7 $ 23.8 $ 18.2 |
Schedule of Reconciliation of Unrecognized Tax Benefits | Unrecognized tax benefits, excluding potential interest and penalties, for the years ended December 31, 2023 and 2022, were as follows: (Dollars in millions) 2023 2022 2021 Beginning balance as of January 1 $ 8.9 $ 6.6 $ 15.7 Gross increases - current period tax positions 1.1 3.4 1.0 Gross increases - tax positions in prior periods — 0.2 1.2 Gross decreases - tax positions in prior periods (0.5) (0.2) (9.2) Foreign currency exchange 0.1 (0.1) — Settlements 0.1 (1.0) (2.1) Lapse of statue of limitations $ (1.2) $ — $ — Ending balance as of December 31 $ 8.5 $ 8.9 $ 6.6 |
Mergers and Acquisitions (Table
Mergers and Acquisitions (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Pro-Forma Information | The following unaudited pro forma financial information presents the combined results of operations of Rogers and Silicone Engineering as if the Silicone Engineering acquisition had occurred on January 1, 2020. The unaudited pro forma financial information is not intended to represent or be indicative of our consolidated results of operations that would have been reported had the Silicone Engineering acquisition been completed as of January 1, 2020 and should not be taken as indicative of our future consolidated results of operations. For the Years Ended December 31, (Dollars in millions) 2021 Net sales $ 973.2 Net income $ 120.1 |
Basis of Presentation, Organi_4
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Organization and Investments in Unconsolidated Joint Ventures) (Details) | 12 Months Ended |
Dec. 31, 2023 joint_venture segment | |
Schedule of Equity Method Investments [Line Items] | |
Number of operating segments | segment | 3 |
Number of joint ventures that are 50% owned | joint_venture | 2 |
Rogers INOAC Corporation (RIC) | |
Schedule of Equity Method Investments [Line Items] | |
Joint venture ownership percentage | 50% |
Rogers INOAC Corporation (RIC) | INOAC Corporation | |
Schedule of Equity Method Investments [Line Items] | |
Joint venture ownership percentage | 50% |
Rogers INOAC Suzhou Corporation (RIS) | |
Schedule of Equity Method Investments [Line Items] | |
Joint venture ownership percentage | 50% |
Rogers INOAC Suzhou Corporation (RIS) | INOAC Corporation | |
Schedule of Equity Method Investments [Line Items] | |
Joint venture ownership percentage | 50% |
Basis of Presentation, Organi_5
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Restricted Cash and Accounts Receivable) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Accounting Policies [Abstract] | ||
Restricted cash | $ 2.2 | $ 2.2 |
Accounts receivable | $ 143.2 | $ 149.2 |
Basis of Presentation, Organi_6
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Foreign Currency) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Foreign currency transaction adjustment (loss) gain | $ 1.1 | $ (1.7) | $ 3 |
Basis of Presentation, Organi_7
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Schedule of Property, Plant and Equipment) (Details) | Dec. 31, 2023 |
Buildings and improvements | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 30 years |
Buildings and improvements | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 40 years |
Machinery and equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 5 years |
Machinery and equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 15 years |
Office equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 3 years |
Office equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 10 years |
Basis of Presentation, Organi_8
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Software Costs) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Net capitalized software and development costs | $ 62.1 | $ 58.9 |
Software and Software Development Costs | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful life (in years) | 3 years | |
Software and Software Development Costs | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful life (in years) | 5 years |
Basis of Presentation, Organi_9
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Goodwill and Intangible Assets) (Details) | 12 Months Ended | |
Dec. 31, 2023 USD ($) reporting_unit | Dec. 31, 2022 USD ($) | |
Indefinite-lived Intangible Assets [Line Items] | ||
Present value of future cash flows through discounted analysis period (in years) | 5 years | |
Number of reporting units | reporting_unit | 4 | |
Goodwill | $ 359,800,000 | $ 352,400,000 |
Indefinite-lived other intangible asset impairment charges | 0 | |
Indefinite-lived other intangible asset | $ 4,300,000 | 4,200,000 |
Definite-lived other intangible asset impairment charges | 17,900,000 | |
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration] | Operating income | |
Definite-lived other intangible assets | $ 119,600,000 | $ 129,500,000 |
RF Solutions | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Goodwill | 51,700,000 | |
Definite-lived other intangible assets | 900,000 | |
EMS | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Goodwill | 239,900,000 | |
Definite-lived other intangible assets | 115,300,000 | |
Curamik | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Goodwill | 66,000,000 | |
Indefinite-lived other intangible asset | 4,300,000 | |
Definite-lived other intangible assets | 3,400,000 | |
ECD | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Goodwill | $ 2,200,000 |
Basis of Presentation, Organ_10
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Fair Value of Financial Statements) (Details) | 12 Months Ended |
Dec. 31, 2023 | |
Fourth Amended and Restated Credit Agreement | Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Basis spread on variable rate (percent) | 1.625% |
Basis of Presentation, Organ_11
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Concentration of Credit and Investment Risk) (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Significant credit losses, amount | $ 0 | $ 0 | $ 0 |
Basis of Presentation, Organ_12
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Equity Compensation) (Details) | 12 Months Ended |
Dec. 31, 2023 | |
Deferred Stock Units | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Anniversary period from grant date (in months) | 13 months |
Basis of Presentation, Organ_13
Basis of Presentation, Organization and Summary of Significant Accounting Policies (Advertising Costs) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Advertising expense | $ 3.5 | $ 3.3 | $ 2.7 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Loss (Schedule of Changes in Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Balance, beginning of period | $ 1,172.5 | $ 1,118.9 | |
Other comprehensive income (loss) before reclassifications | 18.4 | (40.2) | |
Amounts reclassified to earnings | 0.4 | 0.2 | |
Net other comprehensive income (loss) for period | 18.8 | (40) | |
Balance, end of period | 1,259 | 1,172.5 | |
AOCI, pension and other postretirement benefit plans, tax | 1.8 | 1.9 | $ 2.1 |
Accumulated Other Comprehensive Loss | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Balance, beginning of period | (85.2) | (45.2) | |
Balance, end of period | (66.4) | (85.2) | |
Foreign Currency Translation Adjustments | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Balance, beginning of period | (75.6) | (35.6) | |
Other comprehensive income (loss) before reclassifications | 18.8 | (40) | |
Amounts reclassified to earnings | 0 | 0 | |
Net other comprehensive income (loss) for period | 18.8 | (40) | |
Balance, end of period | (56.8) | (75.6) | |
Pension and Other Postretirement Benefits | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Balance, beginning of period | (9.6) | (9.6) | |
Other comprehensive income (loss) before reclassifications | (0.4) | (0.2) | |
Amounts reclassified to earnings | 0.4 | 0.2 | |
Net other comprehensive income (loss) for period | 0 | 0 | |
Balance, end of period | $ (9.6) | $ (9.6) |
Accumulated Other Comprehensi_4
Accumulated Other Comprehensive Loss (Schedule of Reclassification of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||
Other income (expense), net | $ (0.7) | $ 1.1 | $ 4.6 |
Income tax (expense) benefit | (19.7) | (23.8) | (18.2) |
Net income | 56.6 | 116.6 | $ 108.1 |
Reclassification out of accumulated other comprehensive income | Amortization/settlement of pension and other postretirement benefits | |||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||
Pension settlement charges | (0.1) | 0 | |
Other income (expense), net | (0.4) | (0.4) | |
Income tax (expense) benefit | 0.1 | 0.2 | |
Net income | $ (0.4) | $ (0.2) |
Derivatives and Hedging (Notion
Derivatives and Hedging (Notional Values of Derivative Instruments) (Details) - Contracts not designated as hedging instruments € in Thousands, ₩ in Thousands, ¥ in Thousands, $ in Thousands | Dec. 31, 2023 USD ($) tons_per_month | Dec. 31, 2023 KRW (₩) tons_per_month | Dec. 31, 2023 EUR (€) tons_per_month | Dec. 31, 2023 JPY (¥) tons_per_month |
January 2024 - March 2024 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Volume of Copper Derivatives (in metric tons per month) | 69 | 69 | 69 | 69 |
April 2024 - June 2024 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Volume of Copper Derivatives (in metric tons per month) | 69 | 69 | 69 | 69 |
July 2024 - September 2024 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Volume of Copper Derivatives (in metric tons per month) | 69 | 69 | 69 | 69 |
October 2024 - December 2024 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Volume of Copper Derivatives (in metric tons per month) | 69 | 69 | 69 | 69 |
USD/CNH | Foreign Exchange Forward | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notional Values of Foreign Currency Derivatives | $ | $ 25,900 | |||
KRW/USD | Foreign Exchange Forward | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notional Values of Foreign Currency Derivatives | ₩ | ₩ 1,291,700 | |||
EUR/USD | Foreign Exchange Forward | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notional Values of Foreign Currency Derivatives | € | € 12,600 | |||
JPY/EUR | Foreign Exchange Forward | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notional Values of Foreign Currency Derivatives | ¥ | ¥ 250,000 |
Derivatives and Hedging (Additi
Derivatives and Hedging (Additional Information) (Details) | Dec. 31, 2023 contract |
Bank Term Loan | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Number of derivative contracts related to minimizing risk associated with potential rise in copper prices (in contracts) | 12 |
Derivatives and Hedging (Effect
Derivatives and Hedging (Effect and Fair Value of Derivative Instruments) (Details) - Contracts not designated as hedging instruments - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Foreign currency contracts | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Effect of current derivative instruments | $ 1 | $ (0.3) | $ (2.9) |
Copper Derivatives Contracts | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Effect of current derivative instruments | $ (0.6) | $ 0.8 | $ 3.9 |
Derivatives and Hedging (Schedu
Derivatives and Hedging (Schedule of Derivative Instruments Measured at Fair Value on a Recurring Basis) (Details) - Fair Value, Recurring - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Foreign currency contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | $ (0.2) | $ (0.1) |
Foreign currency contracts | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | 0 | 0 |
Foreign currency contracts | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | (0.2) | (0.1) |
Foreign currency contracts | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | 0 | 0 |
Copper derivative contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | 0.4 | 0.5 |
Copper derivative contracts | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | 0 | 0 |
Copper derivative contracts | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | 0.4 | 0.5 |
Copper derivative contracts | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of derivatives | $ 0 | $ 0 |
Inventories, net (Details)
Inventories, net (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 71.5 | $ 87.9 |
Work-in-process | 45.6 | 45.1 |
Finished goods | 36.4 | 49.4 |
Total inventories, net | $ 153.5 | $ 182.4 |
Property, Plant and Equipment_2
Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Property plant and equipment, gross | $ 607.7 | $ 589 |
Accumulated depreciation | (385.7) | (381.6) |
Property, plant and equipment, net | 222 | 207.4 |
Construction in process | 144.3 | 151 |
Total property, plant and equipment, net | 366.3 | 358.4 |
Land and improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property plant and equipment, gross | 16.8 | 23.9 |
Buildings and improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property plant and equipment, gross | 177.2 | 169.5 |
Machinery and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property plant and equipment, gross | 343 | 334.1 |
Office equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property plant and equipment, gross | $ 70.7 | $ 61.5 |
Property, Plant and Equipment_3
Property, Plant and Equipment (Additional Information) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |||
Depreciation expense | $ 37.7 | $ 29.5 | $ 29 |
Fixed assets impairment charges | $ 0 | 47.2 | 0.5 |
Advanced Electronics Solutions | |||
Property, Plant and Equipment [Line Items] | |||
Fixed assets impairment charges | $ 47.2 | $ 0.5 |
Leases (Payment for Operating L
Leases (Payment for Operating Leases Expense) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | |||
Operating leases expense | $ 4.1 | $ 2.8 | $ 3 |
Short-term leases expense | 0.7 | 0.6 | 0.3 |
Payments on operating lease obligations | $ 4 | $ 3.1 | $ 2.8 |
Leases (Schedule of Assets and
Leases (Schedule of Assets and Liabilities Balance Related to Finance and Operating Leases) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Leases [Abstract] | ||
Finance lease right-of-use assets | $ 1.5 | $ 1.7 |
Operating lease right-of-use assets | $ 18.9 | $ 13 |
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] | Other accrued liabilities | Other accrued liabilities |
Finance lease obligations, current portion | $ 0.4 | $ 0.5 |
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | Other long-term liabilities | Other long-term liabilities |
Finance lease obligations, non-current portion | $ 1.1 | $ 1.3 |
Total finance lease obligations | 1.5 | 1.8 |
Operating lease obligations, current portion | 3.5 | 2.8 |
Operating lease obligations, non-current portion | 15.4 | 10.7 |
Total operating lease obligations | $ 18.9 | $ 13.5 |
Leases (Future Minimum Lease Pa
Leases (Future Minimum Lease Payments) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Finance Leases Signed | ||
2024 | $ 0.4 | |
2025 | 0.4 | |
2026 | 0.4 | |
2027 | 0.2 | |
2028 | 0.1 | |
Thereafter | 0.1 | |
Total lease payments | 1.6 | |
Less: Interest | (0.1) | |
Present Value of Net Future Minimum Lease Payments | 1.5 | |
Finance Leases Less: Leases Not Yet Commenced | ||
2024 | 0 | |
2025 | 0 | |
2026 | 0 | |
2027 | 0 | |
2028 | 0 | |
Thereafter | 0 | |
Total lease payments | 0 | |
Less: Interest | 0 | |
Present Value of Net Future Minimum Lease Payments | 0 | |
Finance Leases in Effect | ||
2024 | 0.4 | |
2025 | 0.4 | |
2026 | 0.4 | |
2027 | 0.2 | |
2028 | 0.1 | |
Thereafter | 0.1 | |
Total lease payments | 1.6 | |
Less: Interest | (0.1) | |
Total finance lease obligations | 1.5 | $ 1.8 |
Operating Leases Signed | ||
2024 | 4.4 | |
2025 | 3.9 | |
2026 | 3.1 | |
2027 | 2.6 | |
2028 | 1.9 | |
Thereafter | 7.3 | |
Total lease payments | 23.2 | |
Less: Interest | (4.1) | |
Present Value of Net Future Minimum Lease Payments | 19.1 | |
Less: Operating Leases Not Yet Commenced | ||
2024 | 0 | |
2025 | (0.1) | |
2026 | (0.1) | |
2027 | 0 | |
2028 | 0 | |
Thereafter | 0 | |
Total lease payments | (0.2) | |
Less: Interest | 0 | |
Present Value of Net Future Minimum Lease Payments | (0.2) | |
Operating Leases in Effect | ||
2024 | 4.4 | |
2025 | 3.8 | |
2026 | 3 | |
2027 | 2.6 | |
2028 | 1.9 | |
Thereafter | 7.3 | |
Total lease payments | 23 | |
Less: Interest | (4.1) | |
Total operating lease obligations | $ 18.9 | $ 13.5 |
Leases (Lease Term and Discount
Leases (Lease Term and Discount Rate of Net Future Minimum Lease Payments) (Details) | Dec. 31, 2023 | Dec. 31, 2022 |
Leases [Abstract] | ||
Finance Leases, Weighted Average Remaining Lease Term (in years) | 4 years | 4 years 7 months 6 days |
Operating Leases, Weighted Average Remaining Lease Term (in years) | 7 years | 6 years 6 months |
Finance Leases, Weighted Average Discount Rate (as percent) | 4.14% | 3.89% |
Operating Leases, Weighted Average Discount Rate (as percent) | 5.35% | 5.24% |
Goodwill and Other Intangible_3
Goodwill and Other Intangible Assets (Schedule of Goodwill) (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Beginning balance | $ 352.4 |
Foreign currency translation adjustment | 7.4 |
Ending balance | 359.8 |
Advanced Electronics Solutions | |
Goodwill [Roll Forward] | |
Beginning balance | 115.4 |
Foreign currency translation adjustment | 2.3 |
Ending balance | 117.7 |
Elastomeric Material Solutions | |
Goodwill [Roll Forward] | |
Beginning balance | 234.8 |
Foreign currency translation adjustment | 5.1 |
Ending balance | 239.9 |
Other | |
Goodwill [Roll Forward] | |
Beginning balance | 2.2 |
Foreign currency translation adjustment | 0 |
Ending balance | $ 2.2 |
Goodwill and Other Intangible_4
Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 276 | $ 282 |
Indefinite-lived other intangible asset | 4.3 | 4.2 |
Total other intangible assets, gross carrying amount | 280.3 | 286.2 |
Accumulated Amortization | 156.4 | 152.5 |
Net Carrying Amount | 119.6 | 129.5 |
Total other intangible assets, net carrying amount | 123.9 | 133.7 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 177.9 | 178.6 |
Accumulated Amortization | 90 | 85.6 |
Net Carrying Amount | 87.9 | 93 |
Technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 77.4 | 82.4 |
Accumulated Amortization | 58.1 | 59.1 |
Net Carrying Amount | 19.3 | 23.3 |
Trademarks and trade names | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 19.4 | 19.1 |
Accumulated Amortization | 7.4 | 6.6 |
Net Carrying Amount | 12 | 12.5 |
Covenants not to compete | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 1.3 | 1.9 |
Accumulated Amortization | 0.9 | 1.2 |
Net Carrying Amount | $ 0.4 | $ 0.7 |
Goodwill and Other Intangible_5
Goodwill and Other Intangible Assets (Additional Information) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Amortization expense | $ 13.4 | $ 16.4 | $ 14.3 |
Definite-lived other intangible asset impairment charges | $ 17.9 | ||
Estimated future amortization expense for 2024 | 12.4 | ||
Estimated future amortization expense for 2025 | 10.8 | ||
Estimated future amortization expense for 2026 | 10.4 | ||
Estimated future amortization expense for 2027 | 10 | ||
Estimated future amortization expense for 2028 | $ 7.8 |
Goodwill and Other Intangible_6
Goodwill and Other Intangible Assets (Schedule of Weighted Average Amortization Period, by Intangible Asset Class) (Details) | 12 Months Ended |
Dec. 31, 2023 | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Total definite-lived other intangible assets | 7 years |
Customer relationships | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Total definite-lived other intangible assets | 7 years 4 months 24 days |
Technology | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Total definite-lived other intangible assets | 3 years 3 months 18 days |
Trademarks and trade names | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Total definite-lived other intangible assets | 10 years |
Covenants not to compete | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Total definite-lived other intangible assets | 6 months |
Pension Benefits, Other Postr_3
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Additional Information) (Detail) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 USD ($) plan | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Number of qualified noncontributory defined benefit plans | plan | 1 | ||
Health care cost trend rate assumed for next fiscal year (percent) | 7% | 6.25% | |
Health care cost, employees age | 65 years | 65 years | |
Rogers Employee Savings and Investment Plan (RESIP) | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Employer contributions | $ 4.6 | $ 11.8 | $ 5.6 |
Employer discretionary contribution amount | $ 6.5 | ||
Rogers Employee Savings and Investment Plan (RESIP) | 100% match | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Employee compensation subject to employer matching percent (percent) | 3.50% | ||
Rogers Employee Savings and Investment Plan (RESIP) | 1% of compensation | 100% match | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Employee compensation subject to employer matching percent (percent) | 100% | ||
Employer matching contribution (percent) | 1% | ||
Rogers Employee Savings and Investment Plan (RESIP) | 5% of compensation | 50% match | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Employee compensation subject to employer matching percent (percent) | 5% | ||
Employer matching contribution (percent) | 50% | ||
Pension Benefits | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Expected long-term rate of return on plan assets (percent) | 5.22% | ||
Employer contributions | $ 0.3 | $ 0 | |
Fixed Income | Pension Benefits | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Plan asset allocations (percent) | 90% | 91% | |
Equity Securities | Pension Benefits | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Plan asset allocations (percent) | 10% | 9% |
Pension Benefits, Other Postr_4
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Obligations and Funded Status) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pension Benefits | |||
Change in plan assets: | |||
Fair value of plan assets as of January 1 | $ 26.3 | $ 33.5 | |
Actual return on plan assets | 1.9 | (5.6) | |
Settlement | (0.3) | 0 | |
Employer contributions | 0.3 | 0 | |
Benefit payments | (1.5) | (1.6) | |
Fair value of plan assets as of December 31 | 26.7 | 26.3 | $ 33.5 |
Change in plan benefit obligations: | |||
Fair value of plan benefit obligations as of January 1 | 21.3 | 28.7 | |
Service cost | 0 | 0 | 0 |
Interest cost | 1.1 | 0.7 | 0.7 |
Actuarial (gain) loss | 0.8 | (6.6) | |
Settlement | (0.3) | 0 | |
Benefit payments | (1.5) | (1.5) | |
Fair value of plan benefit obligations as of December 31 | 21.4 | 21.3 | 28.7 |
Amount overfunded (underfunded) | 5.3 | 5 | |
Other Postretirement Benefits | |||
Change in plan assets: | |||
Fair value of plan assets as of January 1 | 0 | 0 | |
Actual return on plan assets | 0 | 0 | |
Settlement | 0 | 0 | |
Employer contributions | 0 | 0 | |
Benefit payments | 0 | 0 | |
Fair value of plan assets as of December 31 | 0 | 0 | 0 |
Change in plan benefit obligations: | |||
Fair value of plan benefit obligations as of January 1 | 1.4 | 1.4 | |
Service cost | 0.1 | 0.1 | 0.1 |
Interest cost | 0.1 | 0 | 0 |
Actuarial (gain) loss | 0 | (0.1) | |
Settlement | 0 | 0 | |
Benefit payments | 0 | 0 | |
Fair value of plan benefit obligations as of December 31 | 1.6 | 1.4 | $ 1.4 |
Amount overfunded (underfunded) | $ (1.6) | $ (1.4) |
Pension Benefits, Other Postr_5
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Amounts Recognized in Balance Sheet) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Pension Benefits | ||
Assets & Liabilities: | ||
Non-current assets | $ 5.3 | $ 5.2 |
Current liabilities | 0 | 0 |
Non-current liabilities | 0 | (0.2) |
Net assets (liabilities) | 5.3 | 5 |
Accumulated Other Comprehensive Loss: | ||
Net actuarial (loss) gain | (11.6) | (11.8) |
Accumulated other comprehensive (loss) income | (11.6) | (11.8) |
Other Postretirement Benefits | ||
Assets & Liabilities: | ||
Non-current assets | 0 | 0 |
Current liabilities | (0.2) | (0.2) |
Non-current liabilities | (1.4) | (1.2) |
Net assets (liabilities) | (1.6) | (1.4) |
Accumulated Other Comprehensive Loss: | ||
Net actuarial (loss) gain | 0.2 | 0.2 |
Accumulated other comprehensive (loss) income | $ 0.2 | $ 0.2 |
Pension Benefits, Other Postr_6
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (PBO and ABO for Pension Plan and for Postretirement Benefit Plan) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Defined Benefit Plan Disclosure [Line Items] | ||
PBO of plan assets for pension plan with plan assets in excess of its ABO | $ 21.5 | $ 21 |
PBO of plan assets for pension plan with plan assets in excess of its PBO | 21.5 | 21 |
ABO of plan assets for pension plan with plan assets in excess of its PBO | 21.5 | 21 |
ABO of plan assets for pension plan with plan assets in excess of its ABO | 21.5 | 21 |
Fair value of the plan assets for pension plan with plan assets in excess of its PBO | 26.7 | 26.3 |
Fair value of the plan assets for pension plan with plan assets in excess of its ABO | 26.7 | 26.3 |
Other Postretirement Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
PBO of plan assets for pension plan with plan assets in excess of its ABO | (1.6) | (1.4) |
PBO of plan assets for pension plan with plan assets in excess of its PBO | (1.6) | (1.4) |
ABO of plan assets for pension plan with plan assets in excess of its PBO | (1.6) | (1.4) |
ABO of plan assets for pension plan with plan assets in excess of its ABO | (1.6) | (1.4) |
Fair value of the plan assets for pension plan with plan assets in excess of its PBO | 0 | 0 |
Fair value of the plan assets for pension plan with plan assets in excess of its ABO | $ 0 | $ 0 |
Pension Benefits, Other Postr_7
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | $ 0 | $ 0 | $ 0 |
Interest cost | 1.1 | 0.7 | 0.7 |
Expected return of plan assets | (1.4) | (1.3) | (1.5) |
Amortization of prior service credit | 0 | 0 | 0 |
Amortization of net loss (gain) | 0.5 | 0.4 | 0.4 |
Settlement | 0.1 | 0 | 0 |
Net periodic benefit cost (credit) | 0.3 | (0.2) | (0.4) |
Other Postretirement Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | 0.1 | 0.1 | 0.1 |
Interest cost | 0.1 | 0 | 0 |
Expected return of plan assets | 0 | 0 | 0 |
Amortization of prior service credit | 0 | 0 | (0.1) |
Amortization of net loss (gain) | 0 | 0 | 0 |
Settlement | 0 | 0 | 0 |
Net periodic benefit cost (credit) | $ 0.2 | $ 0.1 | $ 0 |
Pension Benefits, Other Postr_8
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Assumptions Used) (Details) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Pension Benefits | ||
Weighted average assumptions used in benefit obligations: | ||
Discount rate | 4.75% | 5.25% |
Weighted average assumptions used in net periodic benefit costs: | ||
Discount rate | 5.25% | 2.75% |
Expected long-term rate of return on assets | 5.59% | 4.17% |
Other Postretirement Benefits | ||
Weighted average assumptions used in benefit obligations: | ||
Discount rate | 4.75% | 5% |
Weighted average assumptions used in net periodic benefit costs: | ||
Discount rate | 5% | 2.25% |
Expected long-term rate of return on assets | 0% | 0% |
Pension Benefits, Other Postr_9
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Assets Carried at Fair Value by Level) (Details) - Pension Benefits - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | $ 26.7 | $ 26.3 | $ 33.5 |
Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 3.2 | 2.5 | |
Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 22.4 | 22.7 | |
Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 1.1 | 1.1 | |
Fixed income bonds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 22.5 | 22.2 | |
Fixed income bonds | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0.2 | 0 | |
Fixed income bonds | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 22.3 | 22.2 | |
Fixed income bonds | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0 | 0 | |
Mutual funds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 3 | 2.5 | |
Mutual funds | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 3 | 2.5 | |
Mutual funds | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0 | 0 | |
Mutual funds | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0 | 0 | |
Pooled separate accounts | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0.1 | 0.5 | |
Pooled separate accounts | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0 | 0 | |
Pooled separate accounts | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0.1 | 0.5 | |
Pooled separate accounts | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0 | 0 | |
Guaranteed deposit account | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 1.1 | 1.1 | |
Guaranteed deposit account | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0 | 0 | |
Guaranteed deposit account | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | 0 | 0 | |
Guaranteed deposit account | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Pension assets | $ 1.1 | $ 1.1 |
Pension Benefits, Other Post_10
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Summary of Changes in Fair Value of Guaranteed Deposit Account's Level 3 Assets) (Details) - Pension Benefits $ in Millions | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Fair value of plan assets as of January 1 | $ 26.3 |
Fair value of plan assets as of December 31 | 26.7 |
Level 3 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Fair value of plan assets as of January 1 | 1.1 |
Fair value of plan assets as of December 31 | 1.1 |
Guaranteed deposit account | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Fair value of plan assets as of January 1 | 1.1 |
Fair value of plan assets as of December 31 | 1.1 |
Guaranteed deposit account | Level 3 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Fair value of plan assets as of January 1 | 1.1 |
Change in unrealized gain (loss) | 0 |
Purchases, sales, issuances and settlements (net) | 0 |
Fair value of plan assets as of December 31 | $ 1.1 |
Pension Benefits, Other Post_11
Pension Benefits, Other Postretirement Benefits and Employee Savings and Investment Plans (Estimated Future Payments) (Details) $ in Millions | Dec. 31, 2023 USD ($) |
Pension Benefits | |
Defined Benefit Plan Disclosure [Line Items] | |
2024 | $ 1.7 |
2025 | 1.7 |
2026 | 1.7 |
2027 | 1.7 |
2028 | 1.6 |
2029-2033 | 7.6 |
Other Postretirement Benefits | |
Defined Benefit Plan Disclosure [Line Items] | |
2024 | 0.2 |
2025 | 0.2 |
2026 | 0.2 |
2027 | 0.2 |
2028 | 0.1 |
2029-2033 | $ 0.8 |
Debt (Additional Information) (
Debt (Additional Information) (Details) | 1 Months Ended | 12 Months Ended | ||||||
Mar. 24, 2023 USD ($) option | Feb. 17, 2022 USD ($) | Oct. 16, 2020 USD ($) | Oct. 31, 2020 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Oct. 31, 2021 | |
Debt Instrument [Line Items] | ||||||||
Number of borrowings credit agreement interest options | option | 2 | |||||||
Proceeds from borrowings under revolving credit facility | $ 0 | $ 100,000,000 | $ 190,000,000 | |||||
Borrowings under revolving credit facility | 30,000,000 | 215,000,000 | ||||||
Revolving Credit Facility | ||||||||
Debt Instrument [Line Items] | ||||||||
Borrowings under revolving credit facility | 30,000,000 | 215,000,000 | ||||||
Outstanding line of credit issuance costs | 2,100,000 | 900,000 | ||||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | ||||||||
Debt Instrument [Line Items] | ||||||||
Maximum borrowing capacity | $ 450,000,000 | $ 450,000,000 | ||||||
Additional borrowing capacity | $ 225,000,000 | $ 175,000,000 | ||||||
Variable rate lower range, basis spread | 0.625% | |||||||
Variable rate higher range, basis spread | 1% | |||||||
Leverage ratio | 3.25 | 3.25 | ||||||
One-time leverage ratio maximum option | 3.50 | 3.75 | ||||||
One-time leverage ratio maximum option, period of increased maximum leverage ratio | 1 year | 1 year | ||||||
ICR covenant limit | 3 | 3 | ||||||
Amount of unrestricted domestic cash and cash equivalents permitted to net against indebtedness in calculation of total net leverage ratio (up to) | $ 50,000,000 | $ 50,000,000 | ||||||
Debt instrument, leverage ratio, maximum | 2.75 | 2.75 | ||||||
Proceeds from borrowings under revolving credit facility | 0 | 100,000,000 | 190,000,000 | |||||
Discretionary principal payments on revolving credit facility | $ 185,000,000 | $ 75,000,000 | $ 25,000,000 | |||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Unused capacity, commitment fee (percent) | 0.25% | 0.25% | ||||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Unused capacity, commitment fee (percent) | 0.35% | 0.35% | ||||||
Allowed restricted payments, including cash dividends | $ 20,000,000 | $ 20,000,000 | ||||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Eurocurrency loans | ||||||||
Debt Instrument [Line Items] | ||||||||
Line of credit, LIBOR rate, minimum basis spread (percent) | 1.625% | 1.625% | ||||||
Line of credit, LIBOR rate, maximum basis spread (percent) | 2% | 2% | ||||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | RFR | ||||||||
Debt Instrument [Line Items] | ||||||||
Line of credit, SONIA rate, minimum basis spread (percent) | 0.01625 | |||||||
Line of credit, SONIA rate, minimum basis spread (percent) | 0.02000 | |||||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Federal Funds Rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate (percent) | 0.50% | |||||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | London Interbank Offered Rate (LIBOR) | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate (percent) | 1% | |||||||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Sterling Overnight Index Average (SONIA) | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate (percent) | 0.0326% | |||||||
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | ||||||||
Debt Instrument [Line Items] | ||||||||
Variable rate lower range, basis spread | 0.625% | |||||||
Variable rate higher range, basis spread | 1% | |||||||
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | London Interbank Offered Rate (LIBOR) | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate (percent) | 1.625% | |||||||
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | Fed Funds Effective Rate Overnight Index Swap Rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate (percent) | 0.50% | |||||||
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | Secured Overnight Financing Rate (SOFR) | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate (percent) | 1.10% |
Commitments and Contingencies_2
Commitments and Contingencies (Schedule of Change in Number of Asbestos Claims Outstanding) (Details) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 USD ($) claim | Dec. 31, 2022 USD ($) claim | |
Liability for Asbestos and Environmental Claims [Roll Forward] | ||
Claims outstanding as of January 1 | 537 | 543 |
New claims filed | 136 | 129 |
Pending claims concluded | (167) | (135) |
Claims outstanding as of December 31 | 506 | 537 |
Number of claims dismissed | 155 | 119 |
Number of claims settled | 12 | 16 |
Claims settlements amount | $ | $ 4.5 | $ 2.4 |
Commitments and Contingencies_3
Commitments and Contingencies (Additional Information) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Loss Contingencies [Line Items] | |||
Legal fees | $ 0.4 | $ 0.6 | $ 0.5 |
Environmental Remediation Expense, Statement of Income or Comprehensive Income [Extensible Enumeration] | Other Operating Income (Expense), Net | ||
Connecticut Voluntary Corrective Action Program | |||
Loss Contingencies [Line Items] | |||
Environmental remediation expense | $ 2 | ||
Estimated total cleanup costs, accrual | $ 0.7 |
Commitments and Contingencies_4
Commitments and Contingencies (Schedule of Asbestos-Related Claims and Insurance Receivables) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Commitments and Contingencies Disclosure [Abstract] | ||
Asbestos-related liabilities | $ 61.5 | $ 65.1 |
Asbestos-related insurance receivables | $ 56.5 | $ 59.8 |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Numerator: | |||
Net income | $ 56.6 | $ 116.6 | $ 108.1 |
Denominator: | |||
Weighted average shares outstanding - basic (in shares) | 18.6 | 18.8 | 18.7 |
Effect of dilutive shares (in shares) | 0.1 | 0.2 | 0.2 |
Weighted average shares outstanding - diluted (in shares) | 18.7 | 19 | 18.9 |
Basic earnings per share (in dollars per share) | $ 3.04 | $ 6.21 | $ 5.77 |
Diluted earnings per share (in dollars per share) | $ 3.03 | $ 6.15 | $ 5.73 |
Capital Stock and Equity Comp_3
Capital Stock and Equity Compensation (Schedule of Shares of Capital Stock Reserved for Possible Future Issuance) (Details) - shares | Dec. 31, 2023 | Dec. 31, 2022 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock shares reserved for future issuance (in shares) | 1,157,812 | 1,236,210 |
Shares reserved for issuance under outstanding restricted stock unit awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock shares reserved for future issuance (in shares) | 248,055 | 255,310 |
Deferred compensation to be paid in stock, including deferred stock units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock shares reserved for future issuance (in shares) | 8,100 | 6,850 |
Additional shares reserved for issuance under Rogers Corporation 2019 Long-Term Equity Compensation Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock shares reserved for future issuance (in shares) | 842,046 | 914,439 |
Shares reserved for issuance under the Rogers Corporation Employee Stock Purchase Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock shares reserved for future issuance (in shares) | 59,611 | 59,611 |
Capital Stock and Equity Comp_4
Capital Stock and Equity Compensation (Additional Information) (Details) - USD ($) | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock repurchase program | $ 100,000,000 | |||
Shares of capital stock repurchased (in shares) | 0 | 237,806 | 0 | |
Shares repurchased | $ 25,000,000 | |||
Stock repurchase program remaining | $ 24,000,000 | |||
Performance Shares | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Restricted stock award program, measurement period (in years) | 3 years | |||
Expected dividend yield (as percent) | 0% | |||
Compensation expense | $ 3,700,000 | 2,300,000 | $ 7,700,000 | |
Total unrecognized compensation cost | $ 8,200,000 | |||
Weighted-average remaining contractual life in years, options outstanding (in years) | 1 year | |||
Performance Shares | Minimum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Restricted stock award program, awarded shares as a percentage of the original award amount (as percent) | 0% | |||
Performance Shares | Maximum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Restricted stock award program, awarded shares as a percentage of the original award amount (as percent) | 200% | |||
Time Based Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Compensation expense | $ 9,200,000 | 8,200,000 | 7,600,000 | |
Total unrecognized compensation cost | $ 10,900,000 | |||
Weighted-average remaining contractual life in years, options outstanding (in years) | 10 months 24 days | |||
Conversion ratio | 1 | |||
Deferred Stock Units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Compensation expense | $ 1,300,000 | $ 1,300,000 | $ 1,200,000 | |
Conversion ratio | 1 | |||
Anniversary period from grant date (in months) | 13 months |
Capital Stock and Equity Comp_5
Capital Stock and Equity Compensation (Schedule of Weighted-Average Assumptions Used) (Details) - Performance Shares | Feb. 09, 2023 | Feb. 10, 2021 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected volatility | 53.20% | 51% |
Expected term | 2 years 10 months 24 days | 2 years 10 months 24 days |
Risk-free interest rate | 4.08% | 0.18% |
Capital Stock and Equity Comp_6
Capital Stock and Equity Compensation (Performance Based Restricted Stock Awards) (Details) - Performance Shares - $ / shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Awards Outstanding | |||
Awards outstanding, beginning balance (in shares) | 65,513 | 114,554 | 111,059 |
Awards granted (in shares) | 50,551 | 26,819 | 41,507 |
Stock issued (in shares) | (8,775) | (60,053) | 0 |
Awards forfeited (in shares) | (33,761) | (15,807) | (38,012) |
Awards outstanding, ending balance (in shares) | 73,528 | 65,513 | 114,554 |
Weighted- Average Grant Date Fair Value | |||
Awards outstanding, beginning balance (in dollars per share) | $ 201.18 | $ 196.23 | $ 170.84 |
Awards granted (in dollars per share) | 241.47 | 176.33 | 258.17 |
Stock issued (in dollars per share) | 147.58 | 179.72 | 0 |
Awards forfeited (in dollars per share) | 174.43 | 204.69 | 189.69 |
Awards outstanding, ending balance (in dollars per share) | $ 247.55 | $ 201.18 | $ 196.23 |
Capital Stock and Equity Comp_7
Capital Stock and Equity Compensation (Time Based Restricted Stock Awards) (Details) - Time Based Restricted Stock - $ / shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Awards Outstanding | |||
Awards outstanding, beginning balance (in shares) | 124,284 | 96,989 | 102,142 |
Awards granted (in shares) | 67,734 | 96,620 | 50,640 |
Stock issued (in shares) | (62,251) | (48,253) | (46,329) |
Awards forfeited (in shares) | (28,768) | (21,072) | (9,464) |
Awards outstanding, ending balance (in shares) | 100,999 | 124,284 | 96,989 |
Weighted- Average Grant Date Fair Value | |||
Awards outstanding, beginning balance (in dollars per share) | $ 194.60 | $ 157.49 | $ 120.16 |
Awards granted (in dollars per share) | 148.85 | 219.60 | 180.19 |
Stock issued (in dollars per share) | 173.52 | 183 | 146.45 |
Awards forfeited (in dollars per share) | 213.84 | 223.90 | 146.58 |
Awards outstanding, ending balance (in dollars per share) | $ 171.43 | $ 194.60 | $ 157.49 |
Capital Stock and Equity Comp_8
Capital Stock and Equity Compensation (Deferred Stock Units) (Details) - Deferred Stock Units - $ / shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Awards Outstanding | |||
Awards outstanding, beginning balance (in shares) | 6,850 | 9,500 | 12,450 |
Awards granted (in shares) | 8,100 | 4,800 | 6,450 |
Stock issued (in shares) | (6,850) | (7,450) | (9,400) |
Awards outstanding, ending balance (in shares) | 8,100 | 6,850 | 9,500 |
Weighted- Average Grant Date Fair Value | |||
Awards outstanding, beginning balance (in dollars per share) | $ 232.51 | $ 173.82 | $ 113.96 |
Awards granted (in dollars per share) | 161.90 | 272.12 | 188.60 |
Stock issued (in dollars per share) | 232.51 | 183.20 | 104.68 |
Awards outstanding, ending balance (in dollars per share) | $ 161.9 | $ 232.51 | $ 173.82 |
Operating Segment and Geograp_3
Operating Segment and Geographic Information (Information About Reportable Segments) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Net sales | $ 908.4 | $ 971.2 | $ 932.9 |
Operating income | 85.3 | 144.4 | 117.2 |
Total assets | 1,517.2 | 1,646.2 | 1,598.6 |
Capital expenditures | 57 | 116.8 | 71.1 |
Depreciation & amortization | 51.1 | 45.9 | 43.3 |
Investment in unconsolidated joint ventures | 11.1 | 14.1 | 16.3 |
Equity income in unconsolidated joint ventures | 1.8 | 4.4 | 7 |
Advanced Electronics Solutions | |||
Segment Reporting Information [Line Items] | |||
Net sales | 509.7 | 530.2 | 534.5 |
Operating income | 2.6 | 77.1 | 50.2 |
Total assets | 762.8 | 854.2 | 826.7 |
Capital expenditures | 30.5 | 58.9 | 38.9 |
Depreciation & amortization | 27.6 | 21.7 | 22.9 |
Investment in unconsolidated joint ventures | 0 | 0 | 0 |
Equity income in unconsolidated joint ventures | 0 | 0 | 0 |
Elastomeric Material Solutions | |||
Segment Reporting Information [Line Items] | |||
Net sales | 379 | 420 | 378 |
Operating income | 76.1 | 60.4 | 60.1 |
Total assets | 742 | 778.7 | 759.6 |
Capital expenditures | 25.9 | 57.6 | 31.8 |
Depreciation & amortization | 22.8 | 23.5 | 19.7 |
Investment in unconsolidated joint ventures | 11.1 | 14.1 | 16.3 |
Equity income in unconsolidated joint ventures | 1.8 | 4.4 | 7 |
Other | |||
Segment Reporting Information [Line Items] | |||
Net sales | 19.7 | 21 | 20.4 |
Operating income | 6.6 | 6.9 | 6.9 |
Total assets | 12.4 | 13.3 | 12.3 |
Capital expenditures | 0.6 | 0.3 | 0.4 |
Depreciation & amortization | 0.7 | 0.7 | 0.7 |
Investment in unconsolidated joint ventures | 0 | 0 | 0 |
Equity income in unconsolidated joint ventures | 0 | 0 | 0 |
Recognized over time | |||
Segment Reporting Information [Line Items] | |||
Net sales | 269.5 | 259.3 | 277.8 |
Recognized over time | Advanced Electronics Solutions | |||
Segment Reporting Information [Line Items] | |||
Net sales | 234.1 | 227 | 244.1 |
Recognized over time | Elastomeric Material Solutions | |||
Segment Reporting Information [Line Items] | |||
Net sales | 19.6 | 15.9 | 14.9 |
Recognized over time | Other | |||
Segment Reporting Information [Line Items] | |||
Net sales | 15.8 | 16.4 | 18.8 |
Recognized at a point in time | |||
Segment Reporting Information [Line Items] | |||
Net sales | 638.9 | 711.9 | 655.1 |
Recognized at a point in time | Advanced Electronics Solutions | |||
Segment Reporting Information [Line Items] | |||
Net sales | 275.6 | 303.2 | 290.4 |
Recognized at a point in time | Elastomeric Material Solutions | |||
Segment Reporting Information [Line Items] | |||
Net sales | 359.4 | 404.1 | 363.1 |
Recognized at a point in time | Other | |||
Segment Reporting Information [Line Items] | |||
Net sales | $ 3.9 | $ 4.6 | $ 1.6 |
Operating Segment and Geograp_4
Operating Segment and Geographic Information (Net Sales by Geographic Area) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 908.4 | $ 971.2 | $ 932.9 |
Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 509.7 | 530.2 | 534.5 |
Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 379 | 420 | 378 |
Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 19.7 | 21 | 20.4 |
Total Americas | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 258 | 318.9 | 273.4 |
Total Americas | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 84.7 | 129.3 | 96.7 |
Total Americas | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 169.1 | 184.8 | 171.4 |
Total Americas | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 4.2 | 4.8 | 5.3 |
United States | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 240.4 | 296.6 | 259.3 |
United States | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 81.1 | 122.7 | 93.6 |
United States | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 155.4 | 169.4 | 161.2 |
United States | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 3.9 | 4.5 | 4.5 |
Other Americas | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 17.6 | 22.3 | 14.1 |
Other Americas | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 3.6 | 6.6 | 3.1 |
Other Americas | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 13.7 | 15.4 | 10.2 |
Other Americas | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0.3 | 0.3 | 0.8 |
Total APAC | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 367.5 | 392.8 | 435.5 |
Total APAC | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 232.9 | 229.6 | 278.5 |
Total APAC | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 124.7 | 153.1 | 149.6 |
Total APAC | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 9.9 | 10.1 | 7.4 |
China | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 241.9 | 283.5 | 320.2 |
China | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 144.6 | 154.4 | 193.4 |
China | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 93 | 121.7 | 122 |
China | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 4.3 | 7.4 | 4.8 |
Other APAC | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 125.6 | 109.3 | 115.3 |
Other APAC | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 88.3 | 75.2 | 85.1 |
Other APAC | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 31.7 | 31.4 | 27.6 |
Other APAC | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 5.6 | 2.7 | 2.6 |
Total EMEA | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 282.9 | 259.5 | 224 |
Total EMEA | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 192.1 | 171.3 | 159.3 |
Total EMEA | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 85.2 | 82.1 | 57 |
Total EMEA | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 5.6 | 6.1 | 7.7 |
Germany | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 124 | 110.2 | 102.6 |
Germany | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 95.2 | 78.7 | 72.6 |
Germany | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 28.3 | 30.4 | 29.2 |
Germany | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0.5 | 1.1 | 0.8 |
Other EMEA | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 158.9 | 149.3 | 121.4 |
Other EMEA | Advanced Electronics Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 96.9 | 92.6 | 86.7 |
Other EMEA | Elastomeric Material Solutions | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 56.9 | 51.7 | 27.8 |
Other EMEA | Other | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 5.1 | $ 5 | $ 6.9 |
Operating Segment and Geograp_5
Operating Segment and Geographic Information (Contract Assets by Segment) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Segment Reporting Information [Line Items] | ||
Contract assets | $ 45.2 | $ 38.9 |
Advanced Electronics Solutions | ||
Segment Reporting Information [Line Items] | ||
Contract assets | 41.4 | 33.8 |
Elastomeric Material Solutions | ||
Segment Reporting Information [Line Items] | ||
Contract assets | 0.4 | 1.6 |
Other | ||
Segment Reporting Information [Line Items] | ||
Contract assets | $ 3.4 | $ 3.5 |
Operating Segment and Geograp_6
Operating Segment and Geographic Information (Schedule of Long-lived Assets By Geographic Region) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Segment Reporting Information [Line Items] | ||
Long-lived assets | $ 868.9 | $ 857.5 |
United States | ||
Segment Reporting Information [Line Items] | ||
Long-lived assets | 384.1 | 401.2 |
England | ||
Segment Reporting Information [Line Items] | ||
Long-lived assets | 166.7 | 161.9 |
Germany | ||
Segment Reporting Information [Line Items] | ||
Long-lived assets | 148.9 | 139.7 |
Other | ||
Segment Reporting Information [Line Items] | ||
Long-lived assets | $ 169.2 | $ 154.7 |
Supplemental Financial Inform_3
Supplemental Financial Information (Schedule of Restructuring and Impairment Charges) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring charges | $ 16.9 | $ 1.5 | $ 3.1 |
Impairment charges | |||
Fixed assets impairment charges | 0 | 47.2 | 0.5 |
Other impairment charges | 0 | 17.9 | 0 |
Total impairment charges | 0 | 65.1 | 0.5 |
Total restructuring and impairment charges | 16.9 | 66.6 | 3.6 |
Global workforce reduction | |||
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring charges | 8.8 | 0 | 0 |
Facility consolidations | |||
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring charges | 8.1 | 0.4 | 0 |
Manufacturing footprint optimization | |||
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring charges | $ 0 | $ 1.1 | $ 3.1 |
Supplemental Financial Inform_4
Supplemental Financial Information (Additional Information) (Details) - USD ($) $ in Millions | 12 Months Ended | ||||
Sep. 22, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Feb. 16, 2023 | |
Condensed Financial Statements, Captions [Line Items] | |||||
Restructuring and related cost, expected cost | $ 8.1 | $ 8.8 | |||
Operating segment for a purchase price | 1.8 | ||||
Disposal group, including discontinued operation, selling costs | 1.2 | ||||
Gain on sale of properties | $ 1.9 | ||||
Net book value of assets held-and-used | 13.1 | ||||
Total restructuring charges | 16.9 | $ 1.5 | $ 3.1 | ||
Fixed assets impairment charges | 0 | 47.2 | 0.5 | ||
Insurance recoveries | (31.4) | (6.6) | (6.9) | ||
Professional services | 0.9 | 1.4 | 2.7 | ||
Compensation & benefits | 0 | 2.4 | 2.1 | ||
Fixed assets write-offs | 0 | 0 | 1.1 | ||
Inventory charges | 0 | 0.2 | 0.9 | ||
Third-party property claims | 0 | 0 | 4.7 | ||
Income on termination fee | 0 | 142.1 | 0 | ||
Impairment charges | 0 | 65.1 | 0.5 | ||
Fire | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Deductible | 0.3 | ||||
Advanced Electronics Solutions | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Fixed assets impairment charges | 47.2 | 0.5 | |||
Impairment charges | 65.1 | 0.5 | |||
Manufacturing footprint optimization | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Total restructuring charges | 0 | $ 1.1 | $ 3.1 | ||
Price Road Facility in Chandler, Arizona | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Net book value of assets held-and-used | $ 13.1 | ||||
Suzhou, China Facilities | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Carrying value of property | 3 | ||||
Proceeds from sale of buildings | $ 6.8 |
Supplemental Financial Inform_5
Supplemental Financial Information (Schedule of Severance and Related Benefits Activity) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Restructuring Reserve [Roll Forward] | |||
Provisions | $ 16.9 | $ 1.5 | $ 3.1 |
Severance and Related Benefits | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 0 | ||
Provisions | 8.5 | ||
Payments | (8.6) | ||
Foreign currency translation adjustment | 0.1 | ||
Ending balance | $ 0 | $ 0 |
Supplemental Financial Inform_6
Supplemental Financial Information (Allocation of Restructuring and Impairment Charges to Operating Segments) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring and impairment charges | $ 16.9 | $ 66.6 | $ 3.6 |
Allocated restructuring charges | Advanced Electronics Solutions | |||
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring and impairment charges | 10.7 | 1.1 | 3 |
Allocated restructuring charges | Elastomeric Material Solutions | |||
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring and impairment charges | 6.2 | 0.4 | 0.1 |
Allocated impairment charges | Advanced Electronics Solutions | |||
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring and impairment charges | 0 | 40.5 | 0.5 |
Allocated impairment charges | Elastomeric Material Solutions | |||
Restructuring Cost and Reserve [Line Items] | |||
Total restructuring and impairment charges | $ 0 | $ 24.6 | $ 0 |
Supplemental Financial Inform_7
Supplemental Financial Information (Schedule of Components of Other Operating (Income) Expense, Net) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
UTIS fire | |||
Fixed assets write-offs | $ 0 | $ 0 | $ 1.1 |
Inventory charges | 0 | 0.2 | 0.9 |
Professional services | 0.9 | 1.4 | 2.7 |
Lease obligations | 0 | 0.4 | 1 |
Lease impairments | 0 | 0 | 0.5 |
Compensation & benefits | 0 | 2.4 | 2.1 |
Third-party property claims | 0 | 0 | 4.7 |
Other | 0 | (0.2) | 0.1 |
Insurance recoveries | (31.4) | (6.6) | (6.9) |
Total UTIS fire | (30.5) | (2.4) | 6.2 |
Regulatory termination fee, net | 0 | (142.1) | 0 |
Loss (gain) on sale or disposal of property, plant and equipment | (2.6) | 0.5 | (0.9) |
Total other operating (income) expense, net | $ (33.1) | $ (144) | $ 5.3 |
Supplemental Financial Inform_8
Supplemental Financial Information (Schedule of Components of Interest Expense, Net) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Supplemental Income Statement Elements [Abstract] | |||
Interest on revolving credit facility | $ 9.6 | $ 9 | $ 0.9 |
Line of credit fees | 0.8 | 0.5 | 1.1 |
Debt issuance amortization costs | 0.7 | 0.7 | 0.7 |
Interest income | (1.2) | (0.7) | (0.5) |
Other | 0.2 | 0 | 0.4 |
Total interest expense, net | $ 10.1 | $ 9.5 | $ 2.5 |
Income Taxes (Schedule of Conso
Income Taxes (Schedule of Consolidated Income (loss) from Continuing Operations Before Income Taxes by Location) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ 9.1 | $ 58.4 | $ 34.4 |
Foreign | 67.2 | 82 | 91.9 |
Income before income tax expense | $ 76.3 | $ 140.4 | $ 126.3 |
Income Taxes (Schedule of Incom
Income Taxes (Schedule of Income Tax Expense (Benefit) by Location) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Current | |||
Domestic | $ 0.4 | $ 26.8 | $ 5.2 |
Foreign | 22.9 | 17.6 | 16.2 |
Total | 23.3 | 44.4 | 21.4 |
Deferred | |||
Domestic | (0.6) | (18.8) | (2.9) |
Foreign | (3) | (1.8) | (0.3) |
Total | (3.6) | (20.6) | (3.2) |
Total | |||
Domestic | (0.2) | 8 | 2.3 |
Foreign | 19.9 | 15.8 | 15.9 |
Total | $ 19.7 | $ 23.8 | $ 18.2 |
Income Taxes (Schedule of Defer
Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Deferred tax assets | ||||
Accrued employee benefits and compensation | $ 7.7 | $ 8.7 | ||
Net operating loss carryforwards | 11.8 | 4.4 | ||
Tax credit carryforwards | 6.7 | 2.8 | ||
Reserves and accruals | 5.7 | 4.7 | ||
Operating leases | 3.6 | 4.2 | ||
Capitalized research and development | 25.6 | 21.3 | ||
Other | 6.9 | 10.2 | ||
Total deferred tax assets | 68 | 56.3 | ||
Less deferred tax asset valuation allowance | (11.4) | (2.8) | $ (9.8) | $ (9.3) |
Total deferred tax assets, net of valuation allowance | 56.6 | 53.5 | ||
Deferred tax liabilities | ||||
Depreciation and amortization | 17.7 | 14.4 | ||
Postretirement benefit obligations | 0.7 | 0.7 | ||
Unremitted earnings | 1.5 | 2.6 | ||
Operating leases | 4.1 | 4.6 | ||
Other | 5.8 | 4.2 | ||
Total deferred tax liabilities | 29.8 | 26.5 | ||
Net deferred tax asset (liability) | $ 26.8 | $ 27 |
Income Taxes (Additional Inform
Income Taxes (Additional Information) (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Examination [Line Items] | ||||
State operating loss carryforwards | $ 8.1 | |||
Deferred tax asset valuation allowance | 11.4 | $ 2.8 | $ 9.8 | $ 9.3 |
Foreign tax credits | 3.1 | |||
Foreign, operating loss, carryforwards | $ 52.7 | |||
Effective income tax rate (as a percent) | 25.80% | 16.90% | ||
Deferred tax liability that may result from distribution of undistributed earnings | $ 2.6 | |||
Unrecognized tax benefits that would impact effective tax rate | 6.9 | |||
Unrecognized tax benefits, income tax penalties and interest accrued | 1.4 | $ 1.1 | ||
State and Local Jurisdiction | ||||
Income Tax Examination [Line Items] | ||||
Tax credit carryforwards, research | 3.6 | |||
Deferred tax asset valuation allowance | 1.5 | |||
Federal | ||||
Income Tax Examination [Line Items] | ||||
Tax credit carryforwards, research | 0.8 | |||
Luxembourg Inland Revenue | ||||
Income Tax Examination [Line Items] | ||||
Foreign, operating loss, carryforwards | 31.4 | |||
Operating loss carryforwards, subject to expiration | 3.9 | |||
China | ||||
Income Tax Examination [Line Items] | ||||
Deferred tax assets valuation allowance expired amount | 14.7 | |||
Deferred tax liabilities, undistributed foreign earnings | 1.5 | $ 2.5 | ||
Korea | ||||
Income Tax Examination [Line Items] | ||||
Deferred tax assets valuation allowance expired amount | $ 6.6 |
Income Taxes (Schedule of Effec
Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Tax expense at Federal statutory income tax rate | $ 16 | $ 29.5 | $ 26.5 |
Impact of foreign operations | 4 | 1.5 | 2 |
Foreign source income, net of tax credits | (2.3) | (6.5) | (4.9) |
State tax, net of federal | (0.5) | 6.9 | 0.2 |
Deferred tax adjustment | 1.2 | 0 | 0 |
Unrecognized tax benefits | (0.2) | 1.9 | (8.8) |
Equity compensation excess tax deductions | 0.3 | (3) | 0.3 |
General business credits | (2.4) | (0.8) | (0.9) |
Distribution related foreign taxes | 1.1 | 1.5 | 2.5 |
Executive compensation limitation | 0.9 | 2.9 | 1.6 |
Valuation allowance change | 0.7 | (6.9) | 0.5 |
Other | 0.9 | (3.2) | (0.8) |
Total | $ 19.7 | $ 23.8 | $ 18.2 |
Income Taxes (Schedule of Recon
Income Taxes (Schedule of Reconciliation of Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Beginning balance as of January 1 | $ 8.9 | $ 6.6 | $ 15.7 |
Gross increases - current period tax positions | 1.1 | 3.4 | 1 |
Gross increases - tax positions in prior periods | 0 | 0.2 | 1.2 |
Gross decreases - tax positions in prior periods | (0.5) | (0.2) | (9.2) |
Foreign currency exchange | 0.1 | (0.1) | 0 |
Settlements | 0.1 | ||
Settlements | (1) | (2.1) | |
Lapse of statue of limitations | (1.2) | 0 | 0 |
Ending balance as of December 31 | $ 8.5 | $ 8.9 | $ 6.6 |
Mergers and Acquisitions (Addit
Mergers and Acquisitions (Additional Information) (Details) - USD ($) $ in Millions | 1 Months Ended | ||
Nov. 01, 2022 | Oct. 08, 2021 | Apr. 30, 2022 | |
Business Acquisition [Line Items] | |||
Business combination, holdback period | 6 months | ||
Business combination, payments for extension of holdback period | 6 months | ||
DuPont de Nemours, Inc | |||
Business Acquisition [Line Items] | |||
Proceeds from contract termination | $ 162.5 | ||
Contract termination, transaction fee | $ 20.4 | ||
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | |||
Business Acquisition [Line Items] | |||
Borrowings under credit facility | $ 190 | ||
Silicone Engineering Ltd. | |||
Business Acquisition [Line Items] | |||
Combined purchase price | 172.3 | ||
Holdback amount | $ 4.1 | $ 1.3 |
Mergers and Acquisitions (Sched
Mergers and Acquisitions (Schedule of Pro-Forma Information) (Details) - Silicone Engineering Ltd. $ in Millions | 12 Months Ended |
Dec. 31, 2021 USD ($) | |
Business Acquisition [Line Items] | |
Net sales | $ 973.2 |
Net income | $ 120.1 |
Schedule II (Details)
Schedule II (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Valuation on Allowance for Deferred Tax Assets | |||
Balance at Beginning of Period | $ 2.8 | $ 9.8 | $ 9.3 |
Charged to (Reduction of) Costs and Expenses | 0.7 | 0.4 | 0.5 |
Taken Against Allowance | 7.9 | (7.3) | 0 |
Other (Deductions) Recoveries | 0 | 0 | 0 |
Balance at End of Period | 11.4 | 2.8 | 9.8 |
Allowance for Credit Losses | |||
Allowance for Credit Losses | |||
Balance at Beginning of Period | 1 | 1.2 | 1.7 |
Charged to (Reduction of) Costs and Expenses | 0.4 | 0.2 | 0.4 |
Taken Against Allowance | 0 | (0.4) | (0.2) |
Other (Deductions) Recoveries | (0.3) | 0 | (0.7) |
Balance at End of Period | 1.1 | 1 | 1.2 |
Inventory E&O Reserves | |||
Allowance for Credit Losses | |||
Balance at Beginning of Period | 17 | 16.4 | 22.4 |
Charged to (Reduction of) Costs and Expenses | 14 | 8.2 | 8.4 |
Taken Against Allowance | (5.1) | (4.6) | (7.4) |
Other (Deductions) Recoveries | (3.9) | (3) | (7) |
Balance at End of Period | $ 22 | $ 17 | $ 16.4 |